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ABSTRACT 
 
Biomarkers of oxidative stress, inflammation and endothelial function to study the role of 
blueberry bioactive compounds in vitro and in vivo 
 
Chronic and degenerative diseases, such as cardiovascular disease, are drastically increasing in 
Western Countries with serious economic penalties on health care management. As a consequence, 
there is a strong demand for preventive strategies that can be easily applied by the majority of the 
population. Diet is one of the most important lifestyle factors able to decrease the risk of 
degenerative diseases but also to reduce the complications associated with aberrant metabolic states 
or already established disorders. Besides the recognised biological properties of many bioactive 
compounds, widely distributed in fruit and vegetable, little is known on their mechanisms of action 
and potential synergistic or antagonistic effects. This is partially due to the paucity of well-designed 
dietary intervention studies, able to demonstrate, through sensitive and reproducible biomarkers, 
their physiological and biochemical role.  
Biomarkers can describe indirectly various levels of exposure, functional effects and pathological 
endpoints. While there is no known biomarker that bridges the gap between the intake and endpoint, 
the increase in knowledge regarding functional alterations of specific biomolecules can bring this 
possibility even closer. In this regard, an ambitious goal should be the development of reference 
protocols in which the most reliable, accurate and sensitive biosensors and biomarkers are selected 
in order to study prevention approaches through diet. The objective of the PhD thesis was to study 
the effect of blueberry and its bioactives in the modulation of biomarkers of oxidative stress, 
inflammation and endothelial function through in vitro and in vivo approaches.  
In this context, it is important to identify reliable and reproducible biomarkes able to respond to 
dietary treatment. So, the first part of the thesis was focused on the methodological issue with the 
aim:   
1- to test the reproducibility of DNA damage, as marker of oxidative stress, measured by 
comet assay. In particular two different biomarkers, endogenous and oxidatively induced 
DNA damage, were evaluated in fresh versus cryopreserved human peripheral blood 
mononuclear cells (PBMCs) obtained from volunteers included in a 6-week blueberry 
intervention. This information is critical to assess the suitability of the analysis of these 
biomarkers in stored biological samples;  
2- to test the intra and inter-day reproducibility of the endothelial function, measured as 
Reactive Hyperemia Index (RHI) in a group of volunteers. RHI was evaluated through 
Endo-PAT2000, a non-invasive device that exploits biosensor technology to measure 
endothelial-dependent vasodilation following occlusion of the brachial artery which causes 
an increased signal of peripheral arterial tone. The reproducibility of this measure is very 
important to enable the development of adequate experimental protocols and to reduce 
potential confounding factors that may mask or under/over-estimate the effect of a 
treatment.  
In the whole, the results obtained demonstrated differences in the levels of DNA damage between 
fresh and cryopreserved PBMCs. In particular, in fresh cells we documented a reduction of 
endogenous and oxidatively induced DNA damage following 6-week blueberry intervention. 
Conversely, in cryopreserved cells the protective effect of blueberry was confirmed only when the 
levels of DNA damage were evaluated as endogenous damage (FPG sensitive sites). 
Cryopreservation increased the baseline levels of DNA damage with respect to fresh cells but 
caused an improvement of cell resistance to oxidative stress nullifying the treatment effect.  
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Concerning the intra and inter-day reproducibility of RHI, we documented that multiple 
measurements of endothelial function within the day is related with an increase in RHI response. 
This transient effect may be attributed to production of vasodilators that may eventually mask 
improvement of vascular function due to the treatment under study (i.e. overestimation). On the 
contrary, a low inter-day variability in RHI response was observed. 
 
The second part of the thesis was devoted to study the ability of dietary components, in particular 
blueberry polyphenols, to modulate several biomarkers. Firstly the bioavailability of blueberry 
bioactive compounds was investigated in two different products; subsequently, acute and chronic 
studies on subjects exposed to risk factors for cardiovascular disease (i.e. smoking, endothelial 
dysfunction, etc) were developed to investigate the impact of dietary treatments in the modulation of 
the biomarkers under study. In particular, markers of oxidative stress (e.g. DNA damage), 
inflammation (pro-inflammatory cytokines) and endothelial function (nitric oxide production, RHI, 
arterial stiffness) were evaluated.  
We documented that blueberry bioactives, in particular anthocyanins (ACNs), were bioavailable 
both in blanched and unblanched products even if a higher absorption of ACNs was observed at 
specific time points after the intake of blanched product. Overall, the different dietary interventions 
(acute and chronic) performed, demonstrated a significant reduction in the levels of DNA damage. 
Moreover, the consumption of blueberry had a beneficial effect on endothelial function. In 
particular, the 6-week blueberry consumption showed a subject-related effect on endothelial 
function, with half of the volunteers (those with impaired endothelial function or smokers) 
registering an improvement of RHI. In this regard, the intake of a single portion of blueberry was 
able to reverse endothelial dysfunction induced by acute cigarette smoking.  
No significant effect of long term blueberry intake was observed on markers of inflammation 
considered. 
 
The last part of the thesis was performed at the University of Copenhagen and focused on the 
potential antiatherogenic and antiatherosclerotic effect of different fractions extracted from the wild 
blueberry powder rich in ACNs and phenolic acids. In particular, we tested the ability of the ACN 
and phenolic fractions, as well as the single ACNs and their metabolites, to reduce lipid 
accumulation in THP-1 macrophages, and to counteract THP-1 attachment to endothelial cells 
(HUVEC cell line) following stimulation with pro-inflammatory cytokines.  
We observed that both the fractions and single compounds were able to reduce lipid accumulation 
even if a significant type of treatment/dose interaction was observed. In fact the ACNs fraction was 
effective at all the doses tested, while the phenolic fraction only at low concentration. Moreover, 
supplementation with single compounds showed different effects depending on the type of molecule 
considered suggesting a possible synergistic effect when mix of compounds is present. Regarding 
the anti-atherosclerotic effect, the ACN fraction was able to reduce THP-1 attachment to HUVEC 
cells only at the highest dose while low doses of the phenolic fraction was necessary to observe a 
beneficial effect. 
 
In conclusion, through this PhD thesis it was possible to add important results concerning the 
suitability and reliability of several biomarkers and biosensors of endothelial function exploited in 
dietary intervention studies to demonstrate the protective effect of foods/bioactives.  
Moreover, the in vivo studies developed could supported the beneficial role of blueberry and its 
bioactives in the modulation of biomarkers of oxidative stress and endothelial function in at risk 
subjects. In addition, the potential antiatherogenic and antiatherosclerotic effect of blueberry 
bioactives was supported by the exploited in vitro approach. Future in vitro studies will focus on the 
specific mechanisms involved in such modulation. 
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RIASSUNTO 
 
Biomarkers of oxidative stress, inflammation and endothelial function to study the role of 
blueberry bioactive compounds in vitro and in vivo 
 
Le malattie cronico degenerative, come le malattie cardiovascolari, sono drasticamente in aumento 
nei Paesi occidentali con un grave impatto economico sul sistema sanitario. Di conseguenza vi è una 
forte richiesta da parte delle istituzioni di strategie preventive facilmente applicabili alla 
popolazione. La dieta è senza dubbio uno dei più importanti fattori in grado di ridurre il rischio di 
sviluppare malattie degenerative e le complicazioni ad esse associate. Nonostante le numerose 
riconosciute proprietà biologiche ascrivibili ai composti bioattivi presenti in frutta e verdura, poco si 
conosce circa i loro meccanismi d'azione ed i potenziali effetti sinergici o antagonistici. Questa 
mancanza è in parte attribuita alla carenza di studi di intervento controllati in grado di dimostrare, 
attraverso l'utilizzo di biomarker sensibili e riproducibili, il ruolo fisiologico e biochimico dei 
composti bioattivi. 
Ad oggi pochi sono i biomarker primari riconosciuti in grado di provare la relazione tra esposizione 
alla dieta ed endpoint di malattia. Pertanto, l'aumento delle conoscenze in materia di alterazioni 
funzionali ad opera di molecole biologiche specifiche può contribuire a migliorare le conoscenze a 
riguardo. Un obiettivo ambizioso dovrebbe essere lo sviluppo di protocolli di riferimento in cui 
vengano selezionati biosensori e biomarker in grado di rispondere in modo affidabile, accurato e 
sensibile ad un trattamento dietetico.  
L’obiettivo della presente tesi di dottorato è stato quello di studiare il ruolo del mirtillo, e dei suoi 
composti bioattivi, nella modulazione di biomarker di stress ossidativo, infiammazione e funzione 
attraverso approcci in vitro e in vivo. 
Pertanto la prima parte della tesi è stata focalizzata su alcuni approcci metodologici con l'obiettivo 
di:  
 
1 - testare la riproducibilità del danno al DNA, quale marker di stress ossidativo, attraverso 
l’utilizzo del saggio comet. A tal riguardo sono stati considerati due diversi biomarker quali la 
valutazione del danno indotto ex vivo mediante acqua ossigenata, e quella del danno endogeno. 
L’analisi della riproducibilità è stata condotta in campioni di linfociti (PBMC) freschi e 
congelati ottenuti da volontari in seguito a trattamento per 6 settimane con mirtillo. Questa 
informazione è importante per stabilire la possibilità di utilizzare questi biomarker in campioni 
biologici conservati;  
 
2 - testare la riproducibilità della funzione endoteliale, misurata come indice di iperemia 
reattiva (RHI), valutata all'interno della stessa giornata e in giornate diverse in un gruppo di 
volontari. La funzione endoteliale è stata valutata attraverso l'uso del sistema Endo-PAT2000, 
un dispositivo non invasivo che sfrutta la tecnologia del biosensore per misurare la 
vasodilatazione endotelio- dipendente del tono arterioso periferico in seguito all'occlusione 
dell'arteria brachiale. La riproducibilità di questa misura è molto importante al fine di 
consentire lo sviluppo di adeguati protocolli sperimentali, e di ridurre i potenziali fattori 
confondenti che possono mascherare, attraverso una sotto/sovrastima l'effetto di un 
trattamento. 
 
In generale, i risultati ottenuti hanno dimostrato delle differenze nei livelli di danno al DNA tra 
cellule fresche e congelate. In particolare, nei campioni freschi abbiamo osservato una riduzione dei 
livelli di danno endogeno ed indotto (mediante acqua ossigenata) in seguito al consumo per sei 
settimane di mirtillo. Al contrario, nelle cellule sottoposte a congelamento l’effetto protettivo con il 
mirtillo è stato confermato solo con la valutazione del danno endogeno. Il congelamento ha 
Riassunto 
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aumentato i livelli basali di danno al DNA, e al tempo stesso ha indotto una maggiore resistenza 
cellulare al danno ossidativo annullando l’effetto del trattamento con mirtillo.   
 
Per quanto riguarda la riproducibilità della funzione endoteliale (RHI), abbiamo documentato che 
misurazioni ripetute all'interno della stessa giornata portavano ad un miglioramento della risposta 
endoteliale funzione. Questo effetto, seppur transitorio, potrebbe essere attribuito alla continua 
produzione di sostatnze vasodilatatorie che potrebbero mascherare l’effetto di un intervento 
dietetico.  
Una più bassa variabilità della funzione endoteliale è stata invece riscontrata nelle misurazioni 
eseguite in giornate diverse.  
 
Nella seconda parte della tesi è stata valutato l’effetto in vivo di alcuni componenti della dieta, in 
particolare i polifenoli del mirtillo.  
In primo luogo abbiamo valutato la biodisponibilità dei composti bioattivi in due differenti prodotti 
di mirtillo (prodotto tal quale e prodotto sottoposto a “blanching”); successivamente, sono stati 
utilizzati alcuni approcci di intervento in acuto e in cronico per studiare l’effetto dei trattamenti 
dietetici nella modulazione di biomaker in soggetti esposti a fattori di rischio cardiovascolare (es. 
fumo, disfunzione endoteliale, ecc.). In particolare sono stati valutati marker di stress ossidativo (es. 
danno al DNA), infiammazione (citochine pro-infiammatorie), e funzione endoteliale (ossido 
nitrico, RHI, rigidità arteriosa).  
Abbiamo documentato che la componente polifenolica, in particolare gli antociani, erano 
biodisponibili da entrambi i prodotti di mirtillo, anche se è stato osservato un maggiore 
assorbimento degli antociani, a specifici tempi, dopo il consumo del prodotto che ha subito il 
trattamento di blanching. Gli interventi dietetici in acuto e in cronico hanno mostrato una riduzione 
significativa dei livelli di danno al DNA. Inoltre, il consumo di mirtillo ha avuto un importante 
effetto nella modulazione della funzione endoteliale. In particolare, in acuto è stato dimostrato che 
una porzione di mirtillo era in grado di contrastare la disfunzione endoteliale indotta dal fumo di 
una sigaretta, mentre nello studio in cronico, il consumo per 6 settimane di mirtillo ha mostrato un 
miglioramento della funzione endoteliale su circa la metà dei soggetti. Nessun effetto significativo è 
stato invece osservato sui marker di infiammazione valutati. 
 
L'ultima parte della tesi, svolta presso l'Università di Copenhagen, ha avuto come obiettivo la 
valutazione del potenziale effetto antiaterogenico e antiaterosclerotico di alcune frazioni estratte da 
un liofilizzato di mirtillo selvatico ricco in antociani e composti fenolici. In particolare, abbiamo 
testato la capacità delle frazioni (antociani e fenoli), nonché dei singoli antociani e corrispettivi 
metaboliti, di ridurre l'accumulo di lipidi  in cellule THP-1, e di contrastare l'adesione di 
quest’ultime alle cellule endoteliali (HUVEC) in seguito alla stimolazione con citochine pro-
infiammatorie. 
I risultati della ricerca hanno evidenziato che entrambe le frazioni ed i singoli composti erano in 
grado di ridurre l'accumulo di lipidi, anche se tale effetto risultava dipendente dal tipo di trattamento 
e dalla dose di composto utilizzata. Infatti, mentre la frazione degli antociani risultava efficace a 
tutte le dosi testate, quella fenolica solo alle basse concentrazioni. Inoltre, la supplementazione con i 
singoli composti mostrava effetti differenti legati al tipo di molecola utilizzata, suggerendo un 
potenziale effetto sinergico esercitato dei composti presenti nelle frazioni. 
Per quanto riguarda la capacità di ridurre l'adesione dei monociti alle cellule endoteliali, è stato 
dimostrato che la frazione degli antociani risultava attiva solo alle dosi maggiori, mentre la frazione 
fenolica alle dosi più basse.  
 
In conclusione, attraverso questa tesi di dottorato è stato possibile aggiungere importanti risultati 
riguardanti l'adeguatezza e l'affidabilità di biomarker e biosensori utilizzati negli studi di intervento 
dietetico per dimostrare l'effetto in vivo di alimenti / componenti bioattivi.  
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Dagli studi in vivo effettuati emergono risultati positivi circa il ruolo del mirtillo e dei suoi composti 
bioattivi nella modulazione dello stress ossidativo e della funzione endoteliale nei soggetti esposti a 
fattori di rischio.  
I modelli sviluppati in vitro mostrano inoltre il potenziale effetto antiaterogenico e 
antiaterosclerotico dei composti bioattivi, i cui potenziali meccanismi d'azione saranno oggetto dei 
prossimi studi. 
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ABBREVIATIONS 
 
ACNs, anthocyanins;  
AI, augmentation index;  
AI@75, augmentation index standardized for heart rate of 75 bpm;  
ANOVA, analysis of variance;  
AOAC, association of official analytical chemists;  
ALT, alanine aminotransferase;  
Ara, arabinoside; 
AST, aspartate aminotransferase;  
BAUS, brachial artery ultrasound scanning; 
BB, blueberry;  
BL-P, blanched purée 
BMI, body mass index;  
C3GE, cyanidin 3-glucoside equivalents; 
 
CI, confidence interval;  
CJ, control jelly; 
CRP, C-reactive protein;  
CVD, cardiovascular disease;  
Cy, cyanidin; 
CydG, cyanidin-3,5-diglucoside; 
dAix, digital augmentation index;  
dAix@75, digital augmentation index normalized for the heart rate;  
DiBP, diastolic blood pressure;  
DMSO, dimethyl sulfoxide; 
Dp, delphinidin; 
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ED, endothelial dysfunction;  
EDHF, endothelium-derived hyperpolarizing factor; 
EDTA, ethylenediaminetetraacetic acid; 
ENDOIII, endonuclease III; 
eNOS, endothelial NO synthase; 
ELISA, enzyme-linked immunosorbance assays; 
FBS, fetal bovine serum; 
FMD, flow mediated dilation;  
FPG, formamidopyrimidine DNA glycosylase;  
FRHI, Framingham reactive hyperemia index;  
GAE, gallic acid equivalent;  
Gal, galactoside; 
GC-MS, gas chromatography–mass spectrometry;  
GGT, gamma-glutamyltransferase;  
Glc, glucoside; 
GSH, reduced glutathione;  
GSH-Px, glutathione peroxidase;  
GSSG, oxidized glutathione;  
GST, glutathione S-transferase;  
H2O2, hydrogen peroxide; 
HDL-C, high density lipoprotein; cholesterol; 
HepG2, human hepatocellular liver carcinoma cell line; 
HPLC, high performance liquid chromatography;  
HPLC-EC, high performance liquid cromatography- electrochemical detection;  
HR, heart rate;  
hs-CRP, high sensitive C-reactive protein; 
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HUVEC, human umbilical venous endothelial cells;  
ICAM-1, intercellular cell adhesion molecule-1; 
IL-6, interleukin-6;  
IkB, inhibitor kappa B; 
IQF, individually quick frozen;  
IS, internal standard; 
IsoPs, isoprostanes; 
LC-DAD-MS/MS; liquid chromatography-diode array detector-mass spectrometry; 
LDL-C, low density lipoprotein cholesterol;  
LMP, low melting point; 
LPS, lipopolysaccharide; 
LSD, least significant difference;  
MAP, monomeric anthocyanin pigment; 
MDA, malonildialdehyde; 
MMP, metalloproteinases; 
MPA, metaphosphoric acid; 
Mv, malvidin; 
NB-P, unblanched purée 
NO, nitric oxide;  
NF-κB, nuclear factor kappa B; 
NMP, normal melting point; 
Ogg1, 8-Oxoguanine DNA glycosylase (Ogg1); 
PAT, peripheral arterial tone;  
PBMC, peripheral blood mononuclear cell;  
PBS, phosphate buffer saline;  
PC, polymeric color; 
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Pn, peonidin; 
PMA, phorbol 12-myristate 13-acetate;  
Pt, petunidin; 
RHI, reactive hyperemia index;  
ROS, reactive oxygen species; 
SD, standard deviation;  
SEM, standard error of the mean;  
SOD, superoxide dismutase;  
SPE, solid phase extraction;  
sVCAM-1, soluble vascular adhesion molecule-1;  
TFA, trifluoroacetic acid; 
THP-1, Human acute monocytic leukemia cell line; 
TNF-α, tumor necrosis factor alpha;  
TG, triglycerides;  
TPC, total phenolic content; 
TSC, total serum cholesterol;  
UHPLC-MS/MS, ultra high pressure liquid chromatography-mass spectrometry;  
VEGF, vascular endothelial growth factor; 
WB, wild blueberry; 
8-oxo-dG, 8-oxo-2'-deoxyguanosine. 
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0. PREFACE 
 
Lifestyle and dietary habits are considered the major risk factors in the development and 
progression of degenerative diseases (Mozaffarian et al., 2008; Ignarro et al., 2007; Sofi et al., 
2005). Several epidemiological studies showed an inverse association between the intake of fruit 
and vegetable and chronic diseases (Hartley et al., 2013; Schwenke et al., 2013; Hung et al., 2004; 
Bazzano et al., 2003). This can be attributed to the high content of nutrients and non-nutritive food 
constituents that could play an important role in the disease prevention. In fact, long-term, large-
scale, population-based cohort studies have found that high levels of blood vitamin E, vitamin C, 
folate and carotenoids were associated with a lower risk of cardiovascular disease (CVD) (Stradling 
et al., 2013; Wang et al., 2013; Riccioni et al., 2012; Núñez-Córdoba et al., 2011; Verhaar et al., 
2002). In addition, regular consumption of dietary fiber, particularly from cereal and vegetable 
sources, may improve CVD health through multiple mechanisms including lipid reduction, body 
weight regulation, improved glucose metabolism, blood pressure control, and reduction of chronic 
inflammation (Cho et al., 2013; Bernstein et al., 2013; Satija & Hu 2012). Also polyphenols, widely 
distributed in foods such as tea, coffee, cocoa, olive oil, and berries have been associated to a 
reduction of chronic and CVD (Estruch et al., 2013; Del Rio et al., 2013; Di Castelnuovo et al., 
2013; Tresserra-Rimbau et al., 2013; Lou-Bonafonte et al., 2012; Ros 2012; Chong et al., 2010). 
Historically, biological actions of polyphenols have been attributed to antioxidant activities, but 
recent evidence suggests that immunomodulatory and vasodilatory properties of polyphenols may 
also contribute to CVD risk reduction (Santhakumar et al., 2013; Wallace 2011; Visioli & Davalos 
2011; Scalbert et al., 2005). 
On the base of these premises, it is widely supported the recommendation of consuming five or 
more servings of fruit and vegetable per day (Heimendinger et al., 1996). This information provides 
important basis to judge the preventive potential of a diet rich in fruit and vegetable. In fact, 
exploring the role of diet and more specifically the effect of nutrients and non-nutrients on the 
metabolic processes of disease is critical in designing public health directives for population 
approaches to preventing diseases.  
Biomarkers are useful tools used in nutrition science to estimate the effect of nutrition interventions 
on health outcomes, when these are not directly measurable. However the availability and 
development of more “direct” and non-invasive biomarkers and biosensors is required. 
Biomarkers are defined as a characteristic that is objectively measured and evaluated as an indicator 
of normal biologic processes, pathogenic processes, or pharmacologic responses to a therapeutic 
intervention (Strimbu & Tavel 2010). Biomarkers such as those of DNA damage and repair, lipid 
and protein oxidation, inflammation, have been used in animal and human studies in order to 
evaluate the effects of different treatments both for preventive and therapeutic purposes.  
However, the choice of a biomarker able to respond to a dietary treatment is not easy. In particular it 
is important to think about the purpose of the study and the biologic relationship of the biomarker 
with dietary intake. The current state of knowledge should be evaluated not only for selecting an 
appropriate biomarker, but also in assessing how to evaluate the biomarker appropriately.  
As of today, there is a lack of scientific consensus in the validation of markers in nutrition research 
and this represents one of the difficulties encountered in dietary intervention studies but also in the 
preparation of health claim dossiers for the functional foods.  
The aim of the present PhD thesis is to study the role of polyphenol-rich foods, in particular 
blueberries, in the modulation of biomarkers of oxidative stress, inflammation and endothelial 
function through in vitro and in vivo approaches. 
 
Thus, the research project can be subdivided into three different activities as described below. 
1- selection and application of biomarkers and biosensors of oxidative stress and endothelial 
function to test the feasibility, sensitivity, and reproducibility following a short term 
dietary treatment. In particular, it will be assessed the reproducibility of the levels of cell 
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DNA damage (evaluated as endogenous and oxidatively induced damage by comet assay), 
as marker of oxidative stress. Moreover, it will be test the feasibility, sensitivity and 
intra/inter-day reproducibility of the reactive hypermia index, as marker of endothelial 
function, evaluated by mean of an innovative and noninvasive biosensor named Endo-
PAT2000. 
 
2- Study of the bioavailability of blueberry bioactive compounds and their role in the 
modulation of several makers. In particular: 
 absorption and excretion of bioactive compounds (i.e. ACNs) from different 
blueberry products in a group of young human volunteers;  
 development of acute studies to evaluate the effect of a single portion of blueberry 
in the modulation of markers of oxidative stress, inflammation and endothelial 
function in young non-smoker and smoker volunteers;  
 development of a dietary intervention study to evaluate the effect of 6-week 
blueberry consumption on markers of oxidative stress, inflammation and 
endothelial function, in subjects with risk factors for cardiovascular disease. 
 
3- Role of the potential antiatherogenic and antiatherosclerotic effect of different polyphenol-
rich fractions through an in vitro approach. To this aim, two different cells models will be 
used: human monocytic (THP-1) cell line, and human umbilical venous endothelial cells 
(HUVECs). The first model will be used to evaluate the capacity of polyphenol-rich 
fractions to reduce lipid accumulation (antiatherogenic effect); while the second one to 
assess whether polyphenol-rich fractions will be able to reduce THP-1 cells adhesion to 
HUVECs following stimulation with pro-inflammatory cytokines (antiatherosclerotic 
effect). 
 
 
 
 
 
 
 
 
 
 
 
 
Abbreviations 
___________________________________________________________________ 
 
 
21 
0.1 REFERENCES 
 
 Bernstein AM et al., 2013, Major cereal grain fibers and psyllium in relation to 
cardiovascular health. Nutrients 5:1471-87. 
 
 Cho SS et al., 2013, Consumption of cereal fiber, mixtures of whole grains and bran, and 
whole grains and risk reduction in type 2 diabetes, obesity, and cardiovascular disease. Am 
J Clin Nutr 98:594-619. 
 
 Chong MF et al., 2010, Fruit polyphenols and CVD risk: a review of human intervention 
studies. Br J Nutr 104 Suppl 3:S28-39. 
 Del Rio D et al., 2013, Dietary (poly)phenolics in human health: structures, bioavailability, 
and evidence of protective effects against chronic diseases. Antioxid Redox Signal 
18:1818-92. 
 Di Castelnuovo A et al., 2012, Consumption of cocoa, tea and coffee and risk of 
cardiovascular disease. Eur J Intern Med 23:15-25. 
 
 Estruch R et al., 2013, Primary prevention of cardiovascular disease with a Mediterranean 
diet. N Engl J Med 368:1279-90. 
 
 Hartley L et al., 2013, Increased consumption of fruit and vegetables for the primary 
prevention of cardiovascular diseases. Cochrane Database Syst Rev 6:CD009874. doi: 
10.1002/14651858.CD009874.pub2. 
 
 Heimendinger J et al., 1996, The national 5 A Day for Better Health Program: a large-scale 
nutrition intervention. J Public Health Manag Pract 2:27-35. 
 
 Hung HC et al., 2004, Fruit and vegetable intake and risk of major chronic disease. J Natl 
Cancer Inst 96:1577-84. 
 
 Ignarro LJ et al., 2007, Nutrition, physical activity, and cardiovascular disease: an update. 
Cardiovasc Res 73:326-40. 
 
 Mozaffarian D et al., 2008, Beyond established and novel risk factors: lifestyle risk factors 
for cardiovascular disease. Circulation 117:3031-8.  
 
 Núñez-Córdoba JM, Martínez-González MA et al., 2011, Antioxidant vitamins and 
cardiovascular disease. Curr Top Med Chem 11:1861-9. 
 
 Riccioni G et al., 2012, Carotenoids and vitamins C and E in the prevention of 
cardiovascular disease. Int J Vitam Nutr Res 82:15-26. 
 
 Ros E. 2012, Olive oil and CVD: accruing evidence of a protective effect. Br J Nutr 
108:1931-3.  
 
 Santhakumar AB et al., 2013, A review of the mechanisms and effectiveness of dietary 
polyphenols in reducing oxidative stress and thrombotic risk. J Hum Nutr Diet doi: 
10.1111/jhn.12177. 
 
Abbreviations 
___________________________________________________________________ 
 
 
22 
 Satija A, Hu FB, 2012, Cardiovascular benefits of dietary fiber. Curr Atheroscler Rep 
14:505-14. 
 
 Scalbert A et al., 2005, Dietary polyphenols and the prevention of diseases. Crit Rev Food 
Sci Nutr 45:287-306. 
 
 Schwenke DC. 2013, Focus on fruits and vegetables to reduce cardiovascular disease and 
all-cause mortality. Curr Opin Lipidol 24:526-7. 
 
 Sofi F et al., 2005, Dietary habits, lifestyle and cardiovascular risk factors in a clinically 
healthy Italian population: the 'Florence' diet is not Mediterranean. Eur J Clin Nutr 59:584-
91. 
 
 Stradling C et al., 2013, A review of dietary influences on cardiovascular health: Part 1: the 
role of dietary nutrients. Cardiovasc Hematol Disord Drug Targets.  
 
 Strimbu K, Tavel JA. 2010, What are biomarkers? Curr Opin HIV AIDS 5:463-6. 
 
 Tresserra-Rimbau A et al., 2013, Dietary intake and major food sources of polyphenols in a 
Spanish population at high cardiovascular risk: the PREDIMED study. Nutr Metab 
Cardiovasc Dis 23:953-9.  
 
 Visioli F, Davalos A. 2011, Polyphenols and cardiovascular disease: a critical summary of 
the evidence. Mini Rev Med Chem 11:1186-90. 
 
 Wallace TC. 2011, Anthocyanins in cardiovascular disease. Adv Nutr 2:1-7. 
 
 Wang Y et al., 2013, Plasma and dietary antioxidant status as cardiovascular disease risk 
factors: a review of human studies. Nutrients 5:2969-3004. 
 
 
1.State of the art 
___________________________________________________________________ 
 
 
23 
1 STATE OF THE ART 
1.1 Biomarker definition  
The term biomarker was coined for the first time in 1989, but only in the 1998 a National Institutes 
of Health panel standardized the definition of biomarker or biological marker as “a characteristic 
that is objectively measured and evaluated as an indicator of normal biological process, or 
pharmacologic responses to a therapeutic intervention”(Biomarkers Definitions Working Group 
2001).  
Biomarkers may have the greatest value in early efficacy and safety evaluations such as in vitro and 
in vivo studies, and early-phase clinical trials in order to establish “proof of concept.” Although 
much progress has been made to identify potential biomarkers, the challenge still remains to 
validate them not only by a biological but also from an analytical point of view. A marker is termed 
‘‘validated’’ if it ‘‘has been demonstrated by robust statistical methods to be associated with a 
given clinical endpoint (prognostic markers), to predict the effect of a therapy on a clinical endpoint 
(predictive markers), or to be able to replace a clinical endpoint to assess the effects of a therapy 
(surrogate markers)’’ (Buyse et al., 2010). The ideal biomarker should be measurable, highly 
sensitive, specific, reliable, accessible, standardized, dependable, cost effective, and easily 
interpretable by clinicians (May &Wang 2008).  
Biomarkers can be either biochemical, physiological, anatomical or physical; they can describe 
indirectly various levels of exposure, functional effects and pathological endpoints. A biomarker 
may be measured on a biological sample (as blood, urine, or tissue), it may be a registration 
obtained from a person (e.g. blood pressure), or it may be an imaging test (such as echocardiogram) 
(Ramachandran 2006). Biomarkers may have several other applications in disease detection and 
monitoring of health status. They can be used to select high-risk people or targeted populations for 
preventive interventions, specific screening, and early diagnostic strategies (Mayeux 2004). 
Furthermore, biomarkers may provide important information concerning the pathogenesis of a 
disease or appear to be useful in risk stratification, in disease diagnosis, or in monitoring therapy; 
many others may be risk factors themselves, representing therefore potential targets of therapy 
(Mayeux 2004).  
 
1.2 Classification of biomarkers  
In the clinical practice, three types of biomarkers are distinguished (Biomarkers Definitions 
Working Group 2001). 
 
Type 0 biomarker: a marker of the natural history of a disease and correlates longitudinally with 
knows clinical indices. 
 
Type I biomarker or clinical endpoints: a marker that captures the effects of a therapeutic 
intervention in accordance with its mechanism of action. Clinical endpoints are the most credible 
characteristics used in the assessment of the benefits and risks of a therapeutic intervention in 
randomized clinical trials. 
 
Type II biomarker or surrogate endpoint: surrogate endpoints are a subset of biomarkers used to 
replace a clinical endpoint. They are closer to the exposure/intervention of interest and may be 
easier to relate casually than more distant clinical events. A surrogate endpoint should predict 
clinical benefit on the basis of epidemiological, therapeutic, pathophysiological, or other scientific 
evidence.  
The term surrogate endpoint applies primarily to endpoints in therapeutic intervention trials. In 
addition, the same biomarkers utilized as surrogate endpoints in clinical trials are often extended to 
clinical practice in which disease responses are similarly measured. The application of biomarkes as 
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surrogate endpoints in a clinical research trial is possible, but it requires the specification of the 
clinical endpoints to substitute, as well as the characteristics of population and disease state in 
which the substitution is being made. 
Although all surrogate endpoints can be considered biomarkers, very few have been clinically 
validated to the status of surrogate endpoint. In the cardiovascular area, for example, FDA’s Center 
for Food Safety and Applied Nutrition recognizes three surrogate endpoints when evaluating the 
scientific evidence for a potential health claim and qualified health claim: blood pressure, (plasma 
and serum) total cholesterol, and low-density lipoprotein (LDL) cholesterol (NIH-FDA 1999). 
It should be mentioned that when studying the effect of dietary treatments on disease prevention, 
type I or type II biomarkers are generally selected and they need to be both significant endpoints 
(generally intermediate endpoint) related to a pathological condition (i.e. need to have biological 
plausibility) but also be sensitive enough to detect the modulatory effect, that is generally small, 
following dietary interventions if compared with pharmacological treatments. This consideration is 
fundamental and limits sometime the availability of adequate biomarkers to demonstrate preventive 
roles. 
 
1.3 Biological markers in cardiovascular research 
 
Multiple biological pathways have been implicated in the etiology of chronic and degenerative 
disease such as CVD, including, but not limited to oxidative stress and inﬂammation (May &Wang 
2008). The recognition of biological markers may help in monitoring the efﬁcacy of treatments, and 
facilitate the development of pharmacological tools for those subjects at risk of CVD. So, the most 
promising biomarkers are those that appear to relate closely with the pathophysiological process of 
the disease. However, due to the complexities of CVD pathogenesis, there is no single biomarker 
available to estimate absolute risk of future cardiovascular events. In addition, not all biomarkers 
are equal; the functions of many biomarkers overlap, some offer better prognostic information than 
others, and some are better suited to identify/predict the pathogenesis of particular cardiovascular 
events. Here, are reported some of the biomarkers of oxidative stress, inflammation and endothelial 
function/dysfunction widely used in the research to predict CVD. 
 
1.3.1 Biomarkers of oxidative stress  
Oxidative stress is defined as impairment between antioxidant and pro-oxidant species that 
generates a stress response in cells leading to metabolic dysregulation and alteration in cell 
signaling and other cellular functions, which are involved in the pathogenesis of various disease 
states (Betteridge 2000). 
Since oxidative stress centrally contributes to CVD, it is extremely important to translate this 
knowledge into the characterization and identification of biomarkers able to detect the oxidative 
stress (Lee et al., 2012; Betteridge 2000). 
Biomarkers of oxidative stress can be classiﬁed as molecules that are modiﬁed by interactions with 
reactive oxygen species (ROS), reactive nitrogen species (RNS), and reactive chloride species 
(RCS) in the microenvironment; and molecules of the antioxidant system that change in response to 
increased redox stress (Roberts & Sindhu 2009).  
DNA, lipids (including phospholipids), proteins and carbohydrates are examples of molecules that 
can be modiﬁed by excessive ROS, RNS and RCS in vivo.  
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1.3.1.1 Oxidative DNA damage 
Numerous studies have shown that oxidative DNA damage links pathogenically to a variety of 
aging-associated degenerative diseases such as cancer and CVD (Wu et al., 2004).  
Genomic damage can be caused by a variety of physical and chemical agents such as ultraviolet and 
ionizating radiation, xenobiotics and endogenous ROS that accumulate in cells due to natural 
metabolic processes. DNA damage occurs at a rate of 1,000 to 1,000,000 molecular lesions per cell 
per day. Common types of DNA damage are: base loss, base deamination, base alkylation, base 
dimerization, base oxidation and single/double strand breakage (Saul & Ames 1986). Nuclear and 
mitochondrial DNA from tissue and blood lymphocytes is usually the site of oxidation damage. The 
formation of ROS inside the cell can lead to oxidized DNA bases, apurinic/apyrimidinic sites or 
DNA strand breaks. Among all purine and pyridine bases, guanine is the most prone to oxidation. 
The most common oxidized base lesion is the highly mutagenic 8-oxo-2'-deoxyguanosine (8-oxo-
dG) (Cooke et al., 2001) which can be removed from the 8-oxoGua:Cyt base pair by 8-Oxoguanine 
DNA glycosylase (Ogg1). If 8-oxoGua is not removed from the DNA, this lesion is mutagenic 
because of mispairing with adenine. Moreover, 8-oxo-dG is unstable and can react with compounds 
such as peroxynitrate to even more mutagenic lesions. Urinary 8-OHdG, in particular, has been 
measured most frequently to indicate the extent of oxidative damage because it is noninvasive and 
technically less involved (Cooke et al., 2001); but 8-OHdG is also a biomarker reflecting the 
balance between oxidative damage and repair rate (Wu et al., 2004). 
The methods used to estimate 8-oxodG include high performance liquid cromatography- 
electrochemical detection (HPLC-EC), gas chromatography–mass spectrometry (GC-MS), LC-
MS/MS, antibody-based immunoassays, 32P-post-labelling and enzyme-linked immunosorbance 
assays (ELISA) (Cooke et al, 2006), direct enzymic detection by using bacterial glycosilases and 
endonuclease enzymes (Collins et al, 1993). Urinary 8-OHdG does not directly reflect DNA 
oxidation within cells, but it could be used in combination with direct measurements of oxidative 
damage to DNA. However, a reduction in the excretion could result from either reduced formation 
of oxidised DNA bases (beneficial) or reduced repair of such damage (detrimental) (Ferguson et al, 
2006).  
 
32P-post-labelling procedures allow the detection of both 8-oxodG and DNA adducts, but are 
time-consuming methods (time-span for the analysis is several days) and often characterised by lack 
of specificity or formation of DNA damage during sample preparation (Cooke et al, 2006). 
 
Levels of 8-oxodG detected by means of ELISA assays are often higher than those obtained by 
HPLC-based methods, thus they do not represent a good method of detection (Cooke et al, 2006). 
  
 The single cell gel electrophoresis (comet assay) represents a relatively simple technique 
that allows the measure of DNA single- and double-strand breaks, oxidised bases (purines and 
pyrimidines), as well as resistance to ex vivo treatment by hydrogen peroxide or ionising radiation at 
the level of single cell (McKelvey-Martin et al., 1993).  
The measure of oxidized bases can be performed through the use of specific enzymes that are 
universal in eukaryotes and prokaryotes. For example, E. coli express formamidopyrimidine DNA 
glycosylase (FPG) for base excision repair of oxidised guanines and this enzyme is often used for 
detection of such lesions by means of comet assay. The comet assay has also been used to assess 
DNA repair as rejoining of single- strand breaks and, more recently, to evaluate repair of 8-oxodG 
(Smart et al., 2006).   
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1.3.1.2 Oxidative damage to lipids 
 
Lipids are susceptible targets of oxidation because of their molecular structure often abundant in 
reactive double bounds. Oxidized LDL, lipid hydroperodixe, malonildialdehyde (MDA), and 
isoprostanes (F2-IsoP) are products of lipid peroxidation. Compared to others, F2-IsoP are 
chemically stable end-products and for this reason are the most well studied markers (Ho et al., 
2013). 
F2-IsoPs are a series of prostaglandin F2a-like compounds produced in vivo by non-enzymatic 
peroxidation of arachidonic acid, esterified in phospholipids and then subsequently hydrolysed to 
their free acid form by the platelet activating factor acetylhydrolase (Ho et al., 2013).  
IsoPs are released from the cell membrane into circulation by phospholipases (Stafforini et al., 
2006), and can be quantiﬁed in all human tissues and biological fluids, including plasma, urine, 
cerebrospinal and broncho-alveolar lavage fluid.  
Levels of IsoPs in plasma and urine samples have been shown to correlate with in vivo oxidative 
stress in a number of animal and human studies (Fam & Morrow 2003). IsoPs are elevated in 
association with risk factors such as hyperhomocysteinemia, hypercholesterolaemia, diabetes 
mellitus, obesity, cigarette smoking (Morrow 2005), as well as myocardial ischaemia/reperfusion 
(Delanty et al., 1997). 
F2-IsoP levels are elevated in human atherosclerotic lesions compared with normal vascular tissue 
(Gniwotta et al., 1997), and may participate in the actual pathogenesis of atherosclerosis through 
effects on vasoconstriction, platelet aggregation, and proliferation of vascular smooth muscle cells 
(VSMCs) (Fam & Morrow 2003). 
IsoPs can be measured using GC/MS, LC/MS, ELISA, and radioimmunoassay in plasma and urine 
samples (Musiek et al., 2005). Moreover, commercial immunoassay kits for IsoPs have been 
developed; they are cheap and easy to use but have variable performance and results correlate 
poorly with mass spectrometric techniques (Smith et al., 2011), which still remain the gold standard 
tecniques for IsoP quantiﬁcation (Morrow 2005). 
 
Oxidative damage to lipids (i.e. lipid peroxidation) could also be obtained in vivo by measuring 
oxidized low density lipoprotein (LDL) particles. This may be evaluated in blood using 
immunological methods (i.e. antibodies) with appropriate specificity. Phosphatidylcholine 
hydroperoxidases measured in blood or tissue by HPLC is also an acceptable marker of lipid 
peroxidation (EFSA Panel on Dietetic Products, Nutrition and Allergies 2011). 
 
Thiobarbituric acid reactive substances, MDA, high density lipoprotein (HDL)-associated 
paraoxonases, conjugated dienes, breath hydrocarbons, auto-antibodies against LDL particles and ex 
vivo LDL resistance to oxidation have been proposed, but they are not reliable in vivo markers of 
lipid peroxidation. However, some of these markers can be used as evidence, for example in 
addition to measurements of F2-IsoP and in vivo LDL oxidation, only if appropriate tecniques are 
used for their analysis. In this regard, concentrations of MDA in blood or tissue must be assessed by 
HPLC (EFSA Panel on Dietetic Products, Nutrition and Allergies 2011). 
 
1.3.1.3 Oxidative damage to proteins 
 
Proteins are a major target for biological oxidants as a result of their abundance and high 
rate constants for reaction with many species. Reactions can occur with both the side chains and 
backbone, with the extent of attack at particular sites dependent on multiple factors. In some cases, 
damage is limited to specific residues, whereas with other species (e.g., hydroxyl radicals), damage 
is widespread and nonspecific (Ho et al., 2013).  
Direct measurements of oxidative damage to proteins in vivo, such as measurements of specific 
products of amino acid oxidation in proteins after hydrolysis, can be obtained by means of HPLC-
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MS. Measures of protein oxidation by-products (protein carbonyls) by using conventional assays, 
such as colorimetric or ELISA methods are usually susceptible to interferences by molecules other 
than proteins, and could only be used in combination with at least one direct marker of oxidative 
damage to proteins in vivo if assessed directly in blood or tissue (Ho et al., 2013; Stoner et al., 
2013). 
  
Measure of tyrosine nitration have been used as indicator of oxidative stress since the accumulation 
reﬂects a loss of balance between oxidant formation and antioxidant defence mechanisms (Peluffo 
& Radi 2007). 
Nitrotyrosine originates as tyrosine in both a free and protein-bound form. The protein-bound form 
that is involved in atherosclerosis is attached to LDL. This molecule is then nitrated to form the 
biologically active nitrotyrosine, and occurs in a highly efﬁcient manner in human serum (Gaut et 
al., 2002). Once modiﬁed, the nitrated form of LDL is collected and consumed by macrophages via 
phagocytosis. The end product of this degradation is the deposition of cholesterol and foam cells 
during the plaque development. 
Several animal studies have linked nitrotyrosine to inﬂammation (Gaut et al., 2002; Fernandez et al., 
2003; Bro et al., 2003).  In humans, nitrotyrosine formation has been observed in vascular and 
myocardial tissue in both healthy individuals and those with CVD (Bertesaghi et al., 2007). 
However, nitrotyrosine levels are raised in patients with diabetes mellitus (Zou et al., 2004), 
atheromatous plaques (Pennathur et al., 2004), and in patients with peripheral arterial disease (Da 
Ros et al., 2003), coronary artery disease (Shishehbor et al., 2003), and myocardial infarction (Feng 
et al., 2001).  
Free nitrotyrosine (3-NO 2 -Tyr) can be measured by MS/MS coupled with GC or HPLC as the 
current gold standard technique (Duncan 2003).  
Other ways of quantifying protein nitration are immunocytochemical and immunohistochemical 
assays based on either monoclonal or polyclonal anti 3-NO 2 -Tyr antibodies. 
 
1.3.2 Biomarkers of inflammation  
 
Inflammation is the process of innate immunity in response to physical, physiological and/or 
oxidative stress and is associated with activation of Nuclear Factor kappa B  (NF-κB) signaling 
pathway, a transcription factor and key mediator in the activation of genes involved in the 
inflammatory process (Stoner et al., 2013). Generally, NFκB is retained in an inactive form in the 
cytoplasm by an inhibitor molecule, inhibitor kappa B (IκB) (Hoesel & Schmid 2013). When a pro-
inflammatory stimulus or oxidative event occurs, the inhibitor molecule becomes phosphorylated 
and induces the degradation and liberation of the NF-κB complex in its active form that induce the 
expression of several inflammatory mediators such as cytokines and chemokines (tumor necrosis 
factor alpha, TNFα; interleukins, IL-1, IL-6 and IL-8), and adhesion molecules (vascular cell 
adhesion molecule-1, VCAM-1; intercellular adhesion molecule-1, ICAM-1) (Ho et al., 2013). 
Once produced, cytokines are rapidly trapped by neighbouring cells via their high-afﬁnity receptors. 
Measuring the levels of circulating cytokines is not necessarily a perfect surrogate endpoint. 
Nevertheless, a variety of blood inﬂammatory markers have been shown to predict future CV risk. 
Among them, C-reactive protein (CRP), IL-6 and TNF-α are the major inflammatory markers used 
to predict CVD (Stoner et al., 2013).  
 
1.3.2.1 Tumor necrosis factor alpha 
TNF-α is a cytokine with a wide range of pro-inﬂammatory activities (Vassalli 1992). It is primarily 
produced by macrophages, but it can derive also by a broad variety of cell types including lymphoid 
cells, endothelial cells, mast cells, cardiac myocytes, and adipose tissue (Beutler &Cerami 1989). 
Large amounts of TNF-α are released in response to lipopolysaccharide (LPS), other bacterial 
products and IL-1. In the skin, mast cells appear to be the predominant source of pre-formed TNF-α, 
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which can be released upon inflammatory stimulus. TNF-α may inﬂuence the atherosclerotic 
process both by causing metabolic perturbations and by increasing the expression of cellular 
adhesion molecules. TNF-α induces the expression of chemokines (Rollins et al., 1990), and 
enhances the production of cytokines and growth factors (Libby et al., 1986). TNF-α also stimulates 
new vessel formation and induces features characteristic of developing atheroma. 
Moreover, disturbances in the TNF-α metabolism have been implicated in metabolic disorders, such 
as obesity and insulin resistance (Hotamisligil 1994). Increased plasma concentrations of TNF-α 
have been found in patients with premature, coronary artery disease (Skoog et al., 2002), acute 
myocardial infarction (Prondzinsky et al., 2012), and peripheral arterial disease (Botti et al., 2012). 
 
1.3.2.2  Interleukin-6  
 
IL-6 is a pleiotropic cytokine produced by a variety of cells including ﬁbroblasts, endothelial cells, 
mononuclear phagocytes, neutrophils, hepatocytes, lymphocytes (T and B) and neural tissue-
neurons (Abeywardena et al., 2009). IL-6 is implicated in the generation and propagation of 
inflammation by acting on a wide range of tissues inﬂuencing cell growth and differentiation, 
including angiogenesis and also re-vascularization (Barnes et al., 2011). IL-6 also mediates the 
synthesis and secretion of CRP (Casas et al., 2008), and it plays an important role in the instability 
of vulnerable plaque and in the endothelial cell activation resulting in an increase in the expression 
of adhesion molecules (ICAM-1, VCAM-1), release of chemokines (IL-8) (Barnes et al., 2011). 
Chronically elevated IL-6 levels are common in patients with CVD (Coles et al., 2007), contributing 
to cell damage, oxidative stress, blood clotting and atherothrombotic events (Yudkin et al., 2000). 
IL-6 levels are also elevated in patients with stable coronary artery disease (Jha et al., 2010), and 
acute miorcardial infarction (Kinugawa et al., 2012). 
 
1.3.2.3 C-reactive protein  
 
CRP and high sensitive (hs)-CRP are the most well-known inflammatory markers (Casas et al., 
2008).  The production of CRP occurs primarily in the liver, by the hepatocytes as part of the acute 
phase response upon stimulation by IL-6, and to a lesser degree by TNF-α and IL-1ß, originating at 
the site of inﬂammation. Among other effects, CRP has been shown to enhance the expression of 
ICAM-1, VCAM-1, E-selectin in endothelial cells (Pasceri et al., 2001; Pasceri et al., 2000).  
CRP has been shown in prospective cohort and case-control studies to be a reliable measure of 
underlying systemic inflammation and a strong predictor of future cardiovascular events.   
In patients with unstable angina, CRP concentrations have been demonstrated as predictors of 
recurrent cardiac instability (Biasucci et al., 1999). Similarly, CRP would appear to be useful in the 
diagnostic and prognostic management of peripheral vascular disease (Ridker et al., 1998). Various 
analytical methods are available for CRP determination, such as ELISA, immunoturbidimetry, rapid 
immunodiffusion, and visual agglutination. 
 
1.3.3 Biomarkers of endothelial function  
Vascular endothelial cells play a major role in maintaining cardiovascular homeostasis. In addition 
to providing a physical barrier between the vessel wall and lumen, the endothelium secretes a 
number of mediators that regulate platelet aggregation, coagulation, fibrinolysis, and vascular tone 
(Frick et al., 2007). Endothelial cells secrete several mediators that can alternatively mediate either 
vasoconstriction, such as endothelin-1 and thromboxane, or vasodilation, such as nitric oxide (NO), 
prostacyclin, and endothelium-derived hyperpolarizing factor (EDHF).  
Endothelial dysfunction refers to a condition in which the endothelium loses its physiological 
properties and in particular a decreased bioavailability of NO, a critical endothelium-derived 
vasoactive factor with vasodilatory and antiatherosclerotic properties (Tatematsu et al., 2007).  
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The first step in plaque progression occurs when endothelial cells express adhesion molecules upon 
injury, which facilitates the adhesion of monocytes onto endothelium (Onat et al., 2011). These 
adhesion molecules may include selectins, which mediate a loose rolling of monocytes on the 
activated endothelial cells, and more importantly ICAM-1 and VCAM-1, which mediate the firm 
adhesion (Onat et al., 2011; Li & Glass 2002). The monocytes can subsequently migrate through the 
endothelium to the intima, accumulate lipids and transform to lipid laden foam cells, which result in 
the earliest visible atherosclerotic lesions as fatty streaks (Moore & Tabas 2011; Li & Glass 2002). 
Risk factors, such as hypertension, hyperlipidemia, hyperglycemia and environmental exposure (i.e. 
smoking), could accelerate the progression of plaque, which involves the migration of not only the 
macrophage foam cells, but also smooth muscle cells and as well as increased death of foam cells to 
form the necrotic core (Valledor et al., 2011; Packard & Libby 2008; Li & Glass 2002). 
Furthermore, the foam cells may also contribute to the plaque progression by amplifying the 
inflammatory response and lipoprotein modifications (Packard & Libby 2008; Hansson & Libby 
2006. All of these changes can lead to the formation of advanced vulnerable plaque, which may 
rupture, lead to thrombus formation and finally result in CVD (Moore & Tabas 2011; Packard & 
Libby 2008; Li & Glass 2002). 
Thus, the central role of the endothelium in the development of vascular disease has led to the 
search for biologically relevant biochemical markers to estimate endothelial function and injury. 
This includes soluble biomarkers and physiological parameters such as measures of arterial stiffness 
and endothelial function. 
Several studies have shown that surrogate markers of endothelial dysfunction such as NO, ICAM, 
VCAM, E-selectin, and flow mediated dilation (FMD) may serve as potential markers of endothelial 
damage (Suliman et al., 2006; Wang et al., 2005; Kock et al., 2005)  
 
1.3.3.1 Nitric oxide 
NO is one of the endothelial biomarkers which decreases in condition of endothelial dysfunction. 
NO is generated from L-arginine by the action of endothelial NO synthase (eNOS) in the presence 
of cofactors such as tetrahydrobiopterin (Fostermann & Munzel 2006). This gas diffuses to the 
vascular smooth muscle cells and activates guanylate cyclase which leads to cGMP-mediated 
vasodilatation. 
When NO forms, it has a very short half life (few seconds) and can react with superoxide to form 
peroxynitrite, which can generate damage to the cell membrane inducing lipid peroxidation. 
Superoxide can quench NO thus reducing its bioavailability and induce endothelial dysfunction. In 
normal vascular physiology, NO plays a key role to maintain the vascular wall in a quiescent state 
by inhibition of inflammation, cellular proliferation, and thrombosis. This is in part achieved by s-
nitrosylation of cysteine residues in a wide range of proteins, which reduces their biological activity 
(Stamler et al., 2001). The target proteins include the transcription factor NF-κB, cell cycle–
controlling proteins, and proteins involved in generation of tissue factor (Gosh et al., 2002).  
At present, there are several reasons to believe that in vivo NO synthesis from L-arginine could 
indeed be impaired in atherosclerosis, hypertension, dyslipidemia, diabetes, obesity, insulin 
resistance, metabolic syndrome, as well as in ageing (Vickers et al., 2009; Park et al., 2009; Njajou 
et al., 2009; Huang, 2009; Park et al., 2010; Tabit et al., 2010). 
Determination of the NO radical is difficult because of its radical nature and very short half-life; so 
measurements of plasma nitrite, nitrate and nitrosylated proteins are increasingly being mentioned 
as markers for determining NO bioavailability (Tsikas 2005; Bryan et al., 2004). It has been shown 
that up to 70–90% of plasma nitrite is derived from eNOS activity in fasted humans (Lundberg et 
al., 2006). However, circulating levels of nitrites and nitrosylated proteins are difficult to measure 
(Rassaf et al., 2004; Rassaf et al., 2005), and the values may be perplexed by other sources of NO 
formation and variation in dietary NO (Lundberg 2006).  
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1.3.3.2 Cell adhesion molecules  
 
The role of cell adhesion molecules, such as intercellular cell adhesion molecule-1 (ICAM-1), 
vascular endothelial cell adhesion molecule-1 (VCAM-1) and E-selectin, has been studied 
extensively in the process of endothelial dysfunction (Ross 1999). The determination in blood is 
very easy since these molecules can be measured with commercial immunoassays. 
Soluble ICAM-1 are expressed on the surface of endothelial cells, leukocytes and smooth muscle 
cells in reaction to stimuli such as shear stress, bacterial toxins, pro-inﬂammatory cytokines and 
oxidants. ICAM-1 can be induced by IL-1 and TNF-α and are expressed by the vascular 
endothelium, macrophages and lymphocytes. ICAM-1 mediate attachment of circulating leukocytes 
to the endothelium and their subsequent transmigration and accumulation in the arterial intima 
(Tailor et al., 2000), processes critical to the development and progression of atherosclerosis (Ross 
1999). However, their role in initiation and formation of endothelial lesions is overshadowed by the 
contribution of VCAM-1 (Cybulsky et al., 2001).  
 VCAM-1 is expressed on both large and small vessels after the endothelial cells are 
stimulated by cytokines (Carlos et al., 1990). These molecules facilitate the rolling, adhesion and 
migration of leukocytes across the endothelial barrier.  
In large prospective studies of healthy individuals, sICAM-l, but not sVCAM-1, appears 
consistently related to incident coronary artery disease (Blankenberg et al., 2003; de Lemos et al., 
2000; Ridker et al., 1998). sICAM-l appear as a general marker of a pro-inﬂammatory status 
(Blankenberg et al., 2003). By contrast, VCAM-1 is not expressed in baseline conditions, but is 
rapidly induced by pro-atherosclerotic conditions (O'Brien et al., 1993). Therefore, it seems that 
sVCAM-1 does not appear as a risk factor in healthy individuals, but emerges as a strong risk 
predictor in patients suffering from pre-existing disease. Support for a different role of ICAM-1 and 
VCAM-1 according to the type of population comes from studies on peripheral arterial disease; in 
healthy individuals, higher levels of ICAM-1 have been shown to predict future cardiovascular 
events, symptomatic disease (Luc et al., 2003; Pradhan et al., 2002), whereas in patients with 
established disease, VCAM-1 is a better marker of the extent and severity of atherosclerosis (Jager 
et al., 2000; Peter et al., 1997).  
 
1.3.3.3 Flow-mediated dilatation, blood pressure and arterial stiffness 
 
Surrogate markers of endothelial dysfunction and atherosclerosis, including blood pressure, 
brachial artery flow-mediated dilatation (FMD), and arterial stiffness have been increasingly used.  
Endothelial dependent vasodilation has been identified as the most common used clinical 
assessment of endothelial function. These tests evaluate pharmacological and/or physiological 
stimulation of endothelial release of NO and other vasoactive compounds, and often a comparison 
of vascular responses to endotheliumin dependent dilators such as nitroglycerine. 
Several invasive and non-invasive techniques have been developed to evaluate endothelial function. 
Invasive techniques, which involve intracoronary or intrabrachial infusions of vasoactive agents, are 
still considered to be the gold standard for early detection of endothelial dysfunction (Kandhai-
Ragunath et al., 2013). Invasive tecniques include intracoronary and intrabrachial infusions of 
vasoactive agents. Although intracoronary studies are considered to be the gold standard for early 
detection of endothelial dysfunction in the coronary arteries, they have the disadvantage of being 
invasive and expensive, with the risks of coronary catheterisation, and cannot be used as a screening 
test in the general population (Widlansky et al., 2003). For the assessment of pre-clinical disease, 
the ideal technique for measuring endothelial function must be noninvasive, reliable, reproducible, 
cheap and easy to perform. For that reason several non-invasive techniques have been developed, 
with comparable results and good reproducibility (Kandhai-Ragunath et al., 2013). The non-
invasive testing are: 
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-Ultrasound flow mediated dilatation (FMD) of the brachial artery.  It is the most widely used 
method for both small and large population studies of adults and children (Leeson et al., 2006). This 
testing involves measuring the diameter of an artery by noninvasive ultrasound before and after 
increasing shear stress (provided by reactive hyperemia), with the degree of dilatation reflecting (in 
large part) arterial endothelial NO release (Joannides et al., 1995). Measurement of ultrasound-
based FMD in the brachial artery has intrinsic appeal: it is noninvasive, relatively repeatable and 
reproducible, reflects important biology, has some data to support its predictability, and is useful in 
serial studies of disease reversibility (Celermajer et al., 1992). For these reasons this test represents 
the gold standard for clinical research on conduit artery endothelial biology (Celermajer et al., 
1992). Nevertheless, the measurement of FMD by ultrasound has also proven problematic for risk 
stratification in individuals. The method is technically demanding, requiring specific training and 
also the care required to minimize the effect of environmental or physiological influences, such as 
exercise, eating, caffeine ingestion, and important variations in temperature. FMD tests reflect in 
part the synthesis and bioavailability of NO. Brachial artery FMD has been shown to correlate with 
measures of coronary endothelial function (Anderson et al., 1995). This technique has been 
extensively used with very good reproducibility and low observer variability. This technique is 
excellent for acute interventions with repeated measurements. 
-Pulse amplitude tonometry or peripheral arterial tone (PAT). Interest has recently grown 
particularly in testing endothelial vasomotor function after reactive hyperemia by PAT (RH-PAT), 
as measured in the fingertips (Hamburg et al., 2008). This non-invasive method assesses post-
occlusive volume changes at the fingertip and has been shown to identify coronary artery 
dysfunction and to correlate with brachial artery reactivity testing in adults (Hamburg & Benjamin 
2009).  There more EndoPAT tests can be carried out in both the office and hospital settings, with 
patients positioned either sitting or supine. The test takes 15 minutes to complete, is very easy to 
perform, and is both operator and interpreter independent (Faizi et al., 2009). 
Blood pressure (BP) has long been known to be an important risk factor for cardiovascular risk. 
Risk increases from BP levels 120/80 mm Hg, and there is no level at which the risk suddenly 
increases. An increase of 20 mm Hg in systolic BP is associated with a 2-fold increase in risk of 
death from stroke and ischemic heart disease (Lewington et al., 2002). Moreover, risk increases as 
the level and number of risk factors increases (Kannel 1996). This is especially evident in the case 
of the metabolic syndrome, which includes impaired glucose tolerance or type 2 diabetes mellitus, 
high BP (systolic BP >140 mm Hg), obesity, an increase in serum triglycerides and cholesterol 
(Cohon et al., 2004). While initial work concentrated on diastolic pressure, more recently, it has 
been recognized that systolic and pulse (difference between systolic and diastolic) pressures play a 
more important role in endothelial dysfunction (Cohon et al., 2004). Systolic pressure is influenced 
by arterial stiffness and increases continuously with age.  
Measurements of arterial stiffness provide useful information regarding the health of the arterial 
vasculature. In fact, it provides assessment of both the structure and function of the artery. There are 
many methods that have been used to measure arterial stiffness in humans (Mackenzie et al., 2002). 
Large artery stiffness, as assessed by pulse pressure and pulse wave velocity (PWV), is age-
dependent and reflects structural alterations in the conduit arteries that are accelerated by 
hypertension and atherosclerosis. PWV is considered the gold standard method and most 
consistently predictive of CVD risk (Mitchell et al., 2010). The augmentation index (Aix) is an 
indirect measure of arterial stiffness and increases with age. It is calculated as augmentation 
pressure divided by pulse pressure ×100 to give a percentage (Mackenzie et al., 2002). An increased 
Aix is associated with increased cardiovascular risk (Nürnberg et al., 2002). 
 
1.State of the art 
___________________________________________________________________ 
 
 
32 
1.4 Health effect of polyphenol bioactives: role of anthocyanins in the modulation of 
cardiovascular biomarkers 
Fruit and vegetables are rich sources of numerous phytochemicals with powerful bioactive 
properties. The protective activity and mechanisms of action of several phytochemicals was 
evidenced in a large number of studies carried out in cell culture and animal models. However, it is 
not clear whether the effects in animals can be readily extrapolated to humans because of specie 
differences, employment of genetically susceptible animals and relative doses of bioactives highly 
above those typically consumed through the diet by human beings. 
Therefore, experimental dietary studies in humans represent the link between nutritional 
epidemiological research and trials performed in cell-culture systems and animal models. 
Intervention studies relay on intermediate endpoints related to disease risk by using biological 
markers that could help in understanding the effect and mechanism of phytonutrients in humans.   
In the last years, a great interest has been devoted to the role of a particular class of bioactive 
compounds, included in the class of polyphenols, named anthocyanins (ACNs). 
ACNs provide blue and purple colour to vegetable and fruits, in particular berries, such as 
cranberries, blueberries, strawberries, blackcurrant and raspberries (Wallace 2011).  
ACNs exist in plant predominantly as glycoside conjugates; however, they can be found in different 
structural arrangement depending on the number of glycosilating sugars, position in the aglycon, 
and the degree and nature esterification of the sugar with aliphatic or aromatic acids Fig 1.1 (Wang 
& Stoner 2008).  
 
Fig. 1.1 Chemical structures of anthocyanidins (Adopted from Wang & Stoner 2008) 
 
 
 
 
 
The six ACNs commonly found in plants are named pelargonidin, cyanidin, delphinidin, peonidin, 
petunidin and malvidin (Wallace et al., 2011). The daily intake of ACNs in humans is 
approximately 180–215 mg/d, with the major sources of ACNs being berries, purple grapes and red 
wine (Mink et al., 2007).  
Their bioavailability is very low and only less than 0.1% of the amount introduced is detected in 
urine within 24 h of consumption (Croizier et al., 2010). Most of them reach the colon where are 
extensively metabolized by intestinal microbiota. Various metabolites are formed during the 
metabolism of ACNs and anthocyanidins (aglycon) and include glucuronides and methylated and 
sulphated derivatives of ACNs, but also phenolic acids (Del Rio et al., 2010a). 
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The relation between ACNs intake and CVD mortality was examined in several studies in which 
was observed a decrease in risk comparing higher with lower intakes (McCullough et al., 2012; 
Cassidy et al., 2013). In general, the beneficial effects of ACNs on the cardiovascular system have 
been attributed to their ability to reduce oxidative stress. In addition to the antioxidant effects, 
several in vitro and in vivo studies have demonstrated the anti-inflammatory activity and a 
protective effect on vascular function (Tsuda 2012; Wallace 2011).  
 
1.4.1 Anthocyanins in the modulation of markers of oxidative stress 
 
Antioxidant activity is one of the most important and recognized mechanism exerted by ACN 
compounds. In fact, several in vitro studies documented the capacity of ACNs to modulate markers 
of oxidative stress by acting as scanvenger of ROS (Zhu et al., 2012). For example, Youdin et al., 
(2000) found a significant increase of blood cell resistance to H2O2-induced ROS production after 
incubation with phenolic compounds. Acquaviva et al., (2003) documented that incubation with 
flavonoids, in particular ACNs (cyanidin and cyanidin 3-glucoside: 400µmol/L) inhibited DNA 
cleavage and was able to scavenge free radicals activity. A protective effect, against free radical 
species production and DNA damage induced by Ochratoxin A, was demonstrated in human 
fibroblasts cell culture after addition of cyanidin 3-glucoside (0.125, 0.250 mM) (Russo et al., 
2005). Moreover, Lazzè et al., (2003) demonstrated that ACNs have the ability to protect against 
DNA damage induced by tert-butyl-hydroperoxide in rat smooth muscle and hepatoma cells.  
In addition, numerous in vitro studies reported the capacity of ACNs to prevent peroxinitrate-
induced damage to endothelial cells (Paixão et al., 2012a; Paixão et al., 2012b; Paixão et al., 2011; 
Serraino et al., 2003), reduce oxidative damage to lipids and lipoproteins (Chen et al., 2010).   
 
Apart from studies in vitro, others researchers have examined the impact of polyphenolic 
compounds on measures of oxidative stress in vivo. For example, supplementation of rats with 
blueberry ACNs reduced isolated red blood cell susceptibility to free radical damage and decreased 
liver DNA damage in rats, but unaffected the levels of urinary IsoPs (Dulebohn et al., 2008). Harris 
et al., (2001) reported that 2.5-10% black raspberry supplementation reduced DNA damage in rats 
treated with carcinogens. In a recent study, the supplementation with a mix of blueberry, strawberry 
and red raspberry, rich in ACNs, incorporated to the diet (5% w/w) for 12 weeks resulted in a 
moderate reduction in endogenous DNA adducts in female mice (Aiyer & Kichambare 2008). 
Ramirez-Tortosa et al., (2005) reported that rats fed a vitamin E–deficient diet for 12 wks and then a 
diet containing a highly purified ACN- rich extract (1 g/kg diet) for the same period, resulted in a 
significant reduction of the levels of liver DNA damage estimated as 8-OHdG and lipid 
hydroperoxidation in rats. Moreover, the supplementation with lyophilized extract of Vaccinium 
ashei (10%w/w) for a period of 3 weeks, reduced isolated blood cell susceptibility to free radical 
damage and decreased liver DNA damage in rats (Dulebohn et al., 2008). Barros et al., (2006) 
demonstrated that the supplementation for 4 weeks with lyophilized extract of different berries (2.6–
3.2 mg/kg/day) decreased neural DNA damage in mice. Also in our laboratories, we documented 
that 8-week supplementation with 8% w/w wild blueberry powder (providing about 24mg ACNs per 
day) was able to improved DNA resistance against oxidative damage in rat lymphocytes (Del Bo' et 
al.,2010a).  
 
The effects of ACN-rich foods on oxidative stress biomarkers have been also investigated in 
different human intervention studies, but results are still inconclusive. Riso et al. (2005) 
documented that daily intake for 6 weeks of 600 mL of blood orange juice increased DNA 
resistance to H2O2 in a group of healthy female volunteers. Also Bub et al., (2003) documented that 
the daily dose of 300 mL ACN-rich and flavonol-rich juice for a period of 2 weeks was able to 
decrease endonuclease III (ENDOIII)-sensitive sites in healthy volunteers.  Similar results were also 
reported by Weisel et al., (2006) that documented a reduction in oxidative cell damage in healthy 
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subjects after 3-week consumption of ACN and polyhenol-rich juice, and by Sporemann et al., 
(2008) that reported a significant reduction in the levels of DNA oxidation damage, as well as 
protein and lipid peroxidation after consuming 200 mL/day of red fruit juice for a period of 4 
weeks.  
A significant reduction in the levels of lipid peroxidation was observed after regular consumption of 
blueberries (Basu et al., 2010), strawberries (Basu et al., 2009), pigmented potatoes (Kaspar et al., 
2011), lyophilized grape powder (Zern et al., 2005), and concentrated red grape juice (Castilla et al., 
2006). 
 On the contrary, Duthie et al., (2006) documented that the intake of 750 mL/day for 2 
weeks of cranberry juice (providing 2.2mg of ACNs and 852 mg of total phenols) had no effect on 
endogenous DNA damage, ENDOIII sites, and H2O2 sensitivity. In addition, urinary 8-oxodG 
decreased similarly in the test and control group during the intervention period, indicating no 
specific effect of the juice bioactives (Duthie et al., 2006).  
A significant reduction in the levels of urinary 8-oxodG, but not of urinary excretion of IsoPs, was 
observed after 2 weeks of tart cherry juice (240 mL/day) in a group of older volunteers 
(Traustadóttir et al., 2009). Another study showed no effect in DNA strand breaks following 2-week 
consumption of berry dessert (200g/day) in a group of elderly volunteers consumed (Ramirez 
Tortosa et al., 2004). No effect on strand breaks, as well as ENDOIII and FPG sensitive sites, was 
also found by Moller et al., (2004) following 3-week supplementation with blackcurrant juice and 
ACN drink in a group of healthy volunteers.  
 
1.4.2 Anthocyanins in the modulation of marker of inflammation 
 
ACNs can positively modulate inflammatory status by influencing the expression of 
proinflammatory and anti-inflammatory cytokines, but also to down-regulate the pathways involved 
in the activation of inflammoty processes.  
Direct inhibition of LPS-induced NF-κB transactivation by ACNs was observed in human 
monocytes (Karlsen et al., 2007). Similarly, red wine has been reported to inhibit NF-κB production 
of proinflammatory factors in endothelial cells and inflammatory cells (Blanco-Calio et al., 2000; 
Zern et al., 2003). ACNs may protect against TNFα–induced monocyte chemoattractant protein-1 
secretion in human endothelial cells (Suganami et al., 2005). Treatment of endothelial cells with 
cyanidin 3-glucoside and pelargonidin 3-glucoside has been reported to inhibit the production of 
cytokines and matrix metalloproteinases (MMP), including MMP-1 and MMP-9 (Atalay et al., 
2003).  Also black currant extract and cyanidin-3-O-glucoside have shown to inhibit the LPS-
induced secretion of IL-6 by human macrophages (Desjardins et al., 2012). 
Purified ACN mixture, delphinidin-3-Ο-β-glucoside and cyanidin-3-Ο-β-glucoside were shown to 
inhibit IL-6 and IL-1β-induced CRP production in human hepatocellular liver carcinoma cell line 
(HepG2) in a dose-dependent manner (Zhu et al., 2013). 
Decendit et al., (2013) reported that malvidin-3-O-β glucoside, the major grape ACN, decreased the 
transcription of genes encoding inflammatory mediators, by the inhibition of TNF-α, IL1, IL-6 
expression in human PBMCs. Similar results were also observed in another study in which the anti-
inflammatory effect of purple sweet potato leaf extract, rich in cyanidin-3-O-glucoside, was 
documented in human aortic endothelial cells (Chao et al., 2013).  
 
The anti-inflammatory activity of ACNs and ACN-rich foods was also investigated in several 
animal models. Decreased TNF-α expression was reported in mice fed a high-fat diet and 
supplemented with ACN-rich extracts (Lefevre et al., 2008; Tsuda et al., 2003). Addition of 4% 
w/w whole blueberry powder for 8 weeks to a high fat diet of mice also resulted in reduced 
expression of TNF- α in adypocytes, although IL-6 expression did not change (DeFuria et al., 2009). 
Lim et al., (2013) reported that 12-weeks of mulberry fruit extract (rich in ACNs) were able to 
reduce the levels of CRP, TNF-α and IL-1 in adipose and liver tissue in obese mice. Very recently, 
Vendrame et al., (2013) documented that 8-week supplementation with 8% wild blueberry diet 
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(providing about 24mg/day ACNs) was able to decreased plasma concentration of CRP, TNF-α and 
IL-6 in obese Zucker rats. Moreover, the expression of the same inflammatory markers and NF-kB 
was down-regulated in both the liver and abdominal adipose tissue in the animal model (Vendrame 
et al., 2013). 
 
Different studies reported an inverse association between ACN intake and inflammation (Chun et 
al., 2008). This observation was also confirmed after ACNs and ACN-rich food consumption in 
human intervention studies. Several NF-κB–related proinflammatory chemokines, cytokines, and 
mediators of inflammatory responses were shown to decrease in the plasma of healthy adult 
participants after supplementation with ACNs in parallel-designed, placebo-controlled, clinical 
trials, suggesting mediated inhibition of NF-κB activation by ACNs in vivo (Scarabelli et al., 2009; 
Karlsen et al., 2007; Kelley et al., 2006). In a recent randomized, double-blind trial, the 
consumption of a purified ACN mixture (320 mg/day) twice a day for 24 weeks, significantly 
decreased the levels of serum hs-CRP and plasma IL-1β in hypercolesterolimic subjects (Zhu et al., 
2013).  
Kaspar et al., documented that 6-week intake of 150 g of cooked pigmented potatoes (rich in ACN 
compounds) was able to reduce the circulating levels of CRP and IL-6 in free-living healthy 
subjects. Karlsen et al. (2007) showed significant improvement of plasma risk biomarkers after 
supplementation with bilberries and blackcurrent ACNs (300 mg/d) in a group of volunteers. 
 On the contrary, Basu et al., (2010c) reported that 4-week consumption of two cups of 
strawberry drink did not affect markers of inflammation including C-reactive protein and 
adiponectin in subjects with metabolic syndrome. Similar result was also observed by Stull et al., 
(2010), in which no effect of 6-week blueberry bioactives supplementation was observed, and by 
Hassellund et al., (2013) after 4-week supplementation with ACNs (640mg/day) in a group of pre-
hypertensive men.   
 
1.4.3 Anthocyanins in the modulation of markers of endothelial function 
 
The beneficial effect of ACNs in the modulation of endothelial function has been extensively 
reported in in vitro studies.  
ACNs treatment was shown to upregulate endothelial nitric oxide synthase (eNOS) in bovine artery 
endothelial cells, and increase protein level of eNOS in human umbilical vein endothelial cells (Xu 
et al., 2004; Lazzé et al., 2006). Treatment of rabbit aortic rings with a freeze-dried strawberry 
extract, rich in ACNs, produced a dose-dependent endothelial relaxation attributed to the 
phosphorylation of eNOS (Edirisinghe et al., 2008).  
Mudnic et al., (2012) documented that the vasodilatory effects of blackberry wine, in addition to 
their flavonoid and total phenolic content, was most significantly associated with the content 
of ACNs.  
Andriambeloson et al. (1997) clearly have shown the endothelial-NO dependent effect of ACN-
enriched blueberry extracts on rat aortic rings, by determining that the delphinidin (but not malvidin 
or cyanidin), induced an endothelial-NO dependent vasorelaxation completely mediated by NO. 
Moreover, in another study, Andriambeloson et al. (1998) documented that red wine polyphenolic 
compounds induced endothelial-NO dependent vasorelaxation in rat aortic rings, by increasing the 
production and release of NO and cyclic-guanosine 3', 5-monophosphate.  
Also Auger et al., (2011) showed that fruit juices and purées caused endothelium-dependent 
relaxations in the porcine coronary artery, with blackcurrant, aronia, cranberry, blueberry, 
lingonberry, and grape being the most effective fruits. This effect involved both endothelium-
derived NO and EDHF, and appeared to be dependent on the polyphenolic composition rather than 
on the polyphenolic content. 
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However, the effects of ACN-rich extracts or single ACNs are not limited to the modulation of 
vascular reactivity, but also to several other functions and markers such as capillary permeability, 
platelet aggregation, thrombus formation, vascular cell adhesion molecules, that are directly or 
indirectly related to endothelial function (Youdim et al., 2000; Youdim et al., 2002; Fitzpatrick et 
al., 1993; Serraino et al., 2003, Rechner & Knoner 2005; Cimino et al., 2006; Oak et al., 2006 
Youdin et al., 2008; Chao et al., 2013).  
 
The effect of ACN-rich foods in the modulation of vascular tone in animal models has been deeply 
investigated in our laboratories. For example, we recently documented that 7-week wild blueberry 
supplementation (24 mg/day ACNs) was able to improve vasomotor tone in Sprague-Dawley rats 
(Del Bo' et al., 2010b). Similar effects were also observed after 8-week wild blueberry enriched diet 
supplementation in young and adults spontaneously hypertensive rats (Kristo et al., 2011; Kristo et 
al., 2010; Kalea et al., 2010). We also documented that wild blueberry supplementation influenced 
the structure and organization of the extracellular matrix that may have implications on the 
regulation of the vascular tone and LDL binding (Kalea et al., 2005) and may decrease COX-
derived vasoconstrictors in spontaneously hypertensive rats (Kalea et al., 2006). 
Our results were also corroborated by others studies reported in literature. For example, Mizutani et 
al. (1999) reported that hypertensive rats fed with red wine polyphenolic compounds for 8 weeks 
reduced blood pressure and improved arterial biomechanical properties. Benito et al., (2002) 
reported that flavonoid-rich diets (red wine phenolic compounds) induced endothelium-dependent 
vasorelaxation in rat aorta through increasing NO production and preserving NO bioavailability.  
 
Unfortunately, very few studies investigated the effect of ACN-rich food consumption on the 
endothelial function in humans. Most recently, Rodriguez-Mateos et al., (2013) showed that 
blueberry intake acutely improved vascular function in healthy men in a time- and intake-dependent 
manner. Dohadwala et al., (2011) documented an improvement of vascular function after the intake 
of a portion of cranberry juice (480 ml, providing 835 mg total polyphenols, and 94 mg ACNs) in 
subjects with CVD, while no effect was observed in the same subjects after 4-week cranberry 
consumption. 
Basu et al., (2009) showed that the consumption of 4 cups of freeze-dried strawberry beverage (50 g 
freeze-dried strawberries, approximately 3 cups fresh strawberries) daily for 8 weeks decreased 
circulating levels of sVCAM-1 in subjects with metabolic syndrome.   
 However, most of the beneficial effects on endothelial function derive from studies on 
polyphenol-rich foods. For example, Chavez et al., (2009) reported that acute consumption of grape 
polyphenols, equivalent to 1.25 cups of fresh grapes, caused significant improvement of endothelial 
function and prevented vascular endothelial dysfunction induced after consumption of a high fat 
meal. On the contrary, Van Mierlo et al., (2010) documented that 2-week intervention periods with 
grape polyphenols (about 800 mg/day) had no impact on vascular function in healthy men.  
Recently, the effect of flavonoid-rich dark chocolate on endothelial function, aortic stiffness and 
wave reflections were investigated. The results of the study showed, for the first time, that 
consumption of dark chocolate acutely decreased wave reflection and increased flow mediated 
dilation after chocolate consumption in healthy adults (Loffredo et al., 2011). Similar results were 
also obtained in different acute studies after consumption of flavonol-rich cocoa in subjects with 
endothelial function and dysfunction (West et al., 2013; d'El-Rei et al., 2013) 
Moreover, the beneficial effect on endothelial function has been also demonstrated after green tea 
consumption. Alexopoulos et al., (2008) showed that green tea consumption had an acute beneficial 
effect on endothelial function in healthy individuals. Oyama et al., (2010) found that green tea 
catechins improved dysfunctional vessels in smokers by increasing the level of nitric oxide. 
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1.5 Role of blueberries in the modulation of cardiovascular markers  
 
The consumption of berries fruits (i.e. cranberry, strawberry, raspberry, elderberry, blackberry, 
black current, and blueberry) and their contribution to improving cardiovascular health is subject of 
considerable interest. Berries are low in calories and high in moisture and fiber; moreover they are a 
good source of polyphenols. Their content varies considerably among berries; blueberry and 
cranberry contain predominantly proanthocyanidin and ACNs, whereas blackberries, black 
raspberries and strawberries contain predominantly ellagitannins (Seeram 2008). Blueberries, in 
particular highbush (Vaccinium corymbosum L.) and lowbush blueberry or wild (Vaccinium 
augustifolium) are a good source of ACNs. Five major ACNs have been reported: delphinidin, 
malvidin, petunidin, cyanidin and peonidin found as 3-glucosides, 3-galactosides and 3-arabinosides 
(Basu et al., 2010b; Bushway et al., 1983).  
Therefore, the class of compound present in a particular berry type may contribute significantly to 
its unique biological properties. In this regard, more research is needed to understand which 
molecules are effective and what mechanisms are involved in their action (Del Rio et al., 2013; Del 
Rio et al., 2010b). 
Very few studies evaluated the effect of the consumption of blueberry in the cardiovascular area. As 
of today, the research carried out seems to support that such food is potentially able to improve 
several functions related to antioxidant status and oxidative stress in humans (Table 1.1), while the 
results on inflammation and endothelial function are poor and controversial. 
This suggests a need to investigate the effect of blueberry on such markers. Several factors such as 
the amount consumed, time of administration, the type of subjects, and the selection of biomarker 
could be important determinants that may influence the demonstration that regular consumption of 
blueberry can lead to improvement of one or more functions of the organism.  
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Reference Duration Study design Study subjects Control Intervention Significant findings 
Pederson et 
al., 2000 
Postprandial Randomized 
controlled trial 
Nine healthy female 
volunteers (mean age, 
31 ± 2 years) 
9% (w/v) sucrose in 
water (500ml) 
500 ml blueberry juice or 
cranberry juice 
Increase in plasma antioxidant capacity, 
vitamin C and phenols with cranberry juice 
(P<0.05), while no effect with blueberry 
juice  
Van den Berg 
et al., 2001 
Three weeks Randomized 
controlled trial 
Twenty-two male 
smokers (mean age, 33 
± 11 years) 
Control drink 
(330ml) 
330 ml fruit drink containing 
30% clarified blueberry juice 
concentrate 
Increase in vitamin C, and plasma 
antioxidant capacity (P<0.05) 
Kay & Holub 
2002 
Postprandial Single-blind 
crossover study 
Eight middle-aged male 
subjects (mean age, 47 
± 2 years) 
High-fat meal High-fat meal supplemented 
with 100g freeze-dried wild 
blueberry powder 
Increase in serum antioxidant status 
(P<0.05) 
Mazza et al., 
2002 
Postprandial  Single-blind 
crossover study 
Five male subjects 
(mean age, 47 ± 2 
years) 
High-fat meal High-fat meal supplemented 
with 100g freeze-dried wild 
blueberry powder 
Increase in serum antioxidant status 
(P<0.05) 
Bub et al., 
2003 
Ten weeks Randomized 
crossover study 
Twenty-seven  non-
smoking men (mean 
age, 35 ± 4 years) 
None ACN-rich juice containing 
aronia, blueberries, and 
boysenberries in a mixture of 
apple, mango, and orange 
juice (76% w/w water); 
300ml/day 
Decrease in plasma thiobarbituric acid 
reactive substances; decrease in oxidative 
DNA damage in PBMC (P<0.001) 
McAnulty et 
al., 2005 
Three weeks 
of 
postprandial 
Randomized 
controlled trial 
Twenty smokers (mean 
age: blueberry group, 26 
± 3.3; control group, 29 
± 4.2 years) 
Usual diet and 
lifestyle with 
restriction of large 
amounts of fruits, 
vegetables and 
supplements 
Acute or daily consumption of 
250 blueberries 
Decrease in lipid hydroperoxides in 
blueberry  group versus control at 3 weeks 
(P<0.05) 
Jensen et al., 
2008 
Postprandial Randomized 
double-blind, 
placebo-
controlled, 
crossover trial 
Twelve healthy subjects 
(mean age, 19-52 years) 
Placebo vegetable 
capsules (0.5g each) 
120ml juice containing acai 
berry, cranberry, blueberry, 
wolfberry and bilberry in 
addition to other fruit juices 
Increase in serum antioxidant status and 
inhibition of lipid peroxidation versus 
placebo ( P<0.03) 
Stull et al., 
2010 
Six weeks Randomized 
controlled trial 
Thirty-two obese, 
nondiabetic and insulin-
resistant subjects (mean 
age: blueberry group, 54 
± 3 years; control group, 
49 ± 3 years) 
Control smoothie  Smoothie supplemented with 
22.5 g blueberry powder (731 
mg total phenolics, 334 mg 
ACNs). Two portion per day. 
Improve in insulin sensitivity in the 
blueberry group compared to control group 
(P<0.05).  
No effect on markers of inflammation 
Basu et al., 
2010b 
8 weeks Randomized 
controlled trial 
Forty-eight obese 
subjects with metabolic 
syndrome (4 males and 
Control water Freeze-dried blueberry 
beverage (50 g freeze-dried 
blueberries, approximately 
Decrease in systolic and diastolic blood 
pressures, plasma oxidized LDL, 
malondialdehyde and hydroxynonenal 
Table 1.1 Summary of blueberry intervention trials (adopted from Basu et al., 2010b) 
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.
44 females; mean age, 
50.0 ± 3.0 y)  
350 g fresh blueberries) concentrations in the blueberry-
supplemented group compared to control 
(P<0.05).  No effect on serum glucose 
concentration and lipid profiles.  
Rodriguez-
Mateos et al., 
2013 
Postprandial 
 
 
 
 
 
 
Postprandial 
Randomized 
controlled trial 
 
 
 
 
 
Randomized 
controlled trial 
 
Ten healthy men (mean 
age, 27 ± 1.3 years)  
 
 
 
 
 
Eleven healthy men 
(mean age, 27 ± 1 
years)  
 
Control drink 
 
 
 
 
 
 
Control drink 
 
Different blueberry drinks 
providing (766, 1278 and 
1791 mg total polyphenols, 
equivalent to 240, 400, and 
560 g fresh blueberry, 
respectively). 
 
 
Different blueberry drinks 
providing (319, 639, 766, 
1278 or 1791 mg total 
polyphenols, equivalent to 
100, 200, 240, 400, and 560 g 
fresh blueberry, respectively). 
 
Improve in endothelial function in the 
blueberry group compared to control 
(P<0.05) in a time dependent manner  
 
 
 
Improve in endothelial function in the 
blueberry group compared to control 
(P<0.05) in a dose-dependent manner 
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2. EVALUATION OF THE REPRODUCIBILITY OF DNA DAMAGE 
MEASUREMENTS (BY COMET ASSAY), AS MARKER OF OXIDATIVE STRESS, IN 
FRESH AND CRIOPRESERVED PERIPHERAL BLOOD MONONUCLEAR CELLS 
2.1 Aim of the study 
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2.1 AIM OF THE STUDY 
 
Despite the comet assay is widely recognized as a valid technique for analyzing and quantifying 
DNA damage at the level of the individual cell, only few information is available on the effect of 
freezing and freeze-thaw process on the levels of DNA damage in human cells before and after 
storage. This is particularly important in dietary intervention studies where, for logistic reasons, 
sometimes samples cannot be used immediately and need to be stored even for long time 
periods. The aim of this task was to verify the reproducibility of the DNA damage measurement 
(through the comet assay) in samples of peripheral blood mononuclear cells (PBMCs) stored in 
the freezer and obtained from an intervention study compared to the same marker analysed in 
fresh samples one year before. 
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2.2 MATERIALS AND METHODS 
 
2.2.1 Chemicals 
 
Normal-melting-point (NMP) agarose, low-melting-point (LMP) agarose, 
ethylenediaminetetraacetic acid (EDTA), Na2EDTA, TRIS acetate-EDTA-buffer, Dimethyl 
Sulfoxide (DMSO), Phosphate Saline Buffer (PBS), RPMI-1640 medium, hystopaque 1077, 
Fetal Bovine Serum (FBS), hydrogen peroxide (H2O2), ethidium bromide, N-lauroylsarcosine, 
triton X-100, trizma, sodium hydroxide, albumin from serum bovine, sodium chloride, were 
from Sigma (St. Louis, MO, USA). Formamildopyrimidine DNA glycosylase (FPG) enzyme 
was kindly provided by Prof. Andrew Collins from University of Oslo. 
 
2.2.2 Isolation of peripheral blood mononuclear cells 
 
Venous blood sample (1 x 10mL) was collected from individuals with risk factors for 
cardiovascular disease by venepuncture. The whole blood (100L) was gently mixed in micro 
tubes with 900uL cold RPMI-1640 medium. Then 100L Histopaque-1077 was carefully added 
to the bottom of the tube and centrifuged at 200 xg for 4 min. at room temperature. Cells were 
collected and 1mL PBS solution was used to wash the cells. The samples were then centrifuged 
for 10 sec at 5000 xg at room temperature to pellet the cells. The supernatants were poured off 
and pellets resuspended in PBS and immediately used, or resuspended in freezing mix composed 
of 50% FBS, 40% RPMI, supplemented with 10% DMSO as cryoprotectant, and stored at -80°C 
for 12 months.    
 
2.2.3 Experimental design 
 
Samples under analysis derived from a previous dietary intervention study in which 20 male 
volunteers received, for a period of 6 weeks, a wild blueberry or a placebo drink. PBMCs were 
obtained from blood collected at the beginning and at the end of each experimental period 
(before/after wild blueberry drink and before/after placebo drink; n= 80 samples) (Riso et al., 
2012). The analysis of the levels of DNA damage (endogenously oxidized DNA bases, and the 
levels of H2O2 -induced DNA damage) was performed on fresh PBMCs or cryopreserved cells 
samples. The latter, an aliquot of cells was gently thawed in a water bath at 37°C and 
centrifuged in order to remove the media. Cells were put on ice and washed twice; first with 
PRMI-1640 media and then with PBS. Finally, cells were suspended in 50l of PBS.   
 
2.2.4 Evaluation of DNA damage through Comet assay 
 
The alkaline comet assay was performed as previously described by Riso et al., (2010) and 
Guarnieri et al., (2007). Cell suspension was supplemented with low melting point agarose 
(1.5% w/v) in Tris-acetate EDTA buffer, pH 7.4, at 37°C and immediately pipetted onto frosted 
glass microscope slide (Richardson Supply Co., London, UK) precoated with a layer of 1% 
(w/v) normal melting point agarose similarly prepared in Tris-acetate EDTA buffer. The level of 
oxidized bases in PBMCs was determined as FPG-sensitive sites; the protein detects 8-oxo-7,8-
dihydro-2’-deoxyguanosine (8-oxodG) and ring-opened formamidopyrimidine nucleobases. The 
cell resistance against oxidatively-generated DNA damage (i.e. strand breaks and alkali labile 
sites) was measured by treating cells with H2O2. Two slides with two gels each and for both the 
comet protocols were prepared for all the samples. One slide was treated with H2O2 (500μmol L-
1 in PBS, for 5 min), while the other one with FPG enzyme (100ng mL-1, for 45 min at 37°C). 
The others two slides acted as controls. Figure 2.1.1 summarized the steps of the comet assay for 
the evaluation of endogenous and H2O2-induced DNA damage.   
2.2 Materials and Methods 
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Figure 2.1.1 Evaluation of endogenous and oxidatively-induced DNA damage (cell resistance 
against H2O2 insult) in PBMCs evaluated by comet assay 
 
 
 
Slides were placed in lysis buffer (2.5M NaCl, 0.1M Na2EDTA, 10mM tris 1% TRITON x-100, 
1% dimethyl sulfoxide, 1% N-Lauroylsarcosine sodium salt, pH10) for 1 h at 4°C in the dark, 
and then were left for 40 min in the electrophoresis buffer (0.3M NaOH, 1mM Na2EDTA, 
40min at 4°C in the dark). Electrophoresis was performed at 1.1 V/cm2 for 20 min. Slides were 
successively neutralized (0.4M tris-HCl, pH 7.5) for 15min at 4°C in the dark, stained with 
ethidium bromide (2μg mL-1), washed in PBS, drained, and covered with cover slips. One 
hundred cells from the two gels of each slide were electronically captured using an 
epifluorescence microscope attached to a high sensitivity CCD video camera and to a computer 
provided with an image analysis system (Cometa 1.5; Immagini e Computer, Bareggio, Milan, 
Italy).The levels of DNA damage were calculated as percentage of DNA in tail. For each 
sample, the percentage DNA in tail of control cells (not treated with H2O2 or not incubated with 
FPG) was subtracted from the percentage DNA in tail of H2O2-treated or FPG incubated cells, 
respectively. 
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2.2.4 Statistical analysis 
Statistical analysis was performed using STATISTICA software (Statsoft Inc, Tulsa, OK, USA). 
Two-way ANOVA was used to verify the effect of protocol (independent factor) on FPG-
sensitive sites and oxidatively induced DNA damage in PBMCs before and after wild blueberry 
or control treatment (dependent factor). Differences between means were evaluated by the least 
signiﬁcant difference (LSD) test. Differences were considered signiﬁcant at P≤0.05. 
2.3 Results and Discussion 
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2.3 RESULTS AND DISCUSSION 
Oxidatively damaged DNA is one of the most widely measured biomarkers of oxidative stress. 
The comet assay offers a number of advantages for the detection of DNA damage. In fact, it is 
rapid, simple, and relatively inexpensive to perform (McKelvej-Martin et al., 1993); it allows the 
collection of data at the individual cell level and requires a relatively small number of cells 
(< 10.000) in each sample (Fairbairn et al., 1995). Moreover, comet assay can be used for 
analysis of all types of eukaryotic cells, both in vitro and ex vivo (McKelvej-Martin et al., 1993). 
In addition, comet assay shows a high sensitivity for the detection of DNA damage (Fairbairn et 
al., 1995) and for these reasons is widely used not only in human biomonitoring studies, but also 
to evaluate the detrimental effects of pollutants and environmental contaminants (Kassie et al., 
2000; Moller 2005; Valverde M & Rojas 2009; Azqueta et al., 2009). In the last years, a great 
interest has been turned to the role of the comet assay as tool to study the influence of diet on 
DNA stability and human health (Riso et al., 2012; Riso et al., 2010; Lampe et al., 2009; Brivida 
et al., 2008; Brivida et al., 2007; Moller et al., 2004; Collins et al., 2001).  
Two approaches of the assay are commonly used in dietary intervention studies. One it is the 
measurement of oxidized bases generated by the use of selected enzymes able to detect oxidized 
pyrimidine and purine bases. The FPG protein detects 8-oxodG and ring-opened 
formamidopyrimidine nucleobases. The analysis of oxidatively damaged DNA has been 
thoroughly validated in inter-laboratory trials and showed generally good dose-response 
relationship with agents that preferentially generate 8-oxodG (Ersson et al., 2013). The other 
approach is to study DNA ex vivo resistance to oxidative stress by incubating the cells with 
hydrogen peroxide (Duthie & Collins 1997).  
 One of the most problematic issues of comet assay in human trials concerns the 
adequate experimental design of the studies. Factors such as age, gender, ethnicity, lifestyles of 
the participants should be standardized since they are potential confounding factors (Moller et 
al., 2000). However, also the type of cells and the operational aspects may increase the 
variability. PBMCs provide a convenient and readily available source of human material and are 
routinely used experimentally in the comet assay (Duthie et al., 2002). Cryopreserved PBMCs 
seem a good alternative to fresh sample in clinical trials, especially when samples are collected 
at multiple steps. However, the isolation, freezing and thawing of samples seems to be potential 
bias since can affect the antioxidant capacity of cells.  
In this regard, no information is reported on the variability of the levels of DNA damage in cells 
when comparing fresh versus cryopreserved PBMCs, in particular after a dietary intervention 
trial.  
In present study, it has been evaluated the reproducibility of the levels of DNA damage, 
evaluated as endogenous and oxidatively induced strand breaks in PBMCs, following 12 months 
of storage period at -80°C.   
Samples were obtained from a previous trial in which volunteers received, for a period of 6 
weeks, a wild blueberry or a placebo drink (Riso et al., 2012). We documented that 6-week WB 
drink consumption reduced the level of oxidized DNA bases and increased the protection from 
the ex vivo H2O2 induced DNA damage in fresh PMBCs. In particular, estimation of oxidized 
purines in PBMC DNA through quantification with the formamidopyrimidine DNA glycosylase 
(FPG)-sensitive sites indicated a statistically significant decrease following the WB drink (-
23.2%, p0.01) with respect to the PL drink (-0.83%, p=0.89). Moreover, the intake of the WB 
drink significantly decreased the levels of H2O2-induced DNA damage (-18.8%, p0.01), while 
no effect was observed after the PL drink (-1.11%, p=0.84).  
In Tables 2.1.1 and 2.1.2 are reported the results on the levels of FPG sensitive sites and 
H2O2-induced DNA strand breaks obtained in stored and fresh cells. In general, a small but 
significant effect of cryopreservation on DNA integrity has been observed. In particular, 
cryopreservation increased the levels of DNA damage in untreated cells (control cells: without  
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FPG or H2O2 treatment), as well as in cells treated with FPG enzyme, with respect to fresh 
samples. These results seem in accordance with the evidence indicating that the freezing-
thawing process increased oxidative stress in different cells (Aydin et al., 2013; Muniz et al., 
2011; Labbe et al., 2001), but in contrast with other studies in which no effect on DNA damage 
was observed following storage (Akor-Dewu et al., 2013; Duthie et al., 2002).  
The response of cryopreserved cells to H2O2 treatment was significantly different from 
fresh cells and from that stored and treated with FPG enzyme. Stored cells showed a greater 
resistance against H2O2-induced DNA damage compared to the fresh samples (Table 2.1.2). 
These results are in contrast with what found by Duthie et al., (2002) in which fresh and frozen 
cells responded almost identically to hydrogen peroxide. Moreover, our data are also in contrast 
with the results obtained by Visvardis et al., (1997) in which a significant increase was observed 
in the score of DNA damage following cryopreserved lymphocytes exposure to hydrogen 
peroxide.  
The difference in the response between fresh vs cryopreserved cells may be attributed to 
different time of storage period or different procedures used during freezing and thawing 
process. This could have activated different mechanisms of cell protection such as the 
expression of antioxidant enzymes (i.e. catalase, superoxide dismutase or glutathione 
peroxidase) able to counteract oxidative insult induced by hydrogen peroxide. 
By considering the reproducibility of the results following dietary treatment, it is 
observed that cryopreservation maintained the trend in the reduction of FPG-sensitive site levels 
following wild blueberry consumption (Table 2.1.1), while the protective effect against ex vivo 
H2O2-induced DNA damage documented in the fresh samples was not evidenced in stored 
samples (Table 2.1.2). 
 
Table 2.1.1 Effect of fresh versus cryopreserved on background and FPG-sensitive sites in 
PBMCs evaluated trough the comet assay (N=18).1  
 
DNA damage  Before WB  After WB  Before PL  After PL 
Fresh samples (N= 18 subjects)     
Background SBs (% DNA in tail, EB)                     6.4 ± 1.5a,C 6.6 ± 1.1a,C 6.3 ± 1.4a,C 6.1 ± 1.6a,C 
Net FPG-sensitive site (% DNA in tail) 12.5 ±5.6a,E 9.6 ± 3.5b,E 12.0 ± 4.5a,E 11.9 ± 4.4a,E 
Cryopreserved samples (N= 18 subjects)     
Background SBs (% DNA in tail, EB)                     12.8 ± 7.4D 12.6 ± 8.5D 14.1 ± 7.9D 11.9 ± 6.5D 
Net FPG-sensitive site  (% DNA in tail) 45.1 ± 9.5 45.9 ± 9.8 45.2 ± 12.7 45.7 ± 14.9 
1Data are expressed ad mean ± SD. WB, wild blueberry; PL, placebo; SBs, strand breaks; PBS, 
phosphate buffer saline; EB, endonuclease buffer.  
a,bData with different letters within the same row are significantly different (P≤0.05) 
(C,D); (E,F)Data with different letters between the rows are significantly different (P≤0.05) 
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Table 2.1.2 Effect of fresh versus cryopreserved on background and H2O2-induced strand 
breaks in PBMCs evaluated trough the comet assay (N=16).1  
 
DNA damage  Before WB  After WB  Before PL  After PL 
Fresh samples (N= 16 subjects)     
Background SBs (% DNA in tail, PBS)                     6.1 ± 1.1a,C 6.4 ± 1.1a,C 6.1 ± 1.3a,C 6.5 ± 1.4a,C 
Net H2O2-induced DNA damage 
 (% DNA in tail) 
44.7 ±7.5a,E 36.3 ± 9.3b,E 46.1 ± 11.5a,E 45.9 ± 7.1a,E 
     
Cryopreserved samples (N= 16 subjects)     
Background SBs (% DNA in tail, PBS)                     10.5 ± 5.0a,D 9.7 ± 4.4a,D 11.8 ± 6.0a,D 10.1 ± 4.2a,D 
Net H2O2-induced DNA damage 
 (% DNA in tail) 
22.7 ±6.1a,F 19.1 ± 7.0b,F 21.3 ± 6.4a,F 20.6 ± 6.8a,F 
1Data are expressed ad mean ± SD. WB, wild blueberry; PL, placebo; SBs, strand breaks; PBS, 
phosphate buffer saline; EB, endonuclease buffer. 
a,bData with different letters within the same row are significantly different (P≤0.05) 
(C,D);(E,F)Data with different letters between the rows are significantly different (P≤0.05) 
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2.4 CONCLUSIONS 
 
In conclusion, this study documented that the cryopreservation protocol used is 
associated with DNA damage in PBMCs. The response of the dietary treatment to levels of 
oxidized bases, measured as FPG-sensitive sites, seem comparable in fresh and frozen PBMCs 
even after 1 year storage. On the contrary, cell protection against oxidative insult is consistently 
different between fresh and frozen cells; thus stored cells can be successfully used for the 
detection of FPG-sensitive sites, that but not for the resistance against oxidative insult. By 
considering the results obtained, fresh cells represent the best samples to use for studying the 
effect of dietary intervention through comet assay.  
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3.1 AIM OF THE STUDY  
 
To assess the effect of an intervention on endothelial function, reliable methods are needed. In 
this regard, several invasive and non-invasive techniques have been developed during the last 
years to evaluate endothelial function. Reactive hyperaemia peripheral arterial tonometry (RHI-
PAT) may be considered a valid non invasive approach to measure endothelial function, since it 
is reported to be correlated significantly with the most used frequently method called flow 
mediated dilation (FMD) assessed by brachial artery ultrasound scanning (Flammer et al., 2012; 
Santos-Garcia et al., 2011; Stout 2009; Bonetti et al., 2004). However, information on the 
between-day and within-day variability of PAT technique should be evaluated and these studies 
are lacking and conflicting for this technology. The aim of the present study was to determine 
the inter-day variability of the PAT measure.  
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3.2 MATERIALS AND METHODS  
 
3.2.1 Subjects recruitment 
 
A homogeneous group of thirteen subjects, recruited from the student population of the 
University of Milan, were selected according to the following criteria: 20-30 years of age, 
moderate smoking (about 15 cigarette/day; smoking from at least 5 years), moderate physical 
activity (25-30 min per day of brisk walk or jog) and moderate alcohol consumption (up to 10-
14 drinks per week). Subjects were selected on the basis of an interview by a dietitian to 
evaluate their dietary habits. Subjects declared no history of cardiovascular, coronary, diabetes, 
hepatic, renal, or gastrointestinal diseases, anemia, chronic asthma, allergy, traumas of the arms 
or hand, fingers, atopic dermatitis, thyroid disturbance, depression, anxiety, palpitations and 
chronic backache. Moreover, subjects were supplement/drug/ medication free for at least one 
month before the beginning of the study. 
 
3.2.2 Experimental design 
 
Subjects came in the laboratory in the morning, and the RHI was tested on two consecutive days. 
Following overnight fasting, the subjects were allowed to have a light breakfast before 7 am on 
each of the study days. Tests were performed in a dark, noise-and climate-controlled (22-24°C) 
room, at the same hour.  
Moreover, on a subgroup of 5 people, RHI measurement was repeated, on the same day, for 
three times. The analysis was performed at baseline and after 1h, 2h and 3h.      
 
3.2.3 Evaluation of peripheral arterial function  
 
Endothelial-dependent vasodilation in the small finger arteries was assessed by Endo-PAT2000 
(Itamar Medical Ltd., Caesarea, Israel). 
The Endo-PAT equipment consists of two finger-mounted probes, which include a system of 
inflatable latex air-cushions within a rigid external case; pulsatile volume changes of the 
fingertip are sensed by a pressure transducer, located at the end of each probe, and transferred to 
a personal computer where the signal is band pass-filtered (0.3 to 30 Hz), amplified, displayed, 
and stored. For the evaluation, subjects are in the supine position and both hands on the same 
level in a comfortable, thermoneutral environment. Arterial systolic and diastolic blood pressure 
and heart rate frequency are measured before starting the test. A blood pressure cuff is placed on 
one upper arm (study arm), while the contralateral arm served as a control (control arm). After a 
10-min equilibration period, the blood pressure cuff on the study arm is inflated to 60 mmHg 
above systolic pressure for 5 min. The cuff is then deflated to induce reactive hyperemia (RH) 
while the signals from both PAT channels (Probe 1 and Probe 2) are recorded by a computer. 
The technique provides values for the calculation of Reactive Hyperemia Index (RHI), which 
gives an indication of the endothelial vasodilator function. The Reactive Hyperemia Index (RHI) 
is a ratio of the post-to-pre occlusion PAT amplitude of the tested arm, divided by the post –to-
pre occlusion ratio of the control arm. 
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3.2.4 Statistical analysis 
 
Statistical analysis was performed using STATISTICA software (Statsoft Inc, Tulsa, OK, USA). 
Distribution of data was checked for normality by Shapiro-Wilk test. Analysis of variance was 
used to identify differences between-day (day 1 vs day 2) of RHI. Individual subject’s CV (%) 
of RHI measured inter-day was used to determine the variability of the measure. Moreover, one 
way ANOVA, with time as dependent variable, was used to ascertain the difference in RHI 
values within the same day.   
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3.3 RESULTS AND DISCUSSION 
 
Endothelial nutrition is a new and innovative concept that involves the study of the role of 
dietary compound on endothelial function. Preventing the endothelium from becoming 
dysfunctional with nutrients or non-nutrients that modulate vascular tone and maintain 
homeostasis of the endothelium is of importance to human health. Invasive techniques, which 
involve intracoronary or intrabrachial infusions of vasoactive agents, are still considered to be 
the gold standard for early detection of endothelial dysfunction (Higashi & Yoshizumi 2003). 
However, when studying the effect of a dietary intervention on endothelial function, the ideal 
technique for measuring must be non-invasive, reliable, reproducible, cheap and easy to 
perform.  
The most popular clinical method to assess vascular endothelial function is FMD by means of 
brachial artery ultrasound scanning (BAUS) (Onkelinx et al., 2012; Corretti et al., 2002). This 
technique, recommended by the international Brachial Artery Reactivity Task Force, is based on 
the percent change of the brachial artery diameter (%FMD) caused by reactive hyperaemia 
(Corretti et al., 2002). 
Recently, an alternative method named Endo-PAT (peripheral arterial tone), has been developed 
and widely used to identify patients with coronary endothelial dysfunction. Endo-PAT showed a 
significant correlation with FMD (r = 0.55, p < 0.0001) and has the advantage of being operator 
independent (Patvardhan et al., 2010; Hamburg & Benjamin 2009).  
When studying the effect of an intervention on endothelial function, the between-day 
variability of this technique should be evaluated and studies are lacking for the PAT method. 
The main finding of the present study was the inter-day reproducibility of the RHI measure. In 
Figure 3.3.1A are reported the values of RHI obtained in two consecutive days in each subject. 
The average data obtained from the two PAT measures (2.03±0.30 at day 1 and 2.03±0.29 at day 
2) did not demonstrate (p=0.94) a difference on vascular function. Intra-subject variability of 
RHI presented as CV (%) was very low and around 4% (Figure 3.3.1B). 
 
Fig. 3.3.1 (A) Individual values of RHI measured in two consecutive days; (B) intra-subject 
variability of RHI   
 
 
 
 
 
 
3.3 Results and Discussion 
________________________________________________________________ 
 
 
70
 
 
RHI, reactive hypermia index 
 
Missing information regards also within-day variability of RHI following a multiple 
measurement. In this regard, the International Brachial Artery Reactivity Task Force suggested 
that intra-day multiple measurements may promote vasodilation through NO production 
(Corretti et al., 2002). This effect may eventually mask improvement of vascular function due to 
the treatment under study (i.e. overestimation).  
 
 
In the present study, we determined the within-day variability of PAT by repeating the 
measurements after 1h on the same day. Multiple measurements seemed to increase RHI for the 
tests at 1, 2, and 3 h with respect to baseline in all the subjects (Figure 3.3.2A). The raise was 
significantly different as documented by one-way ANOVA (p= 0.002; Figure 3.3.2B).  
 
Fig. 3.3.2 Mean (A) and individual values (B) of the reactive hyperimia index (RHI) following 
multiple measurements within-day 
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RHI, reactive hypermia index 
a,b,cData with different letters are significantly different (P<0.05) 
In particular, RHI increased significantly after 2 h (+38.2%; p=0.002) and 3h (+47.5%; 
p=0.0005) with respect to time zero, and for time 3h also significantly different compared to 1h 
(+22%; p=0.02). An increase, even if not significant, was also observed at time 1h with respect 
to baseline (+21%; p=0.057). Thus, it seems that the time-period among subsequent 
measurements is an important variable in this type of assessment and it should be seriously 
considered to avoid cross-over effects.  
These data seem in accordance with the observation of Liu et al., (2009) which documented a 
significant increase in the RHI when the PAT was measured at 0.5-hour intervals (for 2.5 h) 
indicating a crossover effect, but not at 1 h intervals (for 4 h) and 2 h intervals (for 12 h) in 
healthy male subjects. In addition, Forchhammer et al., (2012) demonstrated intra-day 
reproducibility in a group of healthy subjects whose vascular function was measured in four 
different occasions (in the morning, before and after lunch, in the afternoon) within the same 
day. 
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3.4 CONCLUSIONS  
In conclusion, the results of the research documented a high inter-day reproducibility of RHI 
values measured through PAT technology. These results are important since they confirm the 
reliability of the instrument and of the outcome obtained in different days. On the contrary, the 
variability of the repeated measurement of endothelial function at intervals of 1h was very high. 
This could prejudge the PAT system for repeated measurements in a relatively short time frame. 
This information is extremely important in many clinical, pharmacological or dietary 
intervention studies where the repeated measures are performed. Thus, further investigations are 
needed in order to clarify the intra-day reproducibility of the PAT technology to prevent a 
crossover effect. 
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4.1 AIM OF THE STUDY 
 
Blueberries contain several phenolic bioactive compounds, such as ACNs, that play a potential 
beneficial role in human health (Del Rio et al., 2010; Chong et al., 2010; Wang & Stoner 2008). 
The health benefits of ACNs are strictly dependent on their absorption, metabolism, distribution 
and excretion. Studies focusing on ACN absorption have shown that their bioavailability is very 
low, and less than 1 % of consumed amounts of ACNs (180-215 mg/day) is generally absorbed, 
and their maximum concentration in the blood is in the order of nanomolar levels (Yang et al., 
2011; Milbury et al., 2010).  
Some studies have reported that the inclusion of a blanching preconditioning step, applied to 
inactivate oxidative enzymes before tissue mechanical processing, may improve ACN recovery 
in berry products, such as blueberries (Syamaladevi et al., 2012; Brambilla et al., 2008; Rossi et 
al., 2003; Skrede et al., 2000). Whole fruit thermal processing may influence not only phenolic 
abundance but also food matrix environment and microstructure with possible implications on 
the bioaccessibility of phenolic compounds (Brambilla et al., 2011; Yang et al., 2011; Parada & 
Aguilera 2007). Since the influence of food processing on ACN absorption rate has been poorly 
investigated, the aim of this study was to examine whether blanching whole berries could affect 
the absorption of ACNs from two blueberry purées in healthy human volunteers. 
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4.2 MATERIALS AND METHODS 
 
4.2.1 Chemicals  
 
Standards of cyanidin (Cy)-, delphinidin (Dp)-, peonidin (Pn)-, petunidin (Pt)- and malvidin 
(Mv)-3-O-glucoside (glc), -3-O-galactoside (gal), and Cy- and Mv-3-O-arabinoside (Ara) were 
purchased from Polyphenols Laboratory (Sandnes, Norway). Folin-Ciocalteau reagent and 
standards of gallic acid, chlorogenic acid and cyanidin-3,5-diglucoside (CydG), as ACN internal 
standard (IS) were purchased from Sigma-Aldrich (St. Louis, MO). Folin-Ciocalteau was from 
Fluka Biochemicals. Sodium carbonate, sodium acetate, metaphosphoric acid (MPA), potassium 
chloride, potassium metabisulfite, hydrochloric acid, methanol, acetonitrile, acetone, formic acid 
and trifluoroacetic acid (TFA) were from Merck (Darmstadt, Germany). Water was obtained 
from a MilliQ apparatus (Millipore, Milford, MA). 
 
4.2.2 Blueberry products  
 
Thirty kilograms of blueberry fruit (Vaccinium corymbosum L., cv. Brigitta) were cleaned, 
individually quick frozen (IQF) in a tunnel (Thermolab, Codogno, Italy) operating at −50 °C air 
temperature and 4.5 m/s air speed, divided into three lots (L1, L2, L3) of 10 kg each and stored 
at −20 °C for 1 month until analysis (L1) and processing (L2, L3). Each lot of berries was 
divided into three aliquots (3.3 kg/aliquot) and processed into three trials (one trial/day). L2 was 
processed into purée (P) after partial thawing at 20°C for 1 h (NB) while L3 was immediately 
processed after steam-blanching for 3 min and tap water-cooling in a pilot steam blanching 
tunnel (Ghizzoni Dante and Figlio, Felino, Parma, Italia).12 Purées were prepared by 
homogenizing berries for 1 min in a commercial food processor (Moulinex, Paris, France). 
Then, 300 g aliquots of purées were packed in 400-mL plastic vessels, sealed under partial 
vacuum using a 25 ìm thick polypropylene film and frozen within 20 minutes at −20 °C. From 
each lot of processed berries, thirty purée servings were obtained, randomly divided into two 
groups and assigned to biochemical analysis (10 servings) and absorption trials (20 servings). 
 
4.2.3 Subject recruitment  
 
Ten healthy male subjects, aged 20.8 ± 1.6 y with body mass index (BMI) 22.5 ± 2.1 kg/m2, 
were recruited from the student population of the University of Milan according to the following 
inclusion criteria: no smoking; no history of cardiovascular, diabetes, hepatic, renal, or 
gastrointestinal diseases; and not having taken any supplement, drug, or medication for at least 
one month before the beginning of the study. Subjects were selected on the basis of an interview 
to evaluate their dietary habits and ensure that they were as homogeneous as possible, in 
particular for fruit and vegetable consumption. This was obtained by means of a food frequency 
questionnaire previously published and specifically revised to focus on food sources rich in 
antioxidants (Porrini et al., 1995). Exclusion criteria were: high (> 5 portions/day) or low (<2 
portions/day) intake of fruit and vegetables, habitual alcohol consumption (< 3 drinks per week 
were tolerated). Volunteers who followed a specific diet (e.g., vegetarian, vegan, or macrobiotic) 
and those who had a specific aversion for blueberry consumption were excluded. The inclusion 
criteria were: sex (male), ethnicity (Western European), BMI within normal range (from 19 to 
25 kg/m2), age (from 19 to 30 years), physical activity (more than 30 minutes/day and from 2 till 
4 days per week) and dietary habits as homogeneous as possible. On the basis of the 
questionnaire, ten volunteers were selected.  All participants gave informed consent and the 
study was approved by the Ethics Committee of the University of Milan.  
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4.2.4 Experimental design  
 
Subjects were deprived of ACN-rich food sources 10 days before experimentation. Each 
volunteer received a complete list of foods to be avoided; the list included ACN-rich foods such 
as berry fruits (i.e. blueberries, cranberries, raspberries, blackcurrants, elderberries) red wine and 
red/violet fruits (i.e. grapes, cherries, pomegranates, red apples, plums, eggplants, tomatoes, 
peppers), and other colored products (i.e. marmalade, jams, juices containing berries). The 
repeated measure crossover design was chosen to limit inter-individual variability. Subjects were 
randomly divided into two groups of five subjects each and consumed a portion of blanched-
purée (BL-P) or unblanched-purée (NB-P) in the following order: group 1 was assigned to the 
sequence BL-P/wash-out/NB-P, whereas group 2 followed the sequence NB-P/wash-out/BL-P. 
The two experimental treatments were separated by a 10 day wash-out period. The breakfast, 
lunch and dinner was standardized one day before the experiment and up to 48 days after purées 
consumption. Breakfast consisted of milk and biscuits (i.e. shortbread) while lunch consisted of 
two sandwiches (one with cooked ham and cheese and one with raw ham), For the dinner 
subjects could eat as first dish (pasta or rice with butter and cheese) and a steak with potatoes 
and two slices of white bread. Coffee, tea, wine, beer and chocolate were not allowed. 
Moreover, subjects were asked to exclude all ACN-containing foods as previously reported. On 
the scheduled day, after an overnight fast, subjects consumed a single dose of thawed NB-P or 
BL-P, providing approximately 300 mg of ACNs. The purées were consumed early in the 
morning and blood was collected by a phlebotomist at time 0 (before the consumption of 
blueberry purées) and after 1 h, 1.5 h, 2 h, 3 h, 4 h, 6 h and 24 h after BL-P or NB-P 
consumption. Blood samples were drawn into evacuated tubes with heparin as anticoagulant. 
Urines were collected 24 h before the experiment and then 24 and 48 h after BL-P or NB-P 
intake. To check for compliance to the dietary instructions, one day food record was kept by 
subjects 2 days before and 1 day after the intake of the blueberry purées. Moreover, a direct 
interview was scheduled with a dietitian. 
 
4.2.5 Phenolic analysis of the blueberry purées 
 
For each NB and BL purée samples, two vessels (2x300g) were thawed and analysis was 
conducted in duplicate on the product. Phenolic compounds were extracted in duplicate with a 
formic acid–water (5:95 v/v) solution according to Brambilla et al., (2008). A subsample (15 g) 
of each blueberry product was homogenized with the extraction solution (25 mL) and left at 
room temperature for 20 min in the dark before centrifuging at 6000 rpm for 5 min (PK 130 
Centrifuge, ALC International, Milan, Italy). The pellet following centrifugation was washed 
with 25 mL of the extraction solution and centrifuged at 6000 rpm for 5 min and the resulting 
supernatant was combined with the initial one.  
Spectrophotometric analysis of total phenolic content (TPC), monomeric anthocyanin pigment 
(MAP) and polymeric color (PC %) was carried out on the extracts with a UV4 UV/vis 
spectrometer (Unicam, Cambridge, U.K.). Total phenolic content, expressed as gallic acid 
equivalents (GAE), was measured by Folin-Ciocalteau assay; MAP, expressed as cyanidin 3-
glucoside equivalents (C3GE), was measured by a pH-differential method and PC % was 
measured by a bisulfite bleaching method (Singleton & Rossi 1965; Giusti & Wrolstad 1991). 
Chlorogenic acid and individual ACN compounds were analyzed by gradient-RP-HPLC and 
diode array detection according to Brambilla et al., (2008). The chromatographic system 
consisted of a PU 1580 pump (Jasco Co., Tokyo, Japan), a 250 × 4.6 mm i.d., 5 μm, Inertsil 
ODS-3 column, heated at 40°C, and a Jasco MD 2010 Plus photodiode array detector. The 
mobile phases consisted of acetonitrile and water/formic acid (90:10, v/v) and elution was 
performed at a flow rate of 0.5 mL min-1 by linear gradient steps. All the ACN monoglycosides  
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were expressed as C3GE and chlorogenic acid was expressed as mg 100g-1 FW by measuring 
detector response to the commercial standard. 
4.2.6 Vitamin C (ascorbic acid) analysis of the blueberry purées 
 
The ascorbic acid was extracted and determined by HPLC analysis according to Riso et al., 
(2005). Briefly, a sample (5 g), in duplicate, of blueberry purées (BL-P and NB-P) was 
homogenized and suspended in 10 mL of MPA (10 %), centrifuged at 3000  g for 1 minute, 
filtered and injected for HPLC analysis. Ascorbic acid was determined by means of a 
chromatographic system consisting of a model 510 system pump (Waters), a 5 µm Atlantis C18 
column (250 x 4.6 mm i.d.; Waters, Ireland) and an UV-Vis detector (Varian 9050). Samples 
were eluted with a mobile phase of 0.1% formic acid (1.4 mL/min) and the detection was 
achieved at 245 nm. The volume of injection was 50 µL. Chromatographic data were acquired 
by a Millenium 4.0 Workstation (Waters). 
 
4.2.7 Plasma separation 
 
Plasma was separated within 30 minutes after collection by centrifugation for 15 min at 2300 × g 
at 4°C. Two aliquots (1 mL) were acidified with TFA (1 %) to preserve ACN stability, 
centrifuged at 4500 × g for 1 minute and the supernatants were stored at −80 °C for no longer 
than 2 months. 
 
4.2.8 Anthocyanin extraction and analysis in plasma  
 
Anthocyanins were extracted from plasma using a Micro-Plate solid phase extraction (SPE) 
HLB Oasys Cartridge preactivated with methanol (500 μL) and washed with 500 μL acidified 
water (1% TFA). Plasma (400 μL) was diluted with 140 μL of acidified water (1% TFA) and 60 
μL of water containing Internal Standard (50 ng mL-1 of CydG) used to correct the loss of ACNs 
during sample preparation. Samples were vortexed, centrifuged and loaded onto the cartridge. 
Samples were drained under gravity and the cartridge was washed with acidified water (100 μL; 
1% TFA) and 100 μL of water-MethOH (80:20 v/v) acidified (TFA 0.1%). The ACNs were 
eluted from the cartridge using 50 μL of methanol containing TFA (0.1%) in order to 
concentrate 8 times the amount of ACNs in plasma. The filtered sample was collected and 20 μL 
were injected into an UHPLC MS/MS system for the analysis of individual ACNs, according to 
a method previously published Del Bo’ et al., (2010). The lower limit of detection was 1 ng mL-1 
for Mv-glc, 4 ng/mL for D-glc, and about 2 ng mL-1 for the other ACNs. For detailed 
information see Del Bo’ et al., (2010). 
 
4.2.9 Hippuric acid extraction and analysis in urine 
 
Urine (0.2 mL) was diluted with 1.8 mL of acidified water (0.1 % formic acid) and centrifuged 
at 900 × g for 10 min. The supernatant was collected and 20 μL were injected into the UHPLC 
system for the analysis according to a method previously published (Del Bo' et al., 2010). 
 
4.2.10 Statistical analysis 
 
Statistical analysis on plasma samples was performed by means of STATISTICA software 
(Statsoft Inc., Tulsa, OK, US), whereas that of the biochemical data on blueberry purées was 
carried out using Statgraphics version 7 (Manugistic Inc., Rockville, MD, USA) software 
package. Data obtained on plasma levels of ACNs were analyzed by a two-way ANOVA for 
repeated measures design, using the type of product and time as dependent factors. Differences  
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between means were further analyzed by the Least Significant Difference (LSD) test. 
Differences were considered significant at P ≤ 0.05. Data of physicochemical parameters of 
berries and blueberry purées, ACNs and phenolic composition were analyzed by one way 
analysis of variance (ANOVA procedure) and means were compared by Tukey’s test (P ≤ 0.05). 
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4.3 RESULTS AND DISCUSSION  
 
4.3.1 Composition and characteristic of the blueberry purées  
The ACN and phenolic profiles of the purée are reported in Table 4.3.1.  
 
Table 4.3.1 - Composition of the unblanched (NB-P) and blanched (BL-P) blueberry purées. 
Data are expressed as mean±SD. 
 
 
                                                                                           NB-P                             BL-P                  
TPC (mg GAE/100g FW)                                          242.43 ± 23.91b            285.17 ± 11.17a 
MAP (mg C3GE/100g FW)                                         88.78 ± 2.59a                92.73 ± 2.84a 
PC (%)                                                                           7.52 ± 1.61a                   2.51 ± 0.47b               
Chlorogenic acid (mg/100g FW)                                 30.09 ± 1.24b                 40.51 ± 3.21a 
Total anthocyanin (mg C3GE/100g FW)                   116.12 ± 6.98a               119.48 ± 6.51a 
 Dp-3-gal                                                                      19.04 ± 2.04b                26.76 ± 2.83a 
 Dp-3-glc                                                                        0.57 ± 0.11a                   0.41 ± 0.03b 
 Cy-3-gal + Dp-3-ara                                                   15.45 ± 1.27b                19.37 ± 1.39a 
 Cy-3-glc                                                                         0.51 ± 0.02a                  0.11 ± 0.05b 
 Pt-3-gal                                                                        12.31 ± 1.44a                14.18 ± 1.39a 
Cy-3-ara                                                                          1.77 ± 0.06a                  1.30 ± 0.10b 
Pt-3-glc                                                                           2.36 ± 0.10a                   2.18 ± 0.79a  
Peo-3-gal + Pt-3-ara                                                      8.07 ± 0.31a                   8.60 ± 0.50a 
Peo-3-glc                                                                         1.26 ± 0.04a                  0.32 ± 0.08b 
Mv-3-gal                                                                        31.18 ± 1.54a                 26.85 ± 1.70b 
Mv-3-glc                                                                          2.72 ± 0.08a                  1.14 ± 0.19b 
Mv-3-ara                                                                       16.71 ± 0.82a                 15.07 ± 1.11a 
TPC, total phenolic content; MAP, monomeric anthocyanin pigment, PC, polymeric color; Dp-
3-gal, delphinidin-3-galactoside; Dp-3-glc, delphidin-3-glucoside; Cy-3-gal + Dp-3-ara, 
cyanidin-3-galactoside + delphinidin-3-arabinoside; Cy-3-glc, cyanidin-3-glucoside; Pt-3-gal, 
petunidin-3-galactoside; Cy-3-ara, cyanidin-3-arabinoside; Pt-3-glc, petunidin-3-glucoside; 
Peo-3-gal + Pt-3-ara, peonidin-3-galactoside + petunidin-3-arabinoside; Peo-3-glc, peonidin-
3-glucoside; Mv-3-gal, malvidin-3-galactoside; Mv-3-glc, malvidin-3-glucoside; Mv-3-ara, 
malvidin-3-arabinoside. 
Data with different letters in the same row are statistically different at P ≤ 0.05 (Tukey’s test). 
 
Total phenolic content (TPC) and chlorogenic acid content was higher in BL-P compared to NB-
P while PC%, index of phenolic degradation products, was higher in NB-P. Total anthocyanin 
content, computed either by the pH differential method or the RP_HPLC detection, was not 
significantly different between the BL and NB samples. Galactoside and arabinoside forms were  
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the prominent compounds detected in the blueberry products with Mv-3-gal, and Dp-3-gal as the 
dominant ACNs, followed by Mv-3-ara, Cy-3-gal + Dp-3-ara and Pt-3-glc (14.4%, 13.3% and 
10.6%, respectively) in NB samples and by Cy-3-gal + Dp-3, Mv-3-ara and Pt-3-glc (16.7%, 
13% and 12.2%, respectively) in the BL samples. On the contrary, glucoside forms were 
detected at very low concentrations. Blanching had an influence on individual ACN amounts 
found in purées: the main differences concerning Dp-3-gal and Cy-3-gal + Dp-3-ara were higher 
in BL-P (+40. % and +25.3 %, respectively) and Mv-3-gal was higher in NB-P (+16.1%). The 
content in ACN-glucoside derivatives was relatively low in all the samples, but significantly 
higher in NB-P with respect to BL-P (7.42 vs 4.16 mg C3GE/100g FW respectively), especially 
for Dp-3-glc, Cy-3-glc and Mv-3-glc. The ascorbic acid content of berries was relatively low 
(0.8 mg/100g FW) and did not significantly change following purée processing.  
 
4.3.2 Plasma anthocyanins concentration after the consumption of unblanched and 
blanched blueberries purées. 
 
In Figure 4.3.2 are reported the plasma levels of ACN following the consumption of NB and BL 
blueberry purées. Only 3 of the 12 ACNs identified in the blueberry purées were detected in 
plasma. These compounds (Cy-3-glc, Mv-3-glc and Dp-3-glc) were present at low concentration 
in both purées. ACNs were rapidly absorbed and their plasma concentration increased 1 h after 
consumption, achieving their maximum concentration at 1.5 h. These levels decreased after 2 
and 3 h reaching baseline values after 4 h (Figure 4.3.2). Two-way ANOVA did not show on the 
whole a significant effect of processing on ACN-absorption, but a significant effect of time (P ≤ 
0.0001). However, post hoc comparisons demonstrated that plasma ACN concentrations were 
different at specific time–points; ACN absorption was higher (+25 %; P ≤ 0.05) after 1.5 h 
following BL-P intake (31.1 ± 11.4 nmol L-1) with respect to NB-P (24.9 ± 14.0 nmol L-1). 
Moreover, plasma ACN concentration tended to decrease after 2 h with respect to 1.5 h for both 
the purées, but remained significantly higher up to 2 h following only the intake of BL-P (24.9 ± 
10.1 nmol L-1 vs 14.3 ± 9.6 nmol L-1; P ≤ 0.001) (Figure 4.3.2a).  
Considering the absorption of single ACNs it has been observed a similar trend for malvidin and 
cyanidin. In particular, it has been documented a significant (P < 0.001) increase of Mv-3-glc 
after the intake of BL-P and NB-P. The concentration remained significantly higher up to 2 h 
after consumption with respect to 1 h following the intake of BL-P (15.9 ± 7.5 nmol L-1 vs 9.8 ± 
7.3 nmol L-1; P ≤ 0.01). Mv-3-glc was the only ACN detected after 3 h from the intake of both 
purées (1.7 ± 1.7 nmol L-1 in BL-P and NB-P) (Figure 4.3.2b). The same trend was observed for 
Cy-3-glc even if plasma concentrations were lower with respect to Mv-3-glc. Plasma Cy-3-glc 
concentrations were higher after BL-P intake with respect to NB-P both at 1.5 h (11.7 ± 4.3 
nmol L-1 for BL-P and 9.5 ± 5.2 nmol L-1 for NB-P; P ≤ 0.05) and at 2 h (9.0 ± 3.2 nmol L-1 for 
BL-P and 6.2 ± 3.2 nmol L-1 for NB-P; P ≤ 0.05) (Figure 4.3.2c). ACN-concentration remained 
significantly higher up to 2 h with respect to 1 h following the intake of BL-P (9.0 ± 3.2 nmol L-
1 vs 4.5 ± 2.6 nmol L-1; P ≤ 0.01). Additionally, Dp-3-glc exhibited similar time patterns as the 
other ACNs; however this compound was detected at low concentrations only in the plasma of 
few volunteers (4 out of 10; data not shown) who were also those having higher absorption of 
Mv and Cy- 3-glc, suggesting subject-specific absorption.  
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Figure 4.3.2- (A) Total plasma anthocyanin (ACNs), (B) Mv-3-glc and Cy-3-glc (C) 
concentration after the consumption of 300 g of unblanched (NB-P) and blanched (BL-P) 
blueberries purées.  
 
Data are present as mean ± SD. 
a BL-P significantly different with respect to NB-P at 1.5 h and 2 h; P ≤ 0.05 
b BL-P at 2 h significantly different with respect to BL-P at1 h; P ≤ 0.05  
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4.3.3 Total hippuric acid concentration in urine before after the consumption of 
unblanched and blanched blueberry purées.  
 
The levels of hippuric acid (expressed as total mg) detected in the urine collected 24 h before 
and 24 and 48 h after the consumption of BL-P and NB-P purée are reported in Figure 4.3.3. 
Statistical analysis did not show a significant effect of the type of purée, but confirmed a 
significant effect of time (P < 0.05). The intake of both purées significantly increased the 
excretion of hippuric acid after 24 h of blueberry consumption in both groups: BL-P (223 ± 124 
mg total vs 469 ± 282 mg total, P < 0.05) and NB-P (210 ± 101 mg total vs 544 ± 311 mg total, 
P < 0.05). The levels of hippuric acid decreased after 48 h from NB-P intake (130 ± 102 mg 
total) while they remained higher, even if not significantly, after the BL-P intake (367 ± 283 mg 
total) with respect to 24 h pre-intervention. These results suggest that ACNs and other phenolic 
compounds were absorbed, metabolized and excreted as hippuric acid within 24 until 48 h after 
the consumption of both purées. 
 
Figure 4.3.3 - Total hippuric acid concentration in urine before and 24 and 48 h after the 
consumption of 300 g of unblanched (NB-P) and blanched (BL-P) blueberry purées.  
 
 
NB-P, unblanched blueberry purée; 
BL-P, blanched blueberry purée; 
Data are present as mean ± SD. 
Data with different letters are significantly different P  0.05 
 
a  a  
a  
ab  
b  
b  
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4.4 CONCLUSIONS 
The impact of food processing on ACN-rich products has not been thoroughly investigated but, 
it is of crucial importance for the food industry since it is recognized that thermal treatment is 
detrimental for nutrients and bioactive components of the food (Tadapaneni et al., 2012). Thus, 
food processing based on mild technologies has been developed to preserve or enhance nutritive 
value of foods. In the present study it has been investigated whether a blanching treatment could 
enhance ACN and phenolic content in a blueberry purée compared to a purée that did not 
undergo the blanching treatment.  
The results of the research documented that, even though the mild blanching process applied had 
no significant effect on total ACN content (possibly due to the low degree of exposure to native 
enzymes responsible for ACN degradation typical of the juice-making process), berry blanching 
enhanced ACN absorption from minimally processed blueberry purées 1.5 and 2 h after 
consumption. This is particularly important for food industry that wants to put on the market 
food products rich in bioactive compounds with potential beneficial effects on human health. 
In addition, these results confirmed that ACNs from foods are poorly absorbed and their 
presence in the blood is limited at few hours as also supported by several studies (Yang et al., 
2011; Mazza et al., 2002). The influence of processing on ACN metabolism and health effects in 
vivo should be the focus of future research.   
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5. DEVELOPMENT OF ACUTE DIETARY INTERVENTION STUDY TO EVALUATE 
THE EFFECT OF A SINGLE PORTION OF BLUEBERRY IN THE MODULATION OF 
MARKERS OF OXIDATIVE STRESS AND ENDOTHELIAL FUNCTION IN YOUNG 
NONSMOKER VOLUNTEERS  
 
5.1 Aim of the study  
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5.1 AIM OF THE STUDY 
 
It has been previously documented that blueberries are rich sources of phenolic compounds such 
as ACNs. Despite their low bioavailability, ACNs play several beneficial effects on human 
health and, in this regard, it has been hypothesized that their intake could improve cell protection 
against oxidative stress and affect endothelial function in humans. The aim of the study was to 
investigate the effect of one portion (300g) of blueberries on selected biomarkers of oxidative 
stress and antioxidant protection (endogenous and oxidatively-induced DNA damage) and of 
vascular function (changes in peripheral arterial tone and plasma nitric oxide levels) in a group 
of healthy male subjects.  
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5.2 MATERIALS AND METHODS 
  
5.2.1 Blueberry and placebo preparation 
 
Blueberries (Vaccinium corymbosum L. “Brigitta”) from a single batch were purchased, sorted 
and immediately frozen by Individually Quick Freezing technique in a tunnel (Thermolab, 
Codogno, Italy) and stored at −20°C until use. For the study, BB was partially thawed (3 h at 
20°C) and homogenized in a commercial food processor (Moulinex, Paris, France). They were 
packed in portions of 300 g, thermally sealed under partial vacuum (Minipack-Torre S.P.A., 
Dalmine, Bergamo, Italy) and stored at −20°C for few days. The evening before the experiment, 
the BB portions were placed at + 4°C for defrosting. The BB was gelatinous in texture; for this 
reason, a control jelly (CJ) was utilized as placebo. The CJ was prepared by suspending 20g of 
food grade gelatin (Universal, Peru) and adding the same amount of BB sugars (about 27.1g 
total, 16.4g fructose and 10.7 g glucose) in 200mL of hot water. The CJ containing a food 
colorant was prepared the day before the experiment and stored at +4°C to solidify.  
 
5.2.2 Study subjects 
 
Ten healthy male subjects, ages 20.8 ± 1.6 y with body mass index (BMI) 22.5 ± 2.1 kg/m2, 
were recruited from the student population of the University of Milan according to the following 
inclusion criteria: no smokers; no history of cardiovascular, diabetes, hepatic, renal, or 
gastrointestinal diseases; not consuming any dietary supplement, drug, or medication for at least 
one month before the beginning of the study. Subjects were selected on the basis of an interview 
to evaluate their dietary habits and ensure that they were as homogeneous as possible, in 
particular for fruit and vegetable consumption. This was obtained by means of a food frequency 
questionnaire previously published and specifically revised to focus on food sources rich in 
antioxidants (Porrini et al., 1995). Exclusion criteria were: hypertension (systolic blood pressure 
> 140 mm Hg and/or diastolic blood pressure > 90 mm Hg), high total serum cholesterol (TSC) 
(≥5.17 mmol L-1), low high-density lipoprotein (HDL)-cholesterol (<1.03 mmol L-1), high low 
density lipoprotein (LDL)-cholesterol (≥3.36 mmol L-1), high triglycerides (TG) (≥1.69 mmol L-
1), overweight (BMI ≥ 25 kg/m2). Other exclusion criteria were as follows: high (> 5 
portions/day) or low (< 2 portions/day) intake of fruit and vegetables and alcohol consumption 
(< 3 drinks per week were acceptable). Volunteers who followed a specific diet (e.g. vegetarian, 
vegan, or macrobiotic) and those who had a specific aversion for blueberry consumption were 
excluded. All participants gave informed consent and the study was approved by the Ethics 
Committee of the University of Milan. 
 
5.2.3 Experimental design 
 
Subjects were deprived of ACN-food sources 10 days before experimentation. Volunteers 
received a complete list of ACN-rich foods to be avoided; the list included ACN-rich foods such 
as berry fruits, red wine and red/purple fruits and other colored products. Subjects were 
randomly divided into two groups of 5 subjects each: group 1 was assigned to the sequence 
BB/wash-out/CJ, whereas group 2 followed the sequence CJ/wash-out/BB. The study was 
scheduled at different days to avoid interference between withdrawal times and the study of 
vascular function. Each analysis was separated by 10 days of wash-out period. Lunch and dinner 
was standardized and subjects were asked to exclude all ACN-containing foods and maintain 
their regular lifestyle. For the present study, peripheral arterial function was measured in two 
consecutive days since no inter-day effect on vascular function was observed as previously 
reported. Baseline levels were assessed the first day, while the second day peripheral arterial 
function was evaluated 1h after the intake of BB or CJ.  
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The subjects fasted overnight before the ingestion of one portion of thawed BB (providing 348 
mg of ACNs) or CJ (without ACNs). The products were consumed early in the morning and 
blood was collected by a phlebotomist at time 0 (before the consumption of the products) and 1 
h, 2 h and 24 h after BB or CJ consumption. Samples were drawn into evacuated tubes with 
heparin as anticoagulant. One day-food records were kept by subjects in each experimental 
session, 2 days before and 1 day after the intake of the BB product to check compliance to the 
dietary instructions. Moreover, a direct interview by a registered dietitian was scheduled. 
 
5.2.4 Sugars, total phenolics and vitamin C determination in blueberry and control jelly 
 
A duplicate sample (50 g) of BB was homogenized and suspended in water, centrifuged at 3000 
x g for 1 minute, filtered and injected for the analysis. Glucose and fructose were quantified by 
ultra performance liquid chromatography (UPLC). The LC consisted of an Alliance model 2695 
(Waters, Milford, MA) equipped with a model 2996 photodiode array detector (Waters), coupled 
with mass spectrometry (Micromass, Beverly, MA). The separation was carried out on BEH 
Amide column (150 x 2.1 mm, 1.7 µm, Waters) at 35°C. Solvents were triethanolamine 0.2% 
and acetonitrile: triethanolamine at a ratio of 74:26 (v/v). The elution gradient was linear and the 
amount of triethanolamine was increased from 0% to 35% in 11 minutes at set up flow rate of 
0.45 mL min-1. The calibration curve was obtained from 5 mg L-1 to 100 mg L-1 for both sugars.  
The percentage relative standard deviation was calculated after injecting standard solutions of 
glucose and fructose at increasing concentration (2 mg L-1, 10 mg L-1 and 50 mg L-1) in 
quintuplicates. Phenolic compounds were extracted in duplicate from BB by applying a formic 
acid-water (5:95 v/v) extracting media, according to Brambilla et al., (2008). Total phenolic 
compounds of the extracts were analyzed by Folin-Ciocalteau assay (Giusti & Wrolstad 2001) 
and expressed as gallic acid equivalents (GAE mg/100g) while chlorogenic acid and individual 
anthocyanin compounds were analyzed by gradient reverse phase-high-performance liquid 
chromatography (RP-HPLC) and diode array detection and were quantified by measuring 
detector response to the commercial standards (Polyphenols Laboratory Sandes, Norway) 
(Brambilla et al., 2008). All ACN monoglycosides were expressed as cyanidin 3-glucoside 
(CydG) equivalents. Vitamin C was extracted and determined by HPLC analysis as previously 
described by Riso et al., (2005). 
 
5.2.5 Analysis of biochemical parameters 
 
Blood samples were drawn and immediately centrifuged at 1000 x g for 15 minutes for plasma 
and serum separation and stored at -80°C until analysis. A general laboratory clinical assessment 
was performed in serum including evaluation of lipid profile (TG, TSC, LDL-C and HDL-C) 
and glucose. All these parameters were determined using a cobas® 6000 analyzer series (Roche 
Diagnostics, North America). Plasma concentration of total NO was calculated by measuring the 
products of oxidation (nitrate and nitrite) by a Fluorometric Assay Kit (Cayman Chemical, Ann 
Arbor, MI). 
 
5.2.6 Anthocyanin extraction and analysis in plasma 
 
Two aliquots of plasma (1 mL) were acidified with trifluoroacetic acid (TFA, 1%), vortexed, 
and centrifuged for 1 min at 4500 x g and the supernatant was stored at -80°C until analysis. 
Anthocyanins were extracted from plasma and analyzed as previously described and reported in 
Del Bo' et al., (2012, 2010). 
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5.2.7 Evaluation of endogenous DNA damage and cell resistance against H2O2-induced 
DNA damage 
 
Peripheral blood mononuclear cells (PBMCs) were separated from whole blood by density 
gradient centrifugation as previously described (see study1) and reported in Collins et al., 
(1996). The FPG-sensitive sites (oxidized purines) and cell resistance against H2O2 (500 μmol L-
1, 5 min) induced DNA damage were evaluated by the comet assay as previously described in 
detail (see study 1) and reported in previous studies (Collins et al., 1996; Riso et al., 1995). 
 
5.2.8 Evaluation of peripheral arterial function  
 
Endothelial-dependent vasodilation in the small finger arteries was assessed by a non-invasive 
plethysmographic method (Endo-PAT 2000, Itamar Medical Ltd., Caesarea, Israel) based on the 
registration of pulsatile blood volume in the fingertips of both hands. Detailed information is 
previously described (see study 2) and reported in a previous study by Bonetti (2005). 
 
5.2.9 Statistical analyses  
 
Sample size has been calculated taking into account the expected variation in the DNA damage 
as primary endpoint. In particular, ten subjects were calculated to be more than sufficient to 
evaluate a difference of DNA damage after the wild blueberry drink of 8.6 (standard deviation 
0.9), with alpha=0.05 and a statistical power of 80%. This number of subjects is comparable to 
those used in previous acute studies (Schroeter et al., 2006; Heiss et al., 2005; Grassi et al., 
2005). For the evaluation of vascular function modulation (secondary endpoint). Moreover, the 
"repeated measure" experimental design used, in which each subject acts as its own control, 
reduces the error variance, thus increasing statistical power.  
Statistical analysis was performed by means of STATISTICA software (Statsoft Inc., Tulsa, OK, 
US). Data were analyzed by ANOVA for repeated measures design. ANOVA with treatment 
(BB vs CJ) and time (before and after each treatment) as dependent factors was applied to 
evaluate the effect of BB on the variables under study. Differences were considered significant 
at P ≤ 0.05; post-hoc analysis of differences between treatments was assessed by the Least 
Significant Difference (LSD) test with P ≤ 0.05 as level of statistical significance. Data are 
presented as means ± standard deviation (SD). 
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5.3 RESULTS AND DISCUSSION 
 
5.3.1 Composition and characteristic of the blueberry portion  
 
The nutritional composition of BB is reported in Table 5.3.1. One portion (300 g) of the BB 
provided about 27 g of sugars (fructose and glucose), 348 mg of ACNs (malvidin-galactoside, 
delphinidin-galactoside and malvidin-arabinoside making up more than 50% of the total ACN 
content), 727 mg of total phenolic acids, 90 mg of chlorogenic acid and 2.4 mg of vitamin C. 
The CJ provided the same amount and type of sugars but not of bioactive compounds.   
 
Table 5.3.1-Nutritional composition of Blueberry (BB) and Control jelly (CJ) 
 
                                                                                              BB                           CJ 
Sugars  (g/100g)   
  Fructose                                                                        5.46  0.10                      5.46 
  Glucose                                                                         3.57  0.18                      3.57 
Total phenolic compounds (mg/100g)                          242.4 ± 23.9                        - 
Chlorogenic acid (mg/100g)                                           30.1 ± 1.2                          -     
Total anthocyanins (mg/100g)                                      116.1 ± 6.9                          - 
Vitamin C (mg/100g)                                                       0.8 ± 0.1                           - 
 
Data are expressed as means ± SD. 
 
5.3.2 Baseline characteristics of the subjects 
 
Baseline anthropometric and clinical characteristics of the subjects are reported in Table 5.3.2. 
All data were within the range of normality.  
 
Table 5.3.2- Subject characteristics 
 
    Value 
Age (y)                                                                              20.8 ± 1.6 
Body weight (kg)                                                              72.4 ± 7.9 
BMI (kg/m2)                                                                      22.5 ± 2.1 
Systolic pressure (mmHg)                                               119.5 ± 8.8 
Diastolic pressure (mmHg)                                               76.5 ± 6.2 
Heart rate (beat/min)                                                         62.2 ± 15.3 
Glucose (mmol L-1)                                                           3.92 ± 0.26  
TG (mmol L-1)                                                                   1.69 ± 0.49 
TSC (mmol L-1)                                                                   4.4 ± 0.64 
HDL-C (mmol L-1)                                                            1.44 ± 0.33 
LDL-C (mmol L-1)                                                            2.43 ± 0.37 
Data (n=10) are expressed as means  SD.  
BMI, body mass index; TG, triglycerides; TSC, total serum 
cholesterol; HDL-C, high density lipoprotein cholesterol; LDL-C, 
low density lipoprotein cholesterol.  
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5.3.4 Plasma concentration of anthocyanins following blueberry and control jelly intake 
 
Anthocyanins were not detectable in plasma at baseline while a significant (P<0.001) increase 
was observed 1 h (13.7 ± 10.7 nmol L-1) and 2 h (18.7 ± 6.4 nmol L-1) after BB intake. Twenty 
four hours after BB intake, ACNs were not detected in plasma; CJ intake resulted in 
undetectable plasma ACNs. 
 
5.3.5 Effect of blueberry and control jelly intake on the levels of DNA damage in 
peripheral blood mononuclear cells  
 
Results on DNA damage in PBMCs are reported in Table 5.3.3. Oxidized purines evaluated 
through quantification of FPG-sensitive sites were not significantly different following BB or CJ 
intake. This result is not surprising, since the levels of FPG-sensitive sites measured, represent 
the steady-state levels of oxidatively damaged DNA. In fact, in cultured cells, the repair of FPG-
sensitive sites has a half-life of 1-5 hours (Danielsen et al., 2009; Collins & Harrington 2002; 
Will et al., 1999). Since the removal of DNA damage is not instantaneous, a long-term 
supplementation may be required to establish the possibility of in vivo efficacy of BB intake on 
endogenous levels of oxidatively damaged DNA (Collins et al., 2001).  
Concerning the levels of H2O2-induced DNA damage, a significant reduction was observed 1 h 
after the BB intake (from 51.7  4.9% to 42.7  8.7%, P  0.01), while no effect was observed 
after CJ (from 53.2 ± 2.8% to 52.0 ± 7.6%, P = 0.84). These results are in accordance with 
several human studies that demonstrated a greater protection against oxidatively induced DNA 
damage after the intake of single portions of fruits such as kiwifruits, apples and orange juice 
(Collins et al., 2001; Brivida et al., 2007; Guarnieri et al., 2007; Nguyen et al., 2003). However, 
the protective effect was transient and the level of H2O2-induced DNA damage returned to 
baseline 2 h after BB consumption when the maximum peak of plasma ACNs absorption was 
observed. Moreover, no correlation between the decrease in H2O2-induced DNA damage and the 
increase in ACNs was observed at 1 h. Thus, the protection against oxidative stress may be 
related to other bioactives absorbed, apart from ACNs (e.g. phenolic acids, vitamin C), acting 
alone or synergistically. Moreover, these compounds could have indirectly activated signaling 
mechanisms of defense (e.g. antioxidant enzymes through gene expression modulation) (Nguyen 
et al., 2003) even though the effect is not maintained at 2 h.  
 
5.3.6 Effect of blueberry and control jelly intake on peripheral arterial function and 
plasma nitric oxide levels 
 
The results on peripheral arterial function (RHI), blood pressure, heart rate and plasma NO 
levels, before and after BB and CJ consumption, are reported in Table 5.3.4. According to the 
repeated measures ANOVA, after either the WB or the CJ intake no significant changes were 
observed for RHI. The mean percent change in RHI index between the pre-to-post intervention 
was +0.5% (95% CI: -7.3%, +8.4%) after the BB and -4.5% (95% CI: -13.9%, +6.4%) after the 
CJ intake. On the whole, a high inter-individual variability was observed in the percent changes 
of RHI index (Figure 1). The lack of the effect in the modulation of peripheral vascular function 
could be dependent to the fact that subjects enrolled were healthy, and most of them had RHIs in 
the normal range (RHI ≥ 1.67). It seems plausible that improvements may be easier 
demonstrated in subjects with reduced vascular function (e.g. elderly or subjects who are at risk 
of developing cardiovascular diseases) or after vascular function challenges (e.g. following 
smoking or a meal rich in saturated fats). Another reason of the lack of modulation may be 
attributed to the length of time between the BB intake and the measurement of peripheral arterial 
function (1 h). In fact, more time may be necessary to detect an effect on endothelial function 
following the exposure to BB and their bioactives. In this regard, Dohadwala et al., (2011) 
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documented an improvement of vascular function at 2 h and 4 h after the intake of a single 
portion of cranberry juice.  
 The observations on vascular function are consistent with the non-significant changes 
in plasma total NO, indicating that the short-term consumption of BB did not exert any changes 
on this marker. Plasma NO concentration is mainly related to systemic inflammation, whereas 
the endothelium-derived nitric oxide synthase (eNOS) production of NO is a minor contributor 
to alterations in its plasma concentration. Nevertheless, it cannot exclude that a modulation of 
NO occurred at the endothelial level without influencing total plasma levels. In fact, some 
authors reported that the consumption of red wine polyphenols and flavonoids may affect 
vascular function by increasing the half-life of endothelial NO (Dell'Agli et al., 2004). Future 
studies with larger numbers of subjects or with established vascular dysfunction may contribute 
to our understanding of the beneficial effects of BB consumption on vascular function and 
modulation of plasma NO levels.  
 
Table 5.3.3- Effect of one portion of Blueberry (BB) or control jelly (CJ) on background, FPG 
sensitive sites and H2O2-induced strand breaks. 
 
                                                                                T 0h              T 1h                 T 2h             T 24h 
BB consumption  
Background SBs (% DNA in tail, EB)                5.9  0.6         5.9  0.6       5.9  0.7       6.0  0.4 
Net FPG-sensitive sites (% DNA in tail)           12.9 ±  2.1      13.1 ± 1.4     12.4 ± 1.4     13.1 ± 1.4 
Background SBs (% DNA in tail, PBS)               8.1  1.0         7.9  1.5     8.00  1.2      8.3  0.8 
Net H2O2-induced DNA damage                        51.7 ± 4.9       42.7 ± 8.7*   50.1 ± 9.1    51.8 ± 6.1        
% (DNA in tail) 
 
CJ consumption  
Background SBs (% DNA in tail, EB)                 6.1  0.6         5.9  0.6        5.9  0.3      5.8  0.2 
Net FPG-sensitive sites (% DNA in tail)            14.5 ± 3.6       14.1 ± 2.7      13.5 ± 1.4    14.8 ± 0.8    
Background SBs (% DNA in tail, PBS)               8.5  0. 7         8.6  0.9       8.7  0.1      8.4  0.3 
Net H2O2-induced DNA damage                        53.2 ± 2.8        52.0 ± 7.6     54.0 ± 4.3    49.3 ± 3.3  
(% DNA in tail)    
Data (n=10) are expressed as means  SD. 
SBs, strand breaks; PBS, phosphate-buffered saline; EB, endonuclease buffer; 
FPG,formamidopyrimidine DNA glycosylase. 
*Significantly different from each other time point in the same row and different with respect to 
each other time point for the CJ group; p≤0.01. 
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Table 5.3.4- Effect of one portion of Blueberry (BB) or Control jelly (CJ) intake on peripheral 
arterial function and total plasma nitric oxide (NO). 
 
Variables                                                  Before BB          After BB        Before CJ            After CJ      
Systolic blood pressure (mmHg)              119.5 ± 8.8      118.6 ± 8.7       122.5 ± 10.4     121.3 ± 8.5       
Diastolic blood pressure (mmHg)              76.5 ± 6.2         73.9 ± 6.1        76.3 ± 4.8         76.3 ±10.3                                                                       
Heart rate (beat min-1)                                62.2 ± 15.3       61.6 ± 17.1      63.5 ± 16.4       64.0 ± 19.8                                        
RHI                                                            1.96 ± 0.39       1.95 ± 0.30      1.94 ± 0.30        1.82 ± 0.16 
Total NO (µmol L-1)                                  64.6 ± 22.5       64.7 ± 18.6      72.2 ± 21.8        72.5 ± 18.7        
 Data (n=10) are expressed as means  SD. 
RHI; reactive hyperemia index; NO, nitric oxide. 
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5.4 CONCLUSIONS 
 
This study documented that blueberries can improve cell resistance against H2O2-induced DNA 
damage, and this is in accordance with previous observations with other fruits provided in single 
portions, thus supporting the importance of consuming vegetable foods regularly.  
Concerning vascular function, no effect was observed after acute consumption of blueberry. 
These results are in contrast with what found by other authors following consumption of red 
wine polyphenols, flavonoids, cocoa and chocolate (Hollenberg & Fisher 2007; Vlachopoulos et 
al., 2005; Fisher et al., 2006; Alexopoulos et al., 2008; Oyama et al., 2010; Vlachopoulos et al., 
2003).  
Possible study limitations are the small sample size of healthy subjects considered for the 
demonstration of an effect on vascular function at one time-point after the ingestion of BB.  
Future studies with larger numbers of subjects or with established vascular dysfunction may 
contribute to our understanding of the beneficial effects of BB consumption on vascular function 
and modulation of plasma NO levels.  
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6. DEVELOPMENT OF A POTENTIAL HUMAN MODEL OF CHRONIC TOBACCO 
SMOKERS FOR STUDYING VASOACTIVE PROPERTIES OF FOOD BIOACTIVES   
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6.1 AIM OF THE STUDY 
 
Based on results obtained in a previous study where we failed to demonstrate a significant 
modulation of endothelial function following the consumption of a single blueberry portion in 
healthy subjects with normal endothelial function, in this study we used smoking as a stressor to 
develop a model that may better demonstrate the effect of dietary vasoactive compounds. In fact, 
cigarette smoking is one condition that increases oxidative stress but also impairs endothelial 
function (Sanada et al., 2012; Giudice et al., 2012). The mechanism of endothelial dysfunction 
through smoking seems to be attributed to the known/unknown substances (i.e. reactive oxygen 
and nitrogen species, nicotine, benzopyrene and acrolein) that constitute the particulate (tar) and 
gaseous phase of the cigarette (Yamaguchi et al., 2007). These components may induce 
oxidative stress and inflammation with detrimental consequences on endothelial function and 
arterial stiffness. Endo-PAT device has been proposed as a tool to evaluate the effect of a single 
or long term exposure to foods/bioactive compounds on arterial function with conflicting results. 
This may depend on subject characteristics such as age, sex, dietary and life-style habits, 
physical activity, but also on the specific experimental protocol used. 
The aim of the present study is to evaluate whether peripheral arterial tone (PAT) technology is 
able to detect the acute effects of a single cigarette smoking on RHI and arterial stiffness in a 
homogeneous group of young healthy male smokers. If PAT technology will be able to detect 
the acute effects of smoking a single cigarette on peripheral arterial function, then this model 
could be applied for studying the impact of dietary bioactive compounds in the modulation of 
endothelial function administered before smoking.  
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6.2 MATERIALS AND METHODS 
 
6.2.1 Subject recruitment 
 
In order to select a homogeneous group of healthy smokers volunteers, twenty males,23.6 ± 2.9 
average age with body mass index (BMI) of 22.4 ± 2.2 kg/m2, were recruited from the student 
population of the University of Milan according to the following criteria:20-30 years of age, 
moderate smoking (about 15 cigarette/day; smoking from at least 5 years), moderate physical 
activity (25-30 min per day of brisk walk or jog) and moderate alcohol consumption (up to 10-
14 drinks per week). Subjects were selected on the basis of an interview by a dietitian to 
evaluate their dietary habits. Exclusion criteria were as follows: hypertension (systolic blood 
pressure >140 mm Hg and/or diastolic blood pressure >90mmHg), hyperglycemia (> 10 mmol 
L-1), hypertriglyceridemia (TG≥1.69 mmol L-1) and hypercholesterolemia [total serum 
cholesterol (TSC) ≥5.17 mmol L-1, low high-density lipoprotein (HDL) cholesterol (C) <1.03 
mmol L-1, high low density lipoprotein (LDL) cholesterol (C) ≥3.36 mmol L-1], and overweight 
(BMI ≥ 25 kg/m2). Endothelial dysfunction (RHI <1.67) was another important exclusion 
criterion. Subjects declared no history of cardiovascular, coronary, diabetes, hepatic, renal, or 
gastrointestinal diseases, anemia, chronic asthma, allergy, traumas of the arms or hand, fingers, 
atopic dermatitis, thyroid disturbance, depression, anxiety, palpitations and chronic backache. 
Moreover, subjects were excluded if they were taking any supplement, drug, or medication for at 
least one month before the beginning of the study. The study was approved by the Ethics 
Committee of the University of Milan. All participants gave informed consent and the study was 
in accordance with the Declaration of Helsinki. 
 
6.2.2 Experimental design  
 
Subjects were asked to avoid foods containing substances with possible vasoactive properties 10 
days before experimentation. Specific attention was devoted to foods such as chocolate, berry 
fruits (i.e. blueberries, cranberries, raspberries, blackcurrants and elderberries), red wine and 
red/violet fruits, green tea. All participants were asked to refrain from physical activity from the 
day before the experiment and to smoke the number of cigarettes/day declared in the 
questionnaire (i.e. about 15 cigarettes per day). The day before the experiments and during the 
trial, breakfast, lunch and dinner were standardized. The standardized dinner was consumed by 
9.00 pm and only one coffee was permitted with a maximum of two coffees during the day. 
Moreover alcoholic drinks or soft drinks were not allowed.  
With regard to the establishment of the peripheral arterial function evaluation protocol, we chose 
to avoid multiple measurements (involving 5 min arterial occlusion through cuff inflation) in a 
short time-period, because it could promote vasodilatation through NO production between test 
and re-test measurements (Onkelink et al., 2012). Thus, peripheral arterial function was 
measured in two consecutive days. Moreover, we pre-tested the protocol to exclude an inter-day 
variability and to assure a within-subject repeatability of basal levels of RHI as also reported by 
other authors (Munir et al., 2008; Bonetti 2005). For the present study, overnight fasted 
volunteers came to our laboratory early in the morning; baseline levels were assessed the first 
day, while the second day RHI was evaluated 20 minutes after smoking a single cigarette 
(containing approximately 8 mg of Tar by volume, 0.6 mg of nicotine and 9 mg of carbon 
monoxide) in a smoking room close to the test room. Systolic blood pressure (SyBP), diastolic 
blood pressure (DiPB) and HR were measured before and 5 min after smoking and at the end of 
the evaluation of peripheral vasoreactivity (30 min after smoking). The study design is reported 
in Figure 6.2.1. 
 
 
6.2 Materials and Methods  
________________________________________________________________ 
 
 
102
 
Figure 6.2.1- Experimental design 
 
BP, blood pressure; HR, heart rate; RHI, reactive hyperemia index; dAix, digital augmentation 
index; dAix@75, digital augmentation index standardized for heart rate of 75 bpm 
 
6.2.3 Determination of peripheral arterial function and arterial stiffness  
 
Endothelial-dependent vasodilation in the small finger arteries was assessed by Endo-PAT2000 
as previously reported (see study 2). 
The EndoPAT device also generates dAix, strongly correlated to aortic Aix, calculated from the 
shape of the pulse wave recorded by the probes during baseline (Reisner et al., 2007). Because 
dAix is influenced in an inverse and linear manner by heart rate, the dAix was automatically 
normalized by the tool for a heart rate of 75 bpm (dAix@75).  
 
6.2.4 Analysis of biochemical parameters 
 
Blood samples were drawn and immediately centrifuged at 1000 x g for 15 minutes for plasma 
and serum separation and stored at -80°C until analysis. A general laboratory clinical assessment 
was performed in serum including evaluation of lipid profile (TG, TSC, LDL-C and HDL-C) 
and glucose. All these parameters were determined using a cobas® 6000 analyzer series (Roche 
Diagnostics, North America).  
 
6.2.5 Statistical analysis  
 
Sample size was calculated according to the expected variation in the primary endpoint 
considered (RHI). In particular, twenty subjects was calculated to be sufficient to evaluate a 
difference of RHI after smoking of 0.28 (standard deviation 0.40), with alpha=0.05 and a 
statistical power of 80%. Statistical analysis was carried out with the Statistical Package for the 
Social Sciences (SPSS inc., Chicago, Ill., U.S.) release 17.0 for Windows. Pre and post-smoking 
differences were tested by paired Student’s t-test while ANOVA with repeated measures, 
followed by the Bonferroni test for multiple comparisons, was used to assess the variation over 
time of SyBP, DiBPand HR. The relationship among different variables was determined using  
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the Pearson correlation test. The level of significance was set at p≤0.05. Data are presented as 
mean and standard deviation. 
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6.3 RESULTS AND DISCUSSION 
 
6.3.1 Baseline characteristics of the study population 
 
The baseline clinical and anthropometric characteristics of the enrolled volunteers are reported 
in Table 6.3.1. Subjects presented normal vital signs (SyBP/DiBP<140/90 mmHg) and 
endothelial function (RHI >1.67) consistent with their young age.  
 
Table 6.3.1- Antropometric and clinical characteristics of the subjects1 
 
Variables               Value 
Age (years)                                        23.6 ± 2.9 
Hight (cm) 
Weight (kg) 
BMI (kg/m2) 
       177.2 ± 6.7 
         70.6 ± 9.9 
         22.4 ± 2.2 
Neck circumference (cm) 
Shoulder circumference (cm) 
Chest circumference (cm) 
Waistline circumference (cm) 
Paunch circumference (cm) 
Sides circumference (cm) 
Arm circumference (cm) 
         36.2 ± 1.4 
       109.5 ± 5.1 
         94.2 ± 6.3 
         78.2 ± 6.2 
         83.0 ± 5.9 
         95.5 ± 6.3 
         27.6 ± 2.4 
Forearm circumference (cm)          25.7 ± 1.8 
Wrist circumference (cm)          17.0 ± 0.6 
Smoking  (cigarettes/day)           15   ±  2 
SyBP (mm Hg)        114.4 ± 7.9 
DiBP (mm Hg)          72.2 ± 6.3 
HR (beat min-1)          57.9 ± 7.6 
RHI 
dAix (%) 
dAix@75 (%) 
         2.23 ± 0.28 
          -8.6 ± 8.0 
        -18.4 ± 8.9 
 
1Data are expressed as means ± SD (standard deviation). BMI, body mass index; SyBP, systolic 
blood pressure; DiBP, diastolic blood pressure; HR, heart rate; RHI, reactive hyperemia index; 
dAix, digital augmentation index; dAix@75, digital augmentation index standardized for heart 
rate of 75 bpm. 
 
6.3.2 Effect of smoking on arterial function and digital augmentation index 
In Table 6.3.2 are reported the values of RHI, dAix and dAix@75 before and after smoking. 
Peripheral arterial function was impaired 20 min after cigarette smoking. The mean percentage 
change pre-to post smoking was –27.6% (95%CI: -35.2%, -20.1%). The RHI reduction was 
observed in all subjects and was particularly high insomuch as to induce endothelial dysfunction 
(RHI<1.67) in more than a half of the subjects (13 out of 20).  
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Table 6.3.2 - Arterial function and arterial stiffness before and 20 min after smoking a cigarette 
in the overall population1 
 
                                  Before smoking              20 min After smoking         p value2 
RHI                             2.23 ± 0.28                       1.59 ± 0.27                        0.0001 
dAix (%)                      -8.6 ± 8.0                        -13.1 ± 7.5                         0.007 
dAix@75 (%)             -18.4 ±8.9                        -18.0 ± 8.9                         0.785 
1N =20. Data are expressed as means ± SD. RHI, reactive hyperemia index; dAix, digital 
augmentation index; dAix@75, digital augmentation index standardized for heart rate of 75 
bpm. 
2Overall P value for t-TEST with Statistical Package for the Social Sciences (SPSS inc., 
Chicago, Ill., U.S.) 
 
These results are in accordance with Xue et al. (2011) that found a significant reduction in 
peripheral arterial function, 20 min after smoking, but in contrast with the study of Moerland et 
al., (2012) in which no effect was observed at 30 and 90 min after smoking. 
The divergence between these results may dependent from the protocol used and subject 
population. It is widely recognized that gender, age and physical activity may strongly influence 
endothelial function (Black et al., 2008). In present study, the protocol has been standardized 
through a selection of a homogeneous population for gender, age, smoking habits, alcohol 
consumption, dietary habits, physical activity and anthropometric characteristics, and thus, it has 
been possible to document that acute smoking induces peripheral arterial dysfunction in young 
male smokers. 
Regarding dAix, in contrast from data previously reported (Doonan et al., 2010), a 
significant reduction was observed after smoking (Table 6.3.2). However, because heart rate has 
been shown to be a possible confounder in the determination of dAix, no effect was observed 
after normalization for heart rate (dAix@75) (Weber et al., 2004). This could be attributed to the 
young age of smokers having a better compensatory response to an injury (Seet et al., 2012; 
Nishiyama et al., 2008). 
 
6.3.3 Effect of smoking on blood pressure and heart rate 
 
Several studies suggest that impaired microvascular function contributes to an increase in blood 
pressure and heart rate. Figure 6.3.1 shows the values of blood pressure and heart rate before and 
after smoking. Repeated measures ANOVA analysis, revealed a significant variation over time 
(P<0.001) of SyBP, DiBP and HR; in particular all parameters assessed 5 min after smoking 
were significantly higher with respect to baseline and after RHI. The mean percent change pre-to 
post smoking was +13.8% (95%CI: +11.4%, +16.2%) for SyBP, +10.2% (95%CI: +6.4%, 
+14%) for DiBP and +12.8% (95% CI: +6.2%, +19.4%) for HR. This effect was transient and 
the values fell to baseline after 30 min.  
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Figure 6.3.1- Variation of systolic and diastolic blood pressure (A) and heart rate (B) in the 
overall population over time.  
 
 
SyBP, systolic blood pressure; DiBP, diastolic blood pressure; HR, heart rate 
*Data not significantly different 
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6.3.4 Correlation among endothelial function, arterial stiffness and vital signs 
 
The correlation among endothelial function variables and vital signs in the overall population is 
presented in Table 6.3.3. As shown, endothelial function was not correlated with blood pressure 
values, HR and dAix and dAix@75. Only baseline dAix@75 and post-smoking dAix@75 
variables correlated with pre-smoking HR (R = 0.503; P = 0.024) and with both pre-smoking (R 
= 0.593; P = 0.006) and post-smoking (R = 0.496; P = 0.026) HR levels, respectively.  
 
Table 6.3.3 - Correlation coefficients among endothelial function variables and vital signs in 
the overall population. 
 
N = 20  SyBP_B DiBP_B HR_B SyBP_S DiBP_S HR_S 
RHI_B R  .255 -.033 .315 .063 -.259 .411 P value .278 .889 .176 .792 .270 .072 
RHI_S R  .012 .007 -.156 .079 .309 .127 P value .960 .976 .513 .742 .185 .592 
dAix_B R  -.349 -.094 .156 -.110 -.174 -.149 P value .132 .693 .513 .643 .463 .531 
dAix_S R  -.370 -.065 -.019 .045 -.066 -.274 P value .108 .785 .935 .850 .784 .242 
dAix@75_B R  -.072 .259 .503 .088 .092 .230 P value .762 .270  .024* .712 .699 .329 
dAix@75_S R  -.146 .326 .593 .125 .183 .496 P value .539 .161  .006* .600 .440 .026* 
 
B, baseline; S, after smoking; RHI, reactive hyperemia index; dAix, digital augmentation index; 
dAix@75, digital augmentation index standardized  for heart rate of 75 bpm; SyBP, systolic 
blood pressure; DiBP, diastolic blood pressure; HR, heart rate. R, correlation coefficient 
 
6.3.5 Correlation among endothelial function, arterial stiffness and biochemical 
parameters 
 
Diet and nutritional status can affect endothelial function and arterial stiffness. It is widely 
recognized that high circulating levels of triglycerides and cholesterol are associated with 
endothelial dysfunction and impairment of arterial stiffness in the brachial artery (Wilkinson et 
al., 2002). However, the association in the small and distal arteries is not well understood. 
Twelve out of the twenty volunteers recruited, gave their consent to provide a blood sample for 
biochemical analysis. Data obtained were used to test the relationship between parameters of 
nutritional status and arterial function measurements. Data on lipid profile (total, HDL and LDL 
cholesterol, and triglycerides), glycaemia (fasting blood glucose) and vitamin status (folate and 
vitamin B12) were within the range of normality (Table 6.3.4).   
No correlation was observed between serum cholesterol and RHI, and dAix@75 at baseline, 
while a positive and interesting correlation was observed between total serum cholesterol levels 
at baseline and the levels of dAix@75 after smoking (Table 6.3.5). This may suggest that people 
with high serum cholesterol levels exhibit a higher vessel stiffness following smoking. This is an 
important finding not only in underlying the role of cholesterol for arterial function even in 
young individuals, but also suggesting that lipid profile characterization may be useful when 
considering subjects enrolled in studies on endothelial function. 
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Table 6.3.4 - Baseline biochemical parameters in a sub-sample.1 
 
Variables Value 
TSC, (mmol L-1) 4.16 ±  0.54 
LDL-cholesterol, (mmol L-1) 1.5  ± 0.34 
HDL-cholesterol, (mmol L-1) 2.17 ± 0.41 
TG, (mmol L-1) 1.04 ± 0.42 
Fasting glucose, (mmol L-1) 3.89 ± 0.67 
Folate, (ng mL-1) 6.4 ± 1.9 
Vitamin B12, (pg mL-1) 403 ± 105 
1N=12. Data are expressed as means ± SD. 
LDL, low density lipoprotein; HDL, high density lipoprotein; TG, triglycerides; TSC, total 
serum cholesterol. 
 
Table 6.3.5-Correlation coefficients among endothelial function variables and baseline 
biochemical parameters in a sub-sample. 
 
N=12 
 
 TSC_B HDL-C_B LDL-C_B TG_B GLC_B VitB12_B Folate_B 
RHI_B R  .125 -.532 .397 .391 -.208 -.074 -.145 P value .714 .092 .226 .235 .540 .830 .672 
RHI_S R  -.213 -.037 -.222 -.074 -.483 -.225 -.328 P value .529 .914 .513 .829 .132 .506 .324 
dAix_B R  .190 .408 .020 -.200 -.149 .203 .406 P value .577 .213 .953 .555 .662 .549 .215 
dAix_S R  .307 .521 -.022 .033 -.391 -.093 .058 P value .359 .101 .949 .924 .234 .786 .865 
dAix@75_B R  .488 .332 .341 .071 -.260 .398 .409 P value .128 .319 .305 .836 .440 .225 .211 
dAix@75_S R  .681 .360 .466 .290 -.063 .429 .394 P value  .021* .276 .148 .388 .855 .188 .230 
B, baseline; S, after smoking; RHI, reactive hyperemia index; Aix, augmentation index, Aix@75 
standardized  for heart rate of 75 bpm; TSC, total serum cholesterol; HDL-C, high density 
lipoprotein-cholesterol; LDL-C, low density lipoprotein-cholesterol; TG, triglycerides; GLC, 
glycaemia; R, correlation coefficient. 
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6.4 CONCLUSIONS 
 
In conclusion, acute cigarette smoking increased arterial blood pressure and heart rate and 
reduced peripheral arterial function, measured by peripheral arterial tonometry, in young 
moderate smokers. The experimental model described here, where a decrease of RHI is easily 
induced by cigarette smoking could be useful in studying the impact of dietary vasoactive 
compounds in modulating peripheral arterial function.  
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7. DEVELOPEMT OF ACUTE DIETARY INTERVENTION STUDY TO EVALUATE 
THE EFFECT OF A SINGLE PORTION OF BLUEBERRY IN THE MODULATION OF 
MARKERS OF OXIDATIVE STRESS, INFLAMMATION AND ENDOTHELIAL 
FUNCTION IN A HOMOGENEOUS GROUP OF YOUNG SMOKER VOLUNTEERS  
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7.1 AIM OF THE STUDY 
 
It has been previously "set up” a potential human model for studying the effects of smoking on 
peripheral arterial function by Endo-PAT2000. In that study, we demonstrated that PAT 
technology was able to detect a peripheral arterial dysfunction following a single cigarette 
smoking in a homogeneous population of smoker volunteers. Thus, in the present study, we 
proposed to use the same human model for studying the impact of blueberry consumption in the 
modulation of RHI and markers of oxidative stress, endothelial function and inflammation. 
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7.2 MATERIALS AND METHODS 
 
7.2.1 Subject recruitment 
 
Sixteen healthy male smokers, 23.6 ± 2.9 average age and BMI of 23.0 ± 1.9 kg/m2, were 
recruited from the student population of the University of Milan according to the following 
criteria: 20-30 years of age, moderate smoking (about 15 cigarette/day), moderate physical 
activity (25-30 min per day of brisk walk or jog) and moderate alcohol consumption (up to 10-
14 drinks per week). Subjects were recruited on the basis of an interview by a dietitian to 
evaluate their dietary habits. This was obtained by means of a food frequency questionnaire 
previously published (Porrini et al., 1995) and revised focusing on berry consumption. Subjects 
were excluded from the study for the following reasons: hypertension (systolic blood pressure > 
140 mm Hg and/or diastolic blood pressure > 90 mm Hg), fasting glycaemia (< 5.5 mmol L-1), 
hypertriglyceridemia (TG ≥1.69 mmol L-1) and hypercholesterolemia (total serum cholesterol 
(TSC) ≥5.17 mmol L-1, low HDL cholesterol (HDL-C) <1.03 mmol L-1, high LDL cholesterol 
(LDL-C) ≥3.36 mmol L-1), endothelial dysfunction (RHI <1.67) and overweight (BMI ≥ 25 
kg/m2). Other exclusion criteria were: history of cardiovascular, coronary, diabetes, hepatic, 
renal, or gastrointestinal diseases, traumas of the arms or hand, fingers, atopic dermatitis, thyroid 
disturbance, depression, anxiety, palpitations and chronic backache. Subjects were excluded if 
they were taking any supplement or medications for at least one month before the beginning of 
the study. The study was performed in accordance with the ethical standards laid down in the 
1964 Declaration of Helsinki and approved by the Ethics Committee of the University of Milan. 
All participants signed informed consent form. 
 
7.2.2 Experimental design 
 
Volunteers were selected for a repeated measures crossover study (Figure 7.2.1) and randomly 
assigned to 3 different groups: 1-smoking (S); 2-control treatment (300 mL of water with sugars 
+ smoking (CS); 3-blueberry treatment (300 g of blueberry + smoking (BS).  
 
Figure 7.2.1- Randomized cross-over experimental design. 
 
G, group; W&S, water + sugars 
 
Each protocol was separated by 7 days of wash-out period. Since sugar seems to affect 
endothelial function (Ceriello et al., 2008), a drink formulated with water and sugars has been 
chosen to mimic the glycaemic response that is produced after blueberry consumption. Subjects 
were deprived of polyphenol vasoactive substances 10 days before experimentation. Specific 
attention was devoted to food such as chocolate, berry fruits (i.e. blueberries, cranberries, 
raspberries, blackcurrants, and elderberries), red wine and red/violet fruits, and green tea. 
Volunteers abstained also from drinking caffeine-rich beverages and limited coffee to three per 
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day. The day before the experiment and during the trial, breakfast, lunch and dinner were 
standardized. Breakfast consisted of milk and biscuits (i.e. shortbread) while lunch was 
composed of two sandwiches (one with cooked ham and cheese and one with raw ham). During 
dinner, subjects could eat pasta or rice with butter and cheese, and a steak with potatoes and two 
slices of white bread. The dinner was consumed by 9.00 pm. Only one coffee was permitted at 
the end of the dinner. No alcoholic drinks or soft drinks were permitted. Moreover, all 
participants were asked to refrain from physical activity from the day before the experiment and 
to continue smoking the number of cigarettes/day as declared in the questionnaire.  
Also for the present study, peripheral arterial function was measured in two consecutive days. 
Therefore, overnight fasted volunteers came in our laboratory early in the morning; baseline 
levels were assessed the first day. The second day, subjects consumed a portion of blueberry or a 
control drink or nothing and smoked one cigarette. The protocol was set to measure peripheral 
arterial function 2 h after blueberry intake; these conditions were chosen by considering 
previous observations on the beneficial effect on endothelial function observed at this specific 
time-point following the intake of a polyphenol-rich food (Dohadwala et al., 2011; Loffredo et 
al., 2011). The cigarette, containing approximately 6 mg of Tar by volume, 0.5 mg of nicotine 
and 0.9 mg of carbon monoxide, was smoked 1 h and 40 min after blueberry or control drink 
consumption. Reactive hyperemia index (RHI), and digital augmentation index (dAix) were 
tested 20 min after smoking. Systolic (Sy), and diastolic (Di) blood pressure (BP), and heart rate 
(HR) were measured before and 5 min after smoking a cigarette and at the end of the endothelial 
function measurement. Blood pressure and heart rate were measured before and 5 min after 
smoking and at the end of the evaluation of peripheral vasoreactivity (30 min after smoking).  
 
7.2.3 Determination of peripheral arterial function and arterial stiffness 
 
Endothelial-dependent vasodilation in the small finger arteries was assessed by Endo-PAT2000. 
In addition to the RHI it has been also reported the Framingham RHI (F-RHI), which was 
automatically calculated using, however, a different post-occlusion hyperaemia period (90 to 
120 s) without baseline correction factor. The F-RHI, that has been shown to correlate with other 
CVD risk markers (Hamburg et al., 2008), was expressed as natural log of the resulting ratio. 
The EndoPAT device also generates dAix, strongly correlated to aortic Aix, calculated from the 
shape of the pulse wave recorded by the probes during baseline (Munir et al., 2008). Because 
Aix is influenced in an inverse and linear manner by heart rate, the dAix was automatically 
normalized by the tool for a heart rate of 75 bpm (dAix@75). 
 
7.2.4 Biochemical Measurements 
 
Blood samples were drawn and immediately centrifuged at 1000 x g for 15 min. for serum 
separation and stored at -80°C until analysis. A general laboratory clinical assessment was 
performed in serum, including evaluation of lipid profile (TG, TSC, LDL-C and HDL-C), and 
glucose. All these parameters were determined using standard laboratory methods (Del Bo’ et 
al., 2013a). 
 
7.2.5 Evaluation of endogenous DNA damage and cell resistance against H2O2-induced 
DNA damage 
 
Peripheral blood mononuclear cells (PBMCs) were separated from whole blood by density 
gradient centrifugation as previously reported (Study 1). The FPG-sensitive sites (oxidized 
purines) and cell resistance against H2O2 (500 μmol L-1, 5 min) induced DNA damage were 
evaluated by the comet assay as previously described in detail (Study 1). 
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7.2.6 Evaluation of marker of inflammation and endothelial function 
 
Serum was obtained within 1 h, by centrifugation for 15 min at 2300 x g at 4°C. Markers of 
inflammation and endothelial function such as: intercellular adhesion molecule-1 (ICAM-1), 
vascular cell adhesion molecule-1 (VCAM-1), vascular endothelial growth factor (VEGF), 
interleukin-8 (IL-8), were measured by Bio" plex Pro TM Array. 
 
7.2.7 Preparation of blueberry portion and control-drink 
 
Blueberries (Vaccinium corymbosum L. “Brigitta”) from a single batch were purchased, sorted 
and immediately frozen by Individually Quick Freezing technique in a tunnel (Thermolab, 
Codogno, Italy) and stored at −20°C until use. For the study, 300g of blueberry was thawed at + 
4°C overnight. The control-drink was prepared daily, by suspending in 300 mL of water the 
same amount of sugars found in the blueberry. No bioactive compounds were added in the 
control drink.  
 
7.2.8 Sugars, anthocyanins, total phenolics and vitamin C determination in blueberry 
portion  
 
Sugar (glucose and fructose) content was quantified by ultra high pressure liquid 
chromatography-mass spectrometry as previously described (Del Bo’ et al., 2013a). Individual 
ACNs were analyzed by high performance liquid chromatography (HPLC) analysis (Del Bo’ et 
al., 2010), while total phenolic compounds were analyzed by Folin-Ciocalteau assay (Singleton 
& Rossi 1965) and expressed as gallic acid equivalents (mg/100g). Vitamin C (ascorbic acid) 
was extracted and determined by HPLC analysis as previously described by Riso et al. (2005). 
 
7.2.9 Statistical analysis  
 
Sample size has been calculated taking into account the expected variation of RHI as primary 
endpoint considered. In particular, by considering our previous observations (Del Bo’ et al., 
2013), sixteen subjects were calculated to be sufficient to evaluate a difference of RHI after 
blueberry intake of 0.30 (standard deviation 0.40), with alpha=0.05 and a statistical power of 
80%. Moreover, the "repeated measure" experimental design in which each subject acts as its 
own control, allows reduction of the error variance.  
Statistical analysis was performed by means of STATISTICA software (Statsoft Inc., Tulsa, OK, 
US). The Shapiro-Wilk test was applied to verify the normal distribution of the variables. Data 
of the variables under study were analyzed by one way ANOVA with time (before and after 
smoking) or treatment (smoking vs consuming a portion of blueberry + smoking vs consuming a 
control drink + smoking) as dependent factors.  The variables of the treatment were reported as 
the percentage change (i.e. [after treatment-before treatment]/ before treatment *100). The mean 
changes are described as mean with 95% confidence interval (CI). Differences are considered 
significant at p ≤ 0.05; post-hoc analysis of differences between treatments was assessed by the 
Least Significant Difference (LSD) test with p ≤ 0.05 as level of statistical significance. Data 
presented as mean values standard error of the mean (SEM). 
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7.3 RESULTS AND DISCUSSION 
 
7.3.1 Baseline characteristics of the study population 
The baseline clinical and anthropometric characteristics of the enrolled volunteers are reported 
in Table 7.3.1. Subjects presented normal vital signs (SyBP/DiBP<140/90 mmHg), endothelial 
function (RHI >1.67), serum lipid profile (TG, TSC, LDL-C and HDL-C), glucose, consistent 
with their young age. 
 
Table 7.3.1- Anthropometric and clinical characteristics of the subjects at baseline (n=16)1 
1Data are expressed as mean ± SEM. SyBP, systolic blood pressure; DiBP, diastolic 
blood pressure; HR, heart rate; RHI, reactive hyperemia index; F-RHI, Framingham 
reactive hyperemia index; dAI, digital augmentation index; dAI@75, digital 
augmentation index standardized for heart rate of 75 bpm; TSC, total serum 
cholesterol; HDL-C, high density lipoprotein cholesterol; LDL-C, low density 
lipoprotein cholesterol. 
 
Variables         Value 
Age (years)                                        23.6 ± 0.7 
Height (cm) 
Weight (kg) 
BMI (kg/m2) 
       178.1 ± 1.7 
         73.1 ± 2.3 
         23.0 ± 0.5 
Neck circumference (cm) 
Shoulder circumference (cm) 
Chest circumference (cm) 
Waistline circumference (cm) 
Abdominal circumference (cm) 
Hip circumference (cm) 
Arm circumference (cm) 
         36.6 ± 0.3 
       110.3 ± 1.3 
         94.8 ± 1.7 
         79.5 ± 1.7 
         84.2 ± 1.5 
         97.5 ± 1.2 
         28.2 ± 0.5 
Forearm circumference (cm)          26.1 ± 0.4 
Wrist circumference (cm)          17.2 ± 0.1 
Smoke (cigarettes/day)           15   ±  1 
SyBP (mm Hg)        116.0 ± 1.7 
DiBP (mm Hg)          76.1 ± 2.1 
HR (beat min-1)          63.3 ± 2.9 
RHI 
F-RHI 
dAI(%) 
dAI@75 (%) 
TSC (mmol L-1) 
HDL-C (mmol L-1) 
LDL-C (mmol L-1) 
Triglycerides (mmol L-1) 
Glucose (mmol L-1) 
         2.23 ± 0.07 
         0.65 ± 0.07 
          -8.6 ± 2.0 
        -18.4 ± 2.2 
         4.13 ± 0.08 
         1.43 ± 0.10 
         2.20 ± 0.10  
         1.01 ± 0.08 
         4.34 ± 0.17 
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7.3.2 Composition and characteristics of the blueberry portion and control drink 
 
Blueberries provided about 27g of sugars (16.4g of fructose and 10.6g of glucose), and 
approximately 309mg of ACNs (malvidin-galactoside, delphinidin-galactoside, petunidin-
galactoside and malvidin-arabinoside were the dominant compounds), 856mg of total phenolic 
acids and 2.4mg of ascorbic acid. The control drink provided the same amount and type of 
sugars but no bioactive compounds.  
 
7.3.3 Effect of smoking on reactive hyperemia index and arterial stiffness 
 
In Table 7.3.2 are reported the values of RHI, F-RHI, dAix and dAix@75 before and after 
smoking. Peripheral arterial function, measured through the digital hyperemic response by the 
RHI, was impaired after 20 min of smoking.  
 
Table 7.3.2- Arterial function and arterial stiffness measure before and 20 min after smoking a 
cigarette (n=16)1 
 Before smoking               20 min After smoking             p value2 
RHI 
F-RHI 
   2.23 ± 0.08 
   0.65 ± 0. 08                      
   1.64 ± 0.07 
 0.31 ± 0.07                      
0.0001 
0.002 
dAix (%)                          -7.8 ± 2.1                             -14.1 ± 1.8                           0.003 
dAix@75 (%)                -18.8 ±2.2                             -19.1 ± 2.2                           0.819 
1Data are expressed as mean ± SEM. RHI, reactive hyperemia index; F-RHI, Framingham 
reactive hyperemia index; dAix, digital augmentation index; dAix@75,  digital augmentation 
index standardized  for heart rate of 75 bpm. 
2Overall P value for one-way ANOVA with STATISTICA (Statsoft Inc., Tulsa, OK, US).  
 
The RHI reduction was particularly high insomuch as to induce an endothelial dysfunction 
(RHI<1.67) in more than a half of the subjects (9 out of 16) and a reduction in the others (Figure 
7.2.2a). A significant impairment was also observed for F-RHI (Table 7.3.2). The F-RHI 
reduction occurred in 13 out of 16 subjects, while a small increase with respect to baseline value 
was observed in 3 subjects (Figure 7.2.2b). The deleterious effects observed are in accordance 
with several studies (Gül et al., 2011; Bard et al., 2010; Lekakis et al., 1997) and with ther 
previous observation in which it has been reported that smoking induced a significant reduction 
(-27.6%) of RHI in young healthy smokers (Del Bo’ et al., 2013b).  
Regarding dAix, a significant (p=0.003) reduction was also observed (Table 7.3.2), while no 
significant (p=0.819) effect was detected after normalization for heart rate (dAix@75), as also 
confirmed in the study previously reported. These results are in agreement with those studies in 
which no effect was observed on arterial stiffness after acute smoking in young smokers (Seet et 
al., 2012), but in contrast with those that showed increase in arterial stiffness in older smokers 
(Rehill et al., 2006). Thus, the lack of an effect or the apparent improvement for dAix could be 
dependent of the age of volunteers. Young people have more elastic walls able to counteract the 
vasoconstriction induced by smoking (Rehill et al., 2006). 
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Figure 7.2.2-Individual values of reactive hyperemia index (A) and Framingham reactive 
hyperemia index (B) measured by before and 20 minutes after smoking a single cigarette in a 
group of smokers (n = 16). 
 
 
RHI, reactive hyperemia index; F-RHI, Framingham reactive hyperemia index 
 
7.3.4 Effect of smoking on blood pressure and heart rate 
 
Short-term smoking has also been shown to increase blood pressure and heart rate. In the present 
study, it has been documented that acute cigarette smoking impaired blood pressure and heart 
rate. Smoking a single cigarette significantly increased the levels of SyBP (+13%), DiBP 
(+10%), and HR (+15%). This effect was transitional and the values dropped to baseline 30 min 
after smoking (Table 7.3.3). These results are in accordance with data reported by Lekakis et al. 
(1997) and Stefanadis et al. (1997), who documented a prompt increment in heart rate and blood 
pressure during the first 5 min after smoking probably attributed to an increase in circulating 
levels of catecholamines that seem to reach a maximum concentration after 5-10 min. from 
smoking and to return to baseline levels after 30 min (Lekakis et al., 1997). 
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Table 7.3.3- Blood pressure and heart rate, before, 5 and 30 min after smoking a cigarette (n 
=16)1 
1Data are expressed as mean ± SEM. SyBP, systolic blood pressure; DiBP, diastolic blood 
pressure; HR, heart rate  
2Overall P value for one-way ANOVA with STATISTICA (Statsoft Inc., Tulsa, OK, US).  
 
7.3.5 Effect of smoking on markers of oxidative stress, inflammation and endothelial 
function  
 
The impairment of vascular function and blood pressure may be related to an increase of 
oxidative stress or inflammatory status. In fact, smoking elevates the circulating levels of 
potential blood vessel vasoconstrictor agents, pro-inflammatory cytokines and the damage of 
several macromolecules such as lipids and DNA due to a rapid decrease of antioxidant status. 
This condition increases immediately after smoking by inducing hypertension and endothelial 
dysfunction (Bard et al., 2010; Csiszar et al., 2009). In Table 7.3.4 are reported the effect of 
cigarette smoking on the levels of DNA damage in a subgroup of 6 subjects. No significant 
effect was also observed for the levels of DNA damage measured as FPG-sensitive sites and 
DNA strand breaks, before and after smoking in the group of subjects (Table 7.3.4).  
 
Table 7.3.4- Effect of cigarette smoking on background FPG sensitive sites, and H2O2 induced 
strand breaks. (n=6)1 
 
1Data are expressed as meanSD. SBs, strand breaks; PBS, phosphate buffer saline; EB, 
endonuclease buffer; FPG, formamidopyrimidine DNA glycosilase.  
2Overall P value for repeated-measured ANOVA with STATISTICA (Statsoft Inc., Tulsa, OK, 
US).  
 
 
 Before smoking      5 min After smoking       30 min After smoking     P value2              
SyBP (mmHg)            116.0 ± 1.7a                   131.7 ± 1.6b                   117.0 ± 1.9a                0.0001 
DiBP (mmHg)                 76.1 ± 2.1a                   83.5 ± 1.9b                      76.8 ± 1.7a                0.005 
HR (beat min-1)                  63.3 ± 2.9a                  70.7 ± 2.9b                  64.0 ± 2.9a                 0.047 
Variables Time 0 min     Time 20 min           Time 24 h     P value2              
Background SBs (%DNA in tail, EB) 
  
Net FPG-sensitive sites (% DNA in 
tail) 
6.3 ± 1.0 
 
14.3 ± 2.3 
6.7 ± 0.8 
 
16.3 ± 4.1 
6.6 ± 0.3 
 
14.3 ± 2.9 
0.201 
 
0.390 
 
Background SBs (% DNA in tail, 
PBS) 
 
Net H2O2- induced DNA damage (% 
DNA in tail) 
 
7.2 ± 1.2 
 
46.6 ± 5.1 
 
6.8 ± 1.1 
 
47.3 ± 3.9 
 
 
7.2 ± 1.3 
 
47.3 ± 4.3 
 
 
0.594 
 
0.370 
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In Figure 7.3.1 are reported the effect of cigarette smoking in the serum circulating levels of 
VEGF, ICAM-1, sVCAM-1, IL-8.  ANOVA did not show any significant effect on these 
markers, even if serum concentrations tended to increase after 20 min from cigarette smoking, 
while a decrease seemed occur for IL-8. If these results will be confirmed on the whole group of 
subjects, they could explain the reasons of this impairment in the endothelial function.   
 
Figure 7.3.1-Effect of cigarette smoking on serum circulating levels of VEGF (A), VCAM (B), 
ICAM (C) and IL-8 (D), (n=6)1 
 
 
1Data are reported as mean±SD 
 
7.3.6 Effect of a single blueberry portion and control drink on reactive hyperemia index 
and arterial stiffness  
 
The role of bioactive rich-food in the modulation of vascular function has been investigated in 
several studies but controversial results have been observed. Short term supplementation with 
vitamin C and E has shown to improve endothelial function in healthy young smokers, while no 
beneficial effect has been observed in the long term (Raitakari et al., 2000; Neunteufl 2000). 
Similar results have been also observed after the consumption of a single portion of polyphenol-
rich food such as red wine (Karatzi et al., 2007), dark chocolate (Loffredo et al., 2011) and 
cranberries (Dohadwala et al., 2011). In the present study, the consumption of a portion of 
blueberry was able to counteract the endothelial dysfunction induced by smoking, 2 hours after 
blueberry consumption. On the contrary, no effect was observed following consumption of the 
control drink. 
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The mean percentage variation values of RHI (A), F-RHI (B), for each treatment are reported in 
Figure 7.3.2. Repeated measures ANOVA revealed a significant effect of treatment for the 
variable RHI (p=0.0006), and F-RHI (p=0.003). The mean percentage change pre to post 
treatment for RHI was -25.2% (95%CI: -34%, -16.2%) after S treatment, -17.5% (95%CI: -26%, 
-8.9%) after CS treatment and -6.6% (95%CI: -13%, -0.5%) after BS treatment (Figure 7.3.2a). 
The mean percentage change pre to post treatment for F-RHI was -42.7% (95%CI: -85.4%, -
0.15%) after S treatment, -8.1 % (95%CI: -36.5%, +20.3%) after CS treatment and +28.3% 
(95%CI: -12.6%, +69.2%) after BS treatment (Figure 7.3.2b). Post-hoc analysis (LSD test) 
revealed that the consumption of a single blueberry portion counteracted significantly the 
reduction of RHI and F-RHI after S treatment (BS vs S, p=0.0001 and p=0.0008, respectively). 
However, the reduction was significantly different with respect to CS treatment (BS vs CS, p= 
0.01) for RHI, but not for F-RHI (BS vs CS, p= 0.006). No effect was observed between S vs CS 
treatment for both the variables (RHI, p=0.09 and F-RHI, p=0.08). These results are in 
accordance with the previous observations in which polyphenol-rich foods affect vascular 
function 2 hours after their intake (Karatzi et al., 2007; Loffredo et al., 2011; Dohadwala et al., 
2011).  
 
Figure 7.3.2- Mean percent variation of RHI (A), F-RHI (B) measured during each treatment 
(n=16)1. 
 
 
1Data are expressed as mean ± SEM. S, smoking treatment; CS, control-drink  + smoking 
treatment; BS, blueberry intake + smoking treatment; RHI, reactive hyperemia index; F-RHI, 
Framingham reactive hyperemia index; dAix, digital augmentation index; dAix@75, digital 
augmentation index standardized  for heart rate of 75 bpm. 
a,b Graphs with different letters are significantly different from other treatments (p≤0.01). 
 
 Endothelial dysfunction is frequently associated with high levels of arterial stiffness. 
Some studies documented that smoking and unbalanced dietary habits (i.e. meals rich in 
saturated fatty acid, refined sugars and salt), may have detrimental effect on arterial stiffness 
(Hall 2009; Mahmud & Feely 2003). On the contrary, the consumption of polyphenol-rich food 
seems to reduce and improve the arterial stiffness (Ruel et al., 2013; Karatzi et al., 2013).  
In the present study, no significant effect was also observed for dAix and dAix@75 (p=0.20 and 
p=0.79, respectively) following the consumption of blueberry and control drink (Figure 7.3.3). 
These results are in accordance with Mathew et al., (2012) in which no effect on arterial stiffness 
was observed following consumption of a high fat meal and pomegranate juice extract, but in 
contrast with Karatzi et al., (2012) that found modulation of arterial stiffness following an acute 
consumption of beer.  
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Figure 7.3.3- Mean percent variation of dAix (A), dAix@75 (B) measured during each treatment 
(n=16)1. 
 
 
1Data are expressed as mean ± SEM. S, smoking treatment; CS, control-drink  + smoking 
treatment; BS, blueberry intake + smoking treatment; dAix, digital augmentation index; 
dAix@75, digital augmentation index standardized  for heart rate of 75 bpm. 
 
 
7.3.7 Effect of a single blueberry portion and control drink on systolic and diastolic blood 
pressure, and heart rate    
 
Diets rich in antioxidant compounds seem to modulate blood pressure levels. A recent meta-
analysis has reported for the first time, that the intake of polyphenol and ACN-rich foods is 
associated with low levels of blood pressure (Jennings et al., 2012). Similar results were also 
observed by Mathew et al., (2012) in which the consumption of pomegranate extract has resulted 
in suppression of the postprandial increase in SyBP following a high-fat meal. On the contrary, 
two recent dietary intervention studies reported that 4-week consumption of an ACN-extract did 
not reduce the levels of blood pressure in healthy and pre-hypertensive men (Hassellund et al., 
2012; Hassellund et al., 2013).  
In the present study, the effect of blueberry consumption on SyBP, DiBP and HR in each 
treatment is reported in Figure 7.3.4 (a-c). The mean percentage change between the pre to post 
treatment was +13.1% (95%CI: 10.5%, 15.7%) after S treatment, +12.7% (95%CI: 10.2%, 
15.2%) after CS treatment, and +8.4% (95%CI: 5.4%, 11.4%) after BS treatment (Figure 7.3.4a). 
Post-hoc analysis (LSD test) showed that the consumption of a single blueberry portion 
counteracted significantly the increment of SyBP after S treatment (BS vs S, p=0.008). This 
effect was also significantly different with respect to CS treatment (BS vs CS, p= 0.01) while no 
difference was observed between S and CS (p=0.90). On the contrary, no effect was observed 
after blueberry intake for the variables DiBP and HR among the three treatments (p=0.71 and 
p=0.50, respectively). 
These results seem to support the potential beneficial effect of polyphenol compounds in the 
modulation of blood pressure as also previously reported by other authors (Jennings et al., 2012; 
Mathew et al., 2012). 
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Figure 7.3.4-Mean percent variation of SyBP(A), DiBP (B) and HR (C) measured during each 
treatment (n=16)1. 
 
1Data are expressed as mean ± SEM. S, smoking treatment; CS, control-drink  + smoking 
treatment; BS, blueberry intake + smoking treatment; SyBP, systolic blood pressure; DiPB, 
diastolic blood pressure; HR, heart rate. 
a,b Graphs with different letters are significantly different from other treatments (p≤0.01). 
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7.4 CONCLUSIONS 
 
In the present study we documented that acute smoking significantly reduced peripheral arterial 
function and increased blood pressure and heart rate in healthy male smoker volunteers, while 
the consumption of blueberries prevented peripheral arterial dysfunction. These results are 
important and confirm the protective role of blueberry in the modulation of vascular function, 
emphasizing the importance of regular berry fruit consumption especially in people exposed to 
oxidative stress such as smokers. The analysis of data on the whole group of subjects will clarify 
the effect of smoking and blueberry in the modulation of biomarkers of oxidative stress, 
inflammation and endothelial function understudy. Prospective short-term studies in healthy 
subjects and in patients with cardiovascular risk factors (i.e. endothelial dysfunction) are needed 
to confirm the beneficial effects on vascular function, focusing also on the mechanisms involved 
in their modulation.  
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8. DEVELOPMENT OF A DIETARY INTERVENTION STUDY TO EVALUATE THE 
EFFECT OF 6-WEEK BLUEBERRY CONSUMPTION ON MARKERS OF 
OXIDATIVE STRESS, INFLAMMATION AND ENDOTHELIAL FUNCTION, IN 
SUBJECTS WITH RISK FACTORS FOR CARDIOVASCULAR DISEASE  
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8.1 AIMS OF THE STUDY 
 
The protective effect of wild blueberry intake has been studied in several animal models in our 
laboratories (Del Bo' et al., 2012; Del Bo' et al., 2010a; Del Bo' et al., 2010b; Kalea et al., 2010; 
Kristo et al., 2010; Kalea et al., 2009; Norton et al., 2005). In particular, we demonstrated that 
the intake of wild blueberries (24 mg ACNs per day) can improve vasomotor tone in the rat 
aorta and lymphocyte resistance against oxidatively induced DNA damage (Del Bo' et al., 2012; 
Del Bo' et al., 2010b). However, such observations in animal experimental models need to be 
confirmed in  controlled human intervention studies where a wide range of biomarkers are used 
and specific targets of  subjects at risk are considered. To our knowledge there is a paucity of 
studies that have evaluated the in vivo effect of blueberry consumption in humans with risk 
factors for CVD (Basu et al., 2010; Stull et al., 2010). 
We have previously reported that blueberry was able to reverse endothelial dysfunction induced 
by acute cigarette smoking in a group of young healthy smokers. In the present study, we 
investigated the effect of 6-week consumption of blueberry on markers of oxidative stress, 
inflammation and endothelial function in subjects with risk factors for CVD. 
8.2 Materials and Methods 
________________________________________________________________ 
 
 
130
 
8.2 MATERIALS AND METHODS 
 
8.2.1 Recruitment of subjects 
 
Subjects involved in the study were recruited from the staff of the University of Milan and other 
Institutes through advertisement on bulletin boards. Inclusion criteria were: healthy subjects with 
at least one risk factor for CVD such as: pre-hypertension (systolic pressure 120-139 mm Hg 
and diastolic pressure between 80-89 mm Hg), high serum cholesterol (≥5.17 mmol L-1), low 
high density lipoprotein (HDL)-cholesterol (<1.03 mmol L-1), high low density lipoprotein 
(LDL)-cholesterol (≥3.36 mmol L-1), high triglycerides (≥1.69 mmol L-1) overweight (BMI ≥25 
kg/m2) and smoking (>10 cigarettes/day). Individuals with secondary hypertension or obesity 
(BMI ≥30) were excluded. A medical history questionnaire was used to exclude subjects with 
clinical diseases such as diabetes, renal insufficiency, known food allergic reactions, chronic 
constipation, diarrhea or any other gastrointestinal problem or disease. Subjects were 
specifically excluded from the study if they were taking drugs, supplements, specific probiotics 
or medications during the last month before the beginning of the experiment. Weight and height 
were assessed and subjects were selected on the basis of an interview to evaluate their dietary 
habits and ensure that they were as homogeneous as possible, in particular for fruit and 
vegetables consumption. This was obtained by means of a food frequency questionnaire 
previously published and specifically revised to focus on food sources rich in antioxidants 
(Porrini et al., 1995). Other exclusion criteria were: high (> 5 portions/day) or low (<2 
portions/day) intake of fruit and vegetables and habitual alcohol consumption (< 3 drinks per 
week were tolerated). Volunteers who followed a specific diet such as vegetarian, vegan or 
macrobiotic, and those who had a specific aversion to blueberries or their products were 
excluded. Twenty male subjects, ages 47.8  9.7 years with body mass index (BMI) 24.8  2.6 
kg/m2 were selected. The study was performed in accordance with the ethical standards laid 
down in the 1964 Declaration of Helsinki and approved by the Ethics Committee of the 
University of Milan. All participants signed informed consent form. 
 
8.2.2 Blueberry and placebo drink preparation 
 
The wild blueberry (WB) drink was prepared by suspending 25 g of WB freeze-dried powder 
(i.e. a composite from Wayman’s (Cherryfield, ME), standardized at 1.5% total ACNs by 
FutureCeuticals, (Momence, IL, USA)) in 250 mL of water to give an amount of WB equivalent 
to 1 cup of raw fruits (148 g, providing approximately 375 mg of ACNs). The nutritional 
composition of the soluble WB powder used in the study is reported in Table 8.2.1. The placebo 
(PL) drink was prepared to have sensory characteristics similar to the WB drink but it did not 
contain polyphenols. The PL drink consisted of 250 mL water, 7.5 g fructose, 7 g glucose, 0.5 g 
citric acid, and 0.03 g blueberry flavor (Kerry Ingredients & Flavours Italia S.p.A., Bergamo, 
Italy). In order to reach the same color, small amounts of food colors typically used by food 
industry for the production of sweetened soft drinks were added to the PL drink.  
 
8.2.3 Experimental design 
 
A randomized, repeated measures crossover design was utilized. Subjects were randomly 
divided (by using a computer random number generator) into two groups of ten subjects each: 
group 1 was assigned to the sequence WB drink/wash-out/PL drink, whereas group 2 followed 
the sequence PL drink/wash-out/WB drink. WB and PL drinks were consumed daily for 6 
weeks; the two treatments were separated by a 6 week wash-out period. Subjects received each 
morning the freshly prepared WB or PL drink in appropriate iceboxes. Participants were 
instructed to keep the drink under refrigeration and to avoid exposing it to a heat source or light  
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and consume the drink within the morning. Additionally participants were asked to mix the 
beverage very well before drinking, rinse out each bottle with water and drink it to ensure 
complete intake of the WB powder. Every Friday, subjects received the drinks for the week-end 
and kept them refrigerated. Subjects were instructed to maintain their normal dietary and 
lifestyle habits (as declared before enrollment) but to abstain from consuming berries and other 
ACN-rich food sources. For this reason, during the experimental period, each subject received a 
complete list of foods high in ACNs to be avoided. A 24 h record of food consumption was kept 
by each volunteer one day before blood collection to check compliance to the dietary 
instructions. Moreover a 3-day food record and a weekly direct interview were scheduled 
randomly during the two experimental periods. At the beginning and at the end of each treatment 
period, fasting venous blood samples were collected early in the morning after an overnight fast.  
 
8.2.4 Variables  
 
The improvement of endothelium-dependent vasodilation (measured by a non-invasive 
plethysmographic method), the reduction of oxidized purines and the improvement of cell 
resistance to H2O2-induced DNA damage (evaluated in mononuclear blood cells by the comet 
assay) were considered as the primary endpoints. The other variables under study were: 
nutritional biomarkers (ACNs, vitamin C, folate, vitamin B12, reduced glutathione (GSH), 
oxidized glutathione (GSSG)), lipid profile (triglycerides, total cholesterol, LDL and HDL-
cholesterol), glucose, markers of inflammation (interleukin-6 (IL-6), tumor necrosis factor-α 
(TNF-α), C-reactive protein (CRP),  soluble vascular adhesion molecule (s-VCAM-1), total 
nitric oxide (NO), augmentation index (AI), augmentation index standardized for heart rate of 75 
bpm (AI@75), blood pressure, DNA repair activity, enzymes activity (glutathione S-transferase 
activity (GST), superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px), serum 
creatinine, aspartate aminotransferase (AST), alanine aminotransferase (ALT) and gamma-
glutamyltransferase (GGT). 
 
8.2.5 Anthocyanin and phenolic acids extraction and analysis in the wild blueberry powder 
by LC-DAD-MS/MS 
 
The Liquid Chromatography-diode array detector-mass spectrometry (LC-DAD-MS/MS) 
analysis of ACNs in the WB powder was performed in accordance to a procedure previously 
published (Del Bo' et al., 2010).  
 
8.2.6 Soluble and insoluble fiber analysis in the wild blueberry powder 
 
Soluble and insoluble dietary fiber in the WB powder was determined by the AOAC 
(Association of Official Analytical Chemists) International method 991.43; an AACC 
(American Association for Clinical Chemistry) 46.13 for the protein in the residue was used 
(AOAC method 1991). 
 
8.2.7 Sample collection and separation 
 
Blood was collected early in the morning by a phlebotomist. Samples were drawn into evacuated 
tubes with or without heparin. Plasma was separated within 30 min after collection while serum 
within 1 h, by centrifugation for 15 min at 2300 x g at 4°C. Peripheral blood mononuclear ells 
(PBMCs) were obtained from whole blood by density gradient centrifugation with Histopaque 
1077 (Sigma Chemicals Co., St. Louis, MO). Mononuclear blood cells were removed from the 
gradient, washed with Phosphate Buffer Saline (PBS) and used for the determination of 
endogenous and cell resistance to H2O2-induced DNA damage. An aliquot of PBMC was  
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isolated and dissolved into an appropriate medium (90% RPMI media, 10% Dimethyl 
sulphoxide, Sigma) and stored at -80°C until evaluation of repair activity. Red blood cells were 
obtained from whole blood by centrifugation at 2300 x g for 10 min and were washed with an 
equal volume of PBS solution. Red blood cells (1 mL) were diluted with iced water (1:4) and 
centrifuged at 10000 x g for 10 min. All samples were then aliquoted, stored at -80°C until 
determination of hemoglobin and evaluation of SOD and GSH-Px activities. Red blood cells 
(500 μL) used for glutathione analysis were acidified with an equal solution of metaphosphoric 
acid (10%) before storage. 
 
8.2.8 Analysis of biochemical parameters 
 
A general laboratory biochemical assessment was performed including evaluation of hepatic and 
renal function (serum creatinine, AST, ALT and GGT), lipid profile (triglycerides, total 
cholesterol, and HDL-cholesterol) and glucose (Campolo et al., 2006). All these parameters 
were determined using standard laboratory methods. LDL cholesterol was calculated using the 
Friedewald’s method. Plasma IL-6, TNF-α, CRP and s-VCAM 1 concentrations were measured 
by Quantikine human colorimetric sandwich ELISA immunoassay kits (R&D Systems, Inc. 
Minneapolis, MN). Plasma concentration of total NO was calculated by measuring the products 
of oxidation (nitrate and nitrite) by a Fluorometric Assay Kit (Cayman Chemical, Ann Arbor, 
MI). Lymphocyte GST activity analysis was performed in accordance to the procedure described 
previously (Riso et al., 2009). GST activity was standardized to milligrams of protein and 
determined using a BCATM Protein Assay Kit (Pierce, Rockford, IL, USA). SOD and GSH-Px 
activities were measured in erythrocytes using commercial kits (Cayman chemical, Ann Arbor, 
USA). Enzyme activities were standardized to milligrams of hemoglobin determined by the use 
of the Drabkins reagent (Sigma Diagnostic, Co., St. Louis, MO). Vitamin C was determined in 
plasma by HPLC analysis as previously published (Riso et al., 2005). Vitamin B12 and total 
folate were measured by competitive immunoassay using direct chemiluminescence (Campolo et 
al., 2006). Analysis of GSH and GSSG in the erythrocyte lysate was performed following the 
instructions reported in a commercially available kit (Cayman chemical, Ann Arbor, USA).  
 
8.2.9 Anthocyanin extraction and analysis in plasma 
 
Two aliquots of plasma (1 mL) were acidified with TFA (1%), vortexed, and centrifuged for 1 
min at 4500 x g and the supernatant was stored at -80°C until analysis. Anthocyanins were 
extracted from plasma and analyzed as previously reported (see Study 3). 
 
8.2.10 Determination of peripheral arterial function  
 
Evaluation of peripheral vasoreactivity was performed before blood drawing to avoid possible 
side effects on blood pressure and vasoactivity. Endothelial-dependent vasodilation and arterial 
stiffness in the small finger arteries was assessed by Endo-PAT2000 as previously reported (see 
Study 2). 
 
8.2.11 Evaluation of DNA damage, repair activity and cell resistance against H2O2-induced 
DNA damage 
 
Peripheral blood mononuclear cells (PBMCs) were separated from whole blood by density 
gradient centrifugation as previously reported (see Study 1). The FPG-sensitive sites (oxidized 
purines) and cell resistance against H2O2 (500 μmol/L, 5 min) induced DNA damage were 
evaluated by the comet assay as previously described in detail (see Study 1). 
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The DNA repair activity was determined in cryopreserved PBMCs. Assessment of DNA repair 
incisions was analysed by the Comet assay as previously described by Guarnieri et al. (2008). 
The repair activity was measured as the incision activity of substrate DNA treated with Ro19-
8022/white light, which generates 8-oxo-7,8-dihydroguanine. Oxidised bases were introduced 
into A549 lung epithelial cells substrate nuclei by irradiating cells with white light in PBS with 1 
lM Ro 19-8022 (the photosensitiser was a gift from F. Hoffmann-LaRoche, Basel, Switzerland) 
at 0°C. The cells were washed and resuspended in freezing medium (50% FBS, 40% RPMI and 
10% DMSO) to a concentration of 3x106 cells/ml and frozen at –80°C. For the preparation of 
human PBMCs extracts, the cryo-preserved cells were centrifuged (300 g, 5 min and 4°C), and 
the pellet was resuspended in buffer A (45 mM HEPES, 0.4 M KCl, 1 mM EDTA, 0.1 mM 
dithiothreitol and 10% glycerol; pH 7.8) at a volume of 20µL per 106 cells. The resuspended 
cells were divided in aliquots of 50 µL to which 12 µL 1% Triton X-100 was added. The lysate 
was centrifuged (700 g, 5 min and 4.C) and the supernatant was mixed with 200 µL buffer B (40 
mM HEPES, 0.1 M KCl, 0.5 mM Na 2 EDTA and 0.2 mM BSA; pH 8). Approximately 3x104 
substrate cells were embedded in agarose and applied on 85-100 mm GelBond. films and lysed 
as described for the Comet assay. After three times washing (5 min each) in buffer B, repair 
incisions were detected by incubation of the agarose-embedded nuclei with 60 µL PBMCs 
extract or buffer B for 20 min at 37°C. The subsequent alkaline treatment and electrophoresis 
were identical to the conditions used to determine DNA damage using the Comet assay. An 
assay control (a sample for FPGsensitive sites evaluation) was included in each electrophoresis 
run. After neutralisation with 0.4 M Tris–HCl (pH 7.5), cells were placed in 96% ethanol for 1.5 
h or overnight. Nuclei were visualised as previously described for strand breaks and FPG-
sensitive sites estimation after staining with 40 µL ethidium bromide (4 µg mL-1) in PBS 
solution. The repair activity of the PBMCs extract was determined as the difference in % DNA 
in tail between parallel gels incubated with extract and control solution. 
 
8.2.12 Statistical analysis  
 
Sample size has been calculated taking into account the expected variation in the primary 
endpoints considered. In particular twenty subjects were calculated to be sufficient to evaluate a 
difference of RHI after WB drink of 0.28 (standard deviation 0.40), with alpha=0.05 and a 
statistical power of 80%. Moreover, the "repeated measure" experimental design in which each 
subject acts as its own control, allows conducting experiment more efficiently reducing the error 
variance.  
Statistical analysis was performed by means of STATISTICA software (Statsoft Inc., Tulsa, OK, 
US). The Shapiro-Wilk test was applied to verify the normal distribution of the variables. Data 
obtained were examined by analysis of variance (ANOVA) with the treatment sequence (WB 
drink vs PL drink or vice versa) as the independent factor in order to exclude the presence of 
carry-over effects. As none was detected, data were analyzed by ANOVA for repeated measures 
design. ANOVA with treatment (WB drink vs PL drink) and time (before and after each 
treatment) as dependent factors was applied to evaluate the effect of the WB drink on the 
variables under study. The difference in responses to the WB and PL drink periods was 
evaluated by statistically significant P-values for the interaction between treatment and time in 
the overall repeated ANOVA. Moreover, ANOVA with type of treatment as the dependent 
factor was used to evaluate percentage change (i.e. [after treatment-before treatment]/ before 
treatment *100) at the different endpoints of peripheral arterial function. The mean changes are 
described as mean with 95% confidence interval (CI). Differences are considered significant at p 
≤ 0.05; post-hoc analysis of differences between treatments was assessed by the Least 
Significant Difference (LSD) test with p ≤ 0.05 as level of statistical significance.  
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8.3 RESULTS AND DISCUSSION 
 
8.3.1 Composition and characteristics of the wild blueberry powder 
 
One portion of the WB powder provided about 102 kcal, 1.5 g of lipids, 1 g of proteins, 17 g of 
sugars (glucose and fructose) and 4.2 g of total fiber. The soluble and insoluble fiber was 0.6 g 
and 3.6 g, respectively. Chlorogenic acid (127.5 mg / 25 g) was the main phenolic acid detected 
in the WB powder. The total ACN concentration was 375 mg / 25 g with peonidin-3-glucoside, 
malvidin-3-galactoside, delphinidin-3-glucoside and delphinidin-3-galactoside as the dominant 
ACN compounds which represented about 35% of the total amount of ACNs. 
 
8.3.2 Baseline characteristics of the subjects 
 
Twenty people began the study and eighteen completed the whole protocol. Two subjects 
withdrew from the study due to personal reasons. Baseline anthropometric and clinical 
characteristics of the remaining 18 subjects are available in Table 8.3.1. Blood pressure, lipid 
profile and inflammatory markers were within the range of normality. According to the 
guidelines of the American Heart Association (AHA 2011), 8 subjects were classified as 
overweight (BMI  25 kg/m2), 7 had high levels of total cholesterol (6.2 mmol L-1) and 7 
borderline high (5.17-6.18 mmol L-1). Six subjects had high levels of LDL-cholesterol (4.13 
mmol L-1) and 7 were borderline high (3.36-4.11 mmol L-1). Ten subjects were pre-hypertensive 
(systolic pressure 120-139 mm Hg and diastolic pressure between 80-89 mm Hg). Nine subjects 
were smokers/ex-smokers. Finally eight subjects had below normal endothelium-dependent 
vasodilation with a RHI value ≤ 1.67.  
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TABLE 8.3.1- Subject characteristics at the beginning of the study (n=18)1  
    
Variables  Value Variables Value 
Age (y) 47.8 ± 9.7 NO (μmol L-1) 45.3 ± 7.3 
Body weight (kg) 75.7 ± 8.7 sVCAM-1 (ng mL-1) 402 ± 116 
BMI (kg/m2) 24.8 ± 2.6 CRP (mg dL-1) 0.19 ± 0.22 
Glucose (mmol L-1) 4.9 ± 0.5 IL-6 (pg mL-1) 2.1 ± 1.1 
TG (mmol/L-1) 1.2 ± 0.5 TNF-α (pg mL-1) 3.4 ± 1.5 
TSC (mmol/L-1) 5.8 ± 1.2 Diastolic pressure (mm Hg) 79.4 ± 8.7 
LDL-cholesterol (mmol/L-1) 3.8 ± 1.0 Systolic pressure (mm Hg) 121 ± 16 
HDL-cholesterol (mmol/L-1)   1.4 ± 0.3 RHI 1.84 ± 0.46 
AST (U L-1)  22.8 ± 4.8 FRHI 0.32 ± 0.27 
ALT (U L-1) 26.7 ± 1.5 dAix 5.22 ± 18.5 
GGT (U L-1) 26.8 ± 10.7 dAix@75 0.0 ± 17.4 
Creatinine (mmol L-1) 79.6 ± 8.8 H2O2-induced DNA damage (% DNA in tail) 
45.6 ± 10.1 
Anthocyanins (µmol L-1) nd FPG sensitive sites (% DNA in tail) 13.4 ± 5.6 
Vitamin C (μmol L-1) 63.1 ± 17.3 DNA repair activity (%DNA in tail) 6.5 ± 1.7 
Folate (nmol L-1) 16.5 ± 4.5   
Vitamin B12 (pmol L) 312 ± 110   
GSH (μmol g-1 Hb) 5.8 ± 1.0   
GSSG (μmol g-1 Hb) 0.65 ± 0.42   
GSH/GSSG ratio 11.2  4.53   
SOD activity (U mg-1 Hb) 4.7 ± 0.5   
GST activity (nmol min-1 mg -
1proteins) 
35.1 ± 17.4   
GSH-Px activity (μmol min-1 mg-1 
proteins) 
17.4 ± 7.3   
1Data are expressed as mean ± SD. BMI, body mass index; nd, not detectable; AST, aspartate 
aminotransferase; ALT, alanine aminotransferase; GGT, gamma-glutamyltransferase; GSH, 
reduced glutathione; GSSG, oxidized glutathione; SOD, superoxide dismutase; GST, glutathione 
S-transferase; GSH-Px, glutathione peroxidase; NO, nitric oxide; sVCAM-1, vascular cell 
adhesion molecule-1; CRP, C-reactive protein; IL-6, interleukin-6; TG, triglycerides; TNF-α, 
tumor necrosis factor alpha; TSC, total serum cholesterol; RHI, reactive hyperemia index; 
FRHI, Framingham reactive hyperemia index; dAix, digital augmentation index; dAix@75, 
digital augmentation index standardized for heart rate of 75 bpm.  
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8.3.3 Effect of intervention on dietary markers 
 
The effect of the 6 week intervention with the WB vs the PL drink on dietary markers evaluated 
in plasma is reported in Table 8.3.2. The intervention resulted in no significant effect on vitamin 
C, vitamin B12, folate, GSH and GSSG concentrations and GSH/GSSG ratio. No ACNs were 
detected in the plasma after the WB or PL drink treatment after 6 weeks of intervention.  
 
TABLE 8.3.2- Effect of a 6-week intervention with the wild blueberry (WB) drink or placebo 
(PL) drink on nutritional biomarkers (n=18)1 
      
Variables Before WB 
Drink 
After WB 
Drink 
Before PL 
Drink 
After PL  
Drink 
P value2 
Anthocyanins (μmol L-1) nd nd        nd nd - 
Vitamin C (µmol L-1)  61.5  16.8 61.7  20.2 64.1  15.8 67.5  16.5 0.488 
Folate (nmol L-1) 16.3  5.0 15.0  4.8 17.2  4.8 15.9  4.1 0.930 
Vitamin B12 (pmol L-1) 308  92 298  99 314  107 322  105 0.392 
GSH (μmol g-1 Hb)  6.8  2.5 6.0  0.9 6.2  1.2 6.6  1.5 0.140 
GSSG (μmol g-1 Hb) 0.77  0.44 0.74  0.27 0.74  0.40 0.83  0.42 0.574 
GSH/GSSG ratio 11.3  6.6 8.99  2.98 9.03  3.74 9.45  4.62 0.216 
1 Data are expressed as mean ± SD. WB, wild blueberry; PL, placebo; nd, not detectable; GSH, 
reduced glutathione; GSSG, oxidized glutathione 
2P-values correspond to the interaction between treatment and time in the overall ANOVA 
(Statsoft Inc., Tulsa, OK, US).  
 
 
8.3.4 Effect of intervention on vascular function and blood pressure 
 
The values of RHI, FRHI, dAix, dAix@75, NO, sVCAM-1 and blood pressure are reported in 
Table 8.3.3. One subject was omitted from the analysis due to abnormal values registered in 2 
different time points. Vascular function of the subjects measured by Endo-PAT2000 did not 
improve significantly, according to the repeated measures ANOVA, after the WB and PL drinks 
(P=0.452 for the interaction between treatment and time). However, an apparent decrease in the 
RHI was observed during consumption of the PL drink with respect to WB drink. The mean 
percent change between the pre-to-post intervention was +4.9% (95%CI: -11%, +20.8%) after 
the WB drink and -4.9% (95%CI: -12.6%, +3.9%) after the PL drink.  
On the whole a high inter-individual variability was observed in the percent change of RHI 
(Figure 8.3.1) with about half of the subjects (53%; 9 out of 17) having an improvement 
following the intervention with the WB drink while the other half experienced (47%; 8 out of 
17) a decrease. In the placebo group we observed that few subjects (23%; 4 out of 17) had an 
improvement following the intervention with the PL drink, while more than a half of the subjects 
(59%; 10 out of 17) showed a decrease. The remaining subjects (18%; 3 out of 17) did not show 
any effect. No significant changes in FRHI, dAix, dAix@75, blood pressure (systolic and 
diastolic), total plasma NO and sVCAM-1 were documented after the 6-week intervention with 
the WB drink or the PL drink. 
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TABLE 8.3.3- Effect of a 6-week intervention with wild blueberry (WB) drink or placebo (PL) 
drink on vascular function, blood pressure, plasma total nitric oxide and soluble vascular cell 
adhesion molecule-1 (n=18)1 
      
Variables Before WB 
Drink 
After WB  
Drink 
Before PL 
Drink 
After PL 
Drink 
P value2 
RHI   1.83  0.43 1.86  0.55 1.87  0.48 1.76  0.41 0.452 
FRHI  0.35  0.28 0.29  0.33 0.34  0.31 0.30  0.25 0.838 
dAix 3.57  15.6 3.18  14.9 6.94  17.5 4.71  16.5 0.407 
dAix@75 -1.71  15.6 -3.76  14.1 0.00  17.9 0.47  16.3 0.458 
Diastolic pressure (mm Hg) 81.6  8.8 81.4  7.2 78.3  8.2 78.8  8.5 0.740 
Systolic pressure (mm Hg)  123  16 122  16 122  16 120  16 0.878 
Total NO (µmol L-1)  48.5  24.1 49.8  23.6 45.9  16.9 43.7  20.2 0.666 
sVCAM-1 (ng mL-1)  410  103 576  364 417  129 540  232 0.762 
1Data are expressed as meanSD; (n=17 vascular function). WB, wild blueberry; PL, placebo; 
RHI, reactive hyperemia index; FRHI, Framingham reactive hyperemia index; AI, augmentation 
index; AI@75, augmentation index standardized for heart rate of 75 bpm; Total NO, total nitric 
oxide; sVCAM-1, vascular cell adhesion molecules-1.  
2P-values correspond to the interaction between treatment and time in the overall ANOVA 
(Statsoft Inc., Tulsa, OK, US).  
 
 
These results are in accordance with Dohadwala et al. (2011) who demonstrated that 4 
weeks of supplementation with cranberry juice (480 ml/day, providing 94 mg ACNs and 835 mg 
total polyphenols) had no effect on vascular function (measured by flow-mediated dilation in the 
brachial artery) in subjects with coronary artery disease. However, many other factors may have 
affected these results such as: the large inter individual variation, individual differences in CVD 
risk factors, the duration of the intervention, and the amount and form of the WB product. We 
provided our subjects with a dietary daily amount of ACNs through the WB drink since it was 
interested in studying a realistic condition. Future studies with larger numbers of subjects with 
homogenous and/or more pronounced CVD risk factors or established endothelial dysfunction 
may show beneficial effect of blueberry intervention.  
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Figure 8.3.1- Individual values of reactive hyperemia index (RHI) measured by Endo-PAT2000 
and registered before and after a six weeks WB drink and PL drink intake in the group of 
volunteers (n = 17).   
 
 
RHI, reactive hyperemia index; WB, wild blueberry drink; PL, placebo drink 
 
8.3.5 Effect of intervention on DNA damage and repair activity in peripheral blood 
mononuclear cells 
 
Results from intervention studies with berries (single berry items or mixture of different berries) 
have shown a reduction of the levels of oxidatively damaged DNA evaluated by means of the 
comet assay (Wilms et al., 2007; Freese 2006), whereas there are studies showing no effect after 
ingestion of ACN-rich blackcurrant juice or an ACN drink (Møller et al., 2004). Results on the 
levels of DNA damage and repair activity are shown in Table 8.3.4. There was a significant 
different treatment effect between the WB and PL drink periods (P=0.039 for the interaction 
between treatment and time). Estimation of oxidized purines in PBMC DNA through 
quantification with the formamidopyrimidine DNA glycosylase (FPG)-sensitive sites indicated a 
statistically significant decrease following the WB drink (from 12.5  5.6% to 9.6  3.5%, 
p0.01) with respect to the PL drink (from 12.0 ± 4.5% to 11.9 ± 4.4%, p=0.89). Moreover, 
there was also a different treatment effect between the WB and PL drink periods (P=0.037 for 
the interaction between treatment and time). The intake of the WB drink significantly decreased 
the levels of H2O2-induced DNA damage (from 45.8  7.9% to 37.2  9.1%, p0.01), while no 
effect was observed after the PL drink (from 44.9 ± 12.2% to 44.4 ± 8.4%, p=0.84).  
The protection against DNA damage was particularly evident in the group of smokers/ex-smoker 
subjects with respect to nonsmokers. In fact, it was observed that the reduction in the levels of 
H2O2-induced DNA damage after the WB intervention was higher: smokers/ex-smokers (44.4 ± 
7.7% vs 33.7 ± 5.9%, p≤0.01) with respect to the nonsmoker group (47.2 ± 8.3% vs 40.7 ± 
10.7%, p=0.08) as indicated by the LSD test. This effect on DNA damage may be dependent on 
phytochemicals present in WB drink that can exert a direct protective effect against oxidative 
insult by scavenging reactive oxygen species in blood. Alternatively, ACNs may act through 
upregulation of the expression of different antioxidant genes involved in the detoxification of 
molecules such as hydrogen peroxide (Shih et al., 2007). Other processes that may have been  
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modulated by the WB drink could be: alkylation or formation of ACN-DNA complexes, and/or 
modulation of DNA repair genes (Traustadóttir et al., 2009; Guarrera et al., 2007). In this regard, 
it has been reported that a flavonoid-rich diet could affect the expression of DNA repair genes 
belonging to different repair pathways like nucleotide excision repair, base excision repair and 
double strand breaks repair (Guarrera et al., 2007). In the present study, 6 weeks of WB drink 
consumption did not show an increase in DNA repair activity (Table..). 
 
Table 8.3.4- Effect of a 6-week intervention with the wild blueberry (WB) drink or placebo (PL) 
drink on background and H2O2 induced strand breaks, FPG sensitive sites, DNA repair activity 
(n=18)1 
      
Variables  Before WB 
Drink 
After WB 
Drink 
Before PL 
Drink 
After PL 
Drink 
P value2 
Background SBs (% DNA in tail, 
EB) 
6.3  1.6 6.7  1.2 6.2  1.4 6.2  1.5 0.201 
Net FPG-sensitive sites (% DNA 
in tail) 
12.5  5.6 9.6  3.5* 12.0  4.5 11.9  4.4 0.039 
Background SBs (% DNA in tail, 
PBS) 
5.9  1.1 6.5  1.2 6.2  1.4 6.8  2.0 0.594 
Net H2O2-induced DNA damage 
(%DNA in tail) 
45.8  7.9 37.2  9.1* 44.9  12.2 44.4  8.4 0.037 
DNA repair activity (% DNA in 
tail)      
6.4  1.7 6.7  1.9 6.6  1.5 6.4  1.8 0.425 
1Data are expressed as meanSD. WB, wild blueberry; PL, placebo; SBs, strand breaks; PBS, 
phosphate buffer saline; EB, endonuclease buffer. *Significantly different from each other point, 
P≤0.05  
2P-values correspond to the interaction between treatment and time in the overall ANOVA 
(Statsoft Inc., Tulsa, OK, US).  
 
8.3.6 Effect of intervention on anthropometric measures and biochemical parameters  
 
Body weight, BMI and biochemical markers before and after the WB or PL drink are presented 
in Table 8.3.5. The intervention had no significant effect on body weight and BMI, glucose, 
creatinine and enzyme activity (AST, ALT and GGT) in liver. In addition, no effect on SOD, 
GSH-Px or GST activity was observed suggesting that upregulation of antioxidant enzymes is 
not the mechanism for the increased resistance toward H2O2-induced DNA damage. 
Studies on ingestion of polyphenol bioactive compounds have shown results on lipid profile data 
that are not univocal. Bilberries, blackcurrants, cranberry juice or extracts have shown a 
favorable effect on the lipid profile in dyslipidemic, hypercholesterolemic or metabolic 
syndrome subjects from improving HDL-cholesterol to lowering LDL-cholesterol and total 
triglycerides (Basu et al., 2009; Erlund et al., 2008; Curtis et al., 2009; Ruel et al., 2008). On the 
contrary Basu et al. (2010) reported that 8 weeks of supplementation with a freeze dried 
blueberry beverage (50 g of powder, providing 742 mg of ACNs per day) did not change the 
plasma lipid profile in subjects with the metabolic syndrome. Similarly Stull et al. (2010) found 
that the consumption of two blueberry smoothies per day (45 g of freeze dried blueberry powder, 
providing 668 mg of ACNs) did not affect the lipid profile in obese subjects after 6 weeks of 
intervention. The above studies are in agreement with the present study, since the WB drink 
intervention did not alter the plasma lipid profile in subjects with risk factors for CVDs.  
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In the present study, no significant differences in lipid profile (triglycerides, total cholesterol, 
LDL and HDL cholesterol) were observed following WB drink consumption.  
 
 
TABLE 8.3.5- Effect of a 6-week intervention with the wild blueberry (WB) drink or placebo 
(PL) drink on anthropometric and biochemical characteristics of volunteers (n=18)1  
1Data are expressed as mean±SD. WB, wild blueberry; PL, placebo; BMI, body mass index; 
AST, aspartate aminotransferase; ALT, alanine aminotransferase; GGT, gamma-
glutamyltransferase; SOD, superoxide dismutase; GSH-Px, glutathione peroxidise; GST, 
glutathione S-transferase; TG, triglycerides; TSC, total serum cholesterol. 
1Data are expressed as mean±SD. WB, wild blueberry; PL, placebo; BMI, body mass index; 
2P-values correspond to the interaction between treatment and time in the overall ANOVA 
(Statsoft Inc., Tulsa, OK, US).  
 
      
Variables Before WB 
Drink 
After WB 
Drink 
Before PL 
Drink 
After PL 
Drink 
P 
value2 
Body weight (kg) 75.9 ± 8.4 75.8 ± 8.7 76.2 ± 9.3 76.1 ± 9.3 0.977 
BMI (kg/m2) 
24.9 ± 2.5 24.8 ± 2.6 24.9 ± 2.7 24.9 ± 2.6 0.977 
Glucose (mmol L-1)  5.0 ± 0.5 5.0 ± 0.3 4.9 ± 0.6 5.0 ± 0.6 0.357 
TG (mmol L-1)  1.3 ± 0.5 1.3 ± 0.5 1.3 ± 0.6 1.4 ± 0.6 0.279 
TSC (mmol L-1) 5.9 ± 1.2 5.7 ± 1.3 5.9 ± 1.2 5.7 ± 1.3 0.774 
LDL-cholesterol (mmol L-1)  3.9 ± 0.9 3.7 ± 1.0 3.8 ± 1.2 3.6 ± 1.0 0.726 
HDL- cholesterol (mmol L-1)  1.4 ± 0.3 1.3 ± 0.2 1.4 ± 0.3 1.3 ± 0.3 0.241 
AST (U L-1) 23.8 ± 8.1 23.3 ± 6.2 23.1 ± 4.8 23.8 ± 6.9 0.644 
ALT (U L-1) 26.4 ± 10.7 27.5 ± 12.8 27.2 ± 12.1 27.5 ± 10.8 0.679 
GGT (U L-1) 27.2 ± 11.0 26.5 ± 11.4 27.0 ± 10.7 25.3 ± 11.0 0.217 
Creatinine (mmol L-1)  81.3 ± 11.5 82.2 ± 13.3 80.4 ± 10.7 80.4 ± 13.3 0.734 
SOD activity (U mg-1 Hb)  4.7 ± 1.3 4.4 ± 1.3 4.8 ± 1.3 4.5 ± 1.4 0.870 
GSH-Px activity (μmol min-1 mL-
1 g Hb)  
18.6 ± 9.5 18.0 ± 5.6 16.5 ± 5.6 19.4 ± 7.0 0.121 
GST activity (nmol min-1 mg-1 
proteins)                                                                                                  
25.9 ± 13.3 25.8 ± 9.6 31.4 ± 17.9 28.5 ± 11.0 0.672 
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8.3.7 Effect of intervention on biomarkers of inflammation 
 
The role of berries in decreasing markers of inflammation has not been well investigated and 
very few observations have shown an antinflammatory effect (Elliss et al., 2011; Stull et al., 
2010). The plasma levels of IL-6, TNF-α and CRP of the subjects before and after the WB and 
PL drink are reported in Table 8.3.6. No significant difference in inflammatory markers was 
detected as a result of the intervention.     
 
TABLE 8.3.6- Effect of a 6-week intervention with the wild blueberry (WB) drink or placebo 
(PL) drink on circulating levels of interleukin 6, Tumor Necrosis Factor-α and C-reactive 
protein (n=18)1 
      
Variables Before WB 
Drink 
After WB 
 Drink 
Before PL  
Drink 
After PL 
 Drink 
P value2 
IL-6 (pg mL-1)  2.1  1.4 2.1  0.9 2.4  1.3 1.9  1.0 0.303 
TNF-α  (pg mL-1)  3.6  2.1 3.1  1.0 3.4  2.1 3.5  1.9 0.438 
CRP (mg dL-1)  0.18  0.20 0.20  0.15 0.16  0.13 0.22  0.21 0.717 
 
1Data are expressed as meanSD. WB, wild blueberry; PL, placebo; IL-6, interleukin-6; TNF-α, 
tumor necrosis factor alpha; CRP, C-reactive protein.  
2P-values correspond to the interaction between treatment and time in the overall ANOVA 
(Statsoft Inc., Tulsa, OK, US).  
 
These results are in accordance with other observations reported in literature (Elliss et al., 2011; 
Stull et al., 2010; Basu et al., 2010). It should be noted that the inflammatory markers in our 
volunteers were in the normal physiologic concentration ranges at the onset of the study, thus the 
potential of WB to affect such biomarkers maybe more appropriately evaluated on subjects with 
high initial levels. 
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8.4 CONCLUSIONS 
 
In conclusion, the consumption of a WB drink, providing 375 mg of ACNs, for 6 weeks reduced 
the level of oxidized purines and improved the resistance against H2O2-induced DNA damage in 
PBMCs. This indicates that regular consumption of wild blueberries can reduce oxidative stress 
in subjects with risk factors for CVD, even though peripheral vascular function and the other 
variables studied here were not significantly affected.  
Future, larger studies are necessary to understand the duration of exposure to ACNs, the dose 
and/or the form of the WB product that may be effective in modulating endothelial function and 
the other parameters studied. 
8.5 References 
________________________________________________________________ 
 
 
143
 
8.5 REREFENCES 
 
 American Heart Association: http://www.heart.org/HEARTORG/ (accessed 25 June 
2011). 
 
 AOAC Method 991.43, Total, Insoluble and Soluble Dietary Fiber in Food-Enzymatic-
Gravimetric Method, MES-TRIS Buffer. Official Methods of Analysis, 16th ed. AOAC 
International, Gaithersburg, MD, 1995. 
 
 Basu A et al., 2009, Freeze-dried strawberry powder improves lipid profile and lipid 
peroxidation in women with metabolic syndrome: baseline and post intervention 
effects. Nutr J 8: 43. 
 
 Basu A et al., 2010, Blueberry decrease cardiovascular risk factors in obese men and 
women with metabolic syndrome. J Nutr 140: 1582-87. 
 
 Campolo J et al., 2006, Methionine challenge paradoxically induces a greater activation 
of the antioxidant defence in subjects with hyper- vs. normohomocysteinemia. Free 
Radic Res 40: 929-35. 
 
 Curtis PJ et al., 2009, Cardiovascular disease risk biomarkers and liver and kidney 
function are not altered in postmenopausal women after ingesting an elderberry extract 
rich in anthocyanins for 12 weeks. J Nutr 139:2266-71.  
 
 Del Bo' C et al., 2010b, Improvement of lymphocyte resistance against H2O2-induced 
DNA damage in Sprague-Dawley rats after eight weeks of a wild blueberry (Vaccinium 
angustifolium)-enriched diet. Mutat Res 703:158-62. 
 
 Del Bo' C et al., 2012, The temporal effect of a wild blueberry (Vaccinium 
angustifolium)-enriched diet on vasomotor tone in the Sprague-Dawley rat. Nutr Metab 
Cardiovasc Dis 22: 127-32.  
 
 Del Bo’ C et al., 2010a, Anthocyanin absorption, metabolism and distribution from a 
wild blueberry-enriched diet (Vaccinium angustifolium) is affected by diet duration in 
the Sprague-Dawley rat. J Agric Food Chem 58: 2491-7. 
 
 Dohadwala MM et al., 2011, Effects of cranberry juice consumption on vascular 
function in patients with coronary artery disease. Am J Clin Nutr 93:934-40. 
 
 Ellis CL et al., 2011, Attenuation of meal-induced inflammatory and thrombotic 
responses in overweight men and women after 6-week daily strawberry (Fragaria) 
intake. A randomized Placebo-controlled trial. J Atheroscler Thromb 18:318-27. 
 
 Erlund I et al., 2008, Favorable effects of berry consumption on platelet function, blood 
pressure, and HDL cholesterol. Am J Clin Nutr 87:323-31. 
 
 Frese R 2006, Markers of oxidative DNA damage in human intervention with fruit and 
berries. Nutr Cancer 54:143-7. 
 
 
8.5 References 
________________________________________________________________ 
 
 
144
 
 Guarnieri S et al., 2008, DNA repair phenotype and dietary antioxidant 
supplementation. Br J Nutr 99:1018-24. 
 
 Guarrera S et al., 2007, Expression of DNA repair and metabolic genes in response to a 
flavonoid-rich diet. Br J Nutr 98:525-33. 
 
 Kalea AZ et al., 2009, Vascular reactivity is affected by dietary consumption of wild 
blueberries in the Sprague-Dawley rat. J Med Food 12: 21-8. 
 
 Kalea AZ et al., 2010, Dietary enrichment with wild blueberries (Vaccinium 
angustifolium) affects the vascular reactivity in the aorta of young spontaneously 
hypertensive rats. J Nutr Biochem 21:14-22. 
 
 Kristo AS et al., 2010,  A wild blueberry-enriched diet (Vaccinium angustifolium) 
improves vascular tone in the adult spontaneously hypertensive rat. J Agric Food Chem 
58: 11600-5.  
 
 Møller P et al., 2004, Oxidative DNA damage in circulating mononuclear blood cells 
after ingestion of blackcurrant juice or anthocyanin-rich drink. Mutat Res  551:119-126. 
 
 Norton C et al., 2005, Wild blueberry-rich diets affect the contractile machinery of the 
vascular smooth muscle in  the Sprague-Dawley rat. J Med Food 8: 8-13. 
 
  Porrini M et al., 1995, Biochemical validation of a self-administered semi-quantitative 
food-frequency questionnaire. Br J Nutr 74: 323-33.  
 
 Riso P et al., 2005, Effects of blood orange juice intake on antioxidant bioavailability 
and on different markers related to oxidative stress. J Agric Food Chem 53: 941-7. 
 
 Riso P et al., 2009, Absorption of bioactive compounds from steamed broccoli and their 
effect on plasma glutathione S-transferase activity. Int J Food Sci Nutr 60: 56-71. 
 
 Ruel G et al., 2008, Low-calorie cranberry juice supplementation reduces plasma 
oxidized LDL and cell adhesion molecule concentrations in men. Br J Nutr 99:352-9. 
 
 Shih PH et al., 2007, Anthocyanins induce the activation of phase II enzymes through 
the antioxidant response element pathway against oxidative stress-induced apoptosis. J 
Agric Food Chem 55:9427-35. 
 
 Stull AJ et al., 2010, Bioactives in blueberries improve insulin sensitivity in obese, 
insulin-resistant men and women. J Nutr 140: 1764-68. 
 
 Traustadóttir T et al., 2009, Tart cherry juice decreases oxidative stress in healthy older 
men and women. J Nutr 139:1896-900. 
 
 Wilms LC et al., 2007, Impact of multiple genetic polymorphisms on effects of a 4-
week blueberry juice intervention on ex vivo induced lymphocytic DNA damage in 
human volunteers. Carcinogenesis 28:1800-6. 
  
 
145
 
9. IN VITRO APPROACHES TO STUDY THE ANTIATHEROGENIC AND 
ANTIATHEROSCLEROTIC EFFECT OF DIFFERENT BLUEBERRY BIOACTIVES  
 
 
9.1 Aim of the study 
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9.1 AIMS OF THE STUDY 
 
Atherosclerosis is a syndrome affecting arterial blood vessels, a chronic inflammatory response 
in the walls of arteries, caused largely by the accumulation of macrophages and white blood 
cells and promoted by low-density lipoproteins (Packard & Libby 2008; Napoli et al., 2006). 
Foods rich in bioactives such as polyphenols seem to prevent atherosclerosis, by reducing 
oxidative stress, inflammatory response, vasocostrictor agents and by increasing the production 
of vasodilators such as NO (Santakumar et al., 2013; Siaos et al., 2013; Tangney et al., 2013; 
Khurana et al., 2013; Quiñoes et al., 2013; Andriantsitohaina et al., 2012).  
The objective of the present study task was to investigate the potential anti-atherogenic and anti-
atherosclerotic effect of WB extracts, rich in different polyphenol compounds through two 
different cells models: the human monocytic (THP-1) cell line, and the human umbilical venous 
endothelial cells (HUVECs). The first model was used to evaluate the capacity of WB extracts to 
reduce lipid accumulation (antiatherogenic effect), while the second one was used to assess 
whether the addition of WB extracts was able to reduce the ability of THP-1 cells to adhere to 
HUVECs following stimulation with pro-inflammatory cytokines (antiatherosclerotic effect).  
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9.2 MATERIALS AND METHODS 
 
9.2.1 Chemicals 
 
Standard of cyanidin (Cy)-, delphinidin (Dp)-, petunidin (Pt)-, peonidin (Pe)-, and malvidin 
(Mv)-3-O-glucoside (glc), Cy- and Pt-3-O-arabinoside (ara), Cy-3-O-galactoside (gal), Dp, Cy, 
and Mv were purchased from Polyphenols Laboratory (Sandes, Norway). Standard of 
chlorogenic, caffeic, ferulic, gallic, protocatechuic and syringic acids, glucose, fructose, Bovine 
Serum Albumin (BSA), Palmitic acid (PA), oleic acid (OA), hydrogen peroxide (H2O2), Hanks 
balanced salt solution, Pluronic F127, Nile Red, Phorbol 12-myristate 13-acetate (PMA), were 
from Sigma-Aldrich (St. Louis, MO, USA). Hydrochloric acid, methanol, ethanol, acetonitrile, 
triethylamine, phosphoric acid, trifluoroacetic acid (TFA) and ethyl acetate were from Merck 
(Darmstadt, D). Water was obtained from Milli-Q apparatus (Millipore, Milford, MA). Hepes, 
Sodium Pyruvate, Gentamin, RPMI-1640, trypsin-EDTA were obtained from Life Technologies 
(Grand Island, NY, USA). Fetal Bovine Serum (FBS) was purchased from Biological Industries 
(Kibbutz Beit Haemek, Israel). Endothelial cell basal medium and endothelial cell growth 
supplement were from Cells applications, INC (San Diego, CA, USA). Freeze-dried Wild 
Blueberry (WB) powder, standardized at 1.5% total ACNs, was provided by Future-Ceuticals 
Company (Momence, IL, USA). 
 
9.2.2 Extraction of bioactives from the wild blueberry powder  
 
The freeze-dried WB powder was used to extract two different fractions providing the main WB 
bioactives: the ethyl acetate soluble fraction (containing mainly chlorogenic acid -Phe fraction) 
and the methanol soluble fraction (containing mainly anthocyanins - ACN fraction). Moreover, 
also a water soluble fraction (WS fraction), containing sugars and organic acid, was obtained. 
Extraction was performed following the method described by Wrolstad (2005) with few 
modifications. Briefly, the WB powder was suspended in water, sonicated for 10 min, and 
centrifuged at 3000 × g for 10 min. Fractions separation from the supernatant was obtained 
through solid-phase extraction (SPE)-cartridge (Strata-X 300 mg/3 mL, Phenomenex, Torrence, 
CA). Three ml of supernatant was loaded and the elution of WS, Phe and ACN fractions were 
carried out respectively with HCl 0.01 N (5 mL), ethyl acetate (10 mL) and methanol (5 mL) 
containing 0.1% HCl. The WS fraction was discarded, while the other fractions were dried under 
vacuum with rotavapor (RC Jouan 10, Jouan, Winchester, VA) at 20°C for ACN, 40°C for Phe. 
The residues were dissolved in methanol acidified with HCl (0.05 mM). The solutions were 
analyzed for the content of ACNs, Phe and sugars, and stored at -20°C until use. 
 
9.2.3 Analysis of anthocyanin and phenolic fractions 
 
The analysis of ACN and Phe compounds of the fractions was performed by HPLC, which 
consisted of an Alliance mod. 2695 (Water, Milford, MA) equipped with a mod. 2998 
photodiode array detector (Waters). The separation was carried out through a C18 Kinetex 
column (150 x 4.6 mm, 2.6 µm, Phenomenex, Torrence, CA) at 45°C and 1.7 mL min-1 as flow 
rate. The eluents were (A) 1% H3PO4 and (B) acetonitrile/water (35:65, v/v). The elution 
gradient was linear as indicated: 0-15 min 14% B; 15-25 min from 14 to 20% B; 25-35 min from 
20 to 32% B; 35-45 min from 32 to 50% B; 45-48 min from 50 to 90% B; 90 % for 3 minutes. 
Chromatographic data were acquired from 200 to 700 nm and integrated at 520 (ACNs) and 320 
nm (phenolic acids). Calibration curves ranged from 2 to 50 µg mL-1 were obtained for cyanidin 
(Cy-), delphinidin (Dp-), petunidin (Pt-), peonidin (Pe-) and malvidin (Mv-) 3-O-glc, Cy- and 
Pt-3-O-gal and Pt-3-O-ara and chlorogenic acid. For the ACNs, the working solution was diluted  
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from the stock solution with methanol acidified with 0.1% TFA. Each analysis was carried out 
in duplicate (Del Bo’ et al., 2010).  
 
9.2.4 Analysis of sugars  
 
Glucose and fructose were quantified in the ACN and Phe fractions by UPLC (Acquity, Waters) 
coupled with a triple quadrupole mass spectrometer mod. Quattro micro (Micromass, Beverly, 
MA). The separation was carried out on BEH (Ethylene Bridged Hybrid) Amide column (150 x 
2.1 mm, 1.7 µm, Waters) at 35°C. Solvents were (A) triethylamine 0.2% and (B) triethylamine 
0.2% in acetonitrile. Flow-rate was 0.40 mL min-1. The calibration curve was obtained from 1 to 
50 µg mL-1 for both sugars. The mass spectrometer operated in ESI negative mode monitoring 
the ions with m/z 179 (glucose, fructose). The capillary voltage was set to 3.0 kV, the cone 
voltage to 20 V, the source temperature to 120 °C, and the desolvating temperature to 250°C.   
 
9.2.5 Preparation of fatty acids and control solution 
 
The stock solution of FA (0.2M OA/PA; 2:1 ratio) was prepared in EtOH and stored at -20°C. 
On the day of use, 5mM of FA water soluble solution (FA/BSA solution) was generated by 
incubating the FA in Hanks solution containing 10% BSA at 37°C for about 30 min with 
occasional vortex. The FA/BSA solution was added to the media to obtain final 500μM FA 
concentration for the exposure. Equal volumes of the Hanks solution/EtOH/fatty acid-free BSA 
were applied to control cells. The final concentrations of EtOH and BSA in exposure media 
were 0.05% and 0.2%, respectively.  
 
9.2.6 Preparation of single anthocyanins and their metabolites 
 
A stock solution of standards of Mv, Cy and Dp 3-O-glc, as well as their correspondent 
metabolic products as syringic, protocatechuic and gallic acid respectively, was prepared. We 
have chosen these ACNs because they were the compounds absorbed and detectable in plasma 
after consumption of a single portion of blueberry as recently reported (Del Bo’ et al., 2012). 
Lyophilized standards (10 mg) were dissolved in 10 mL of acidified methanol (HCl 0.05 mM). 
Aliquots (1 mL) of standard were concentrated under nitrogen and subsequently quantified by 
spectrophotometric analysis. Standards were then stored at -20°C until use.  
 
9.2.7 THP-1 cell culture 
 
The monocytic THP-1 cell line was purchased from American Type Culture Collection 
(Manassas, VA, USA).  THP-1 cells were originally cultured from the peripheral blood of 1 year 
kid with acute monocytic leukemia from 1980s (Tsuchiya et al., 1980). According to the authors 
the cells maintained their monocytic characteristics for over 14 months (Tsuchiya et al., 1980), 
but in the study the cells were maintained for up to 3 months to keep their monocytic 
characteristics. The THP-1 cells are non-adherent cells, which can be differentiated into 
macrophage-like cells using PMA through a protein kinase C mediated ROS dependent 
signaling pathway (Traore et al., 2005). Treatment of THP-1 with PMA leads to a decrease in 
the expression of LDL receptor and an increase in the expression of scavenger receptors 
(Johnson et al., 2003). These alterations allow the cells to take up modified lipoproteins and to 
become foam cells with excessive accumulation of lipid, primarily cholesteryl ester, that make  
THP-1 a reasonable model to mimic monocyte-macrophage behaviour during the atherogenesis 
process.  
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9.2.8 HUVEC cell culture 
 
The human umbilical vein endothelial cells (HUVECs) were purchased from Cell Application 
(San Diego, CA, USA).These are primary cells that are derived from the endothelium of veins 
from the umbilical cord. When cultured in vitro, the cells form a monolayer which is similar to 
the endothelial cells in vivo, therefore they are commonly used as the in vitro model for the 
study of the function of endothelial cells (Park et al., 2006).  
 
9.2.9 Study of the effect of the wild blueberry fractions in the modulation of lipid 
accumulation in THP-1 macrophages 
 
Cells were cultured in complete RPMI cell media (RPMI-1640 medium supplemented with 1% 
Hepes, 1% sodium pyruvate, 0.1% gentamicin, and fetal bovine serum to a final concentration of 
10%) at 37 °C and 5 – 7 % CO2. After growth, cells were differentiated into macrophages by 
treating with 10 ng mL-1 PMA overnight. Macrophages become adherent to the surface of the 
culture flasks, thus cells were washed with Hanks Solution to remove all non-adherent cells. 
Subsequently, 3 mL trypsin (0.05%)–EDTA (0.53mM) was added and incubatedfor 2 min at 37 
°C and 5 – 7 % CO2 in order to re-suspend cells adherent to the flask. After incubation, 2 mL of 
complete RPMI cell media was added to inactivate trypsin. Cells were collected in falcon tubes, 
quantified in a CASY1 cell counter (Roche Innovatis AG, Reutlingen, D), and then centrifuged 
(mod. Sigma compact centrifuge 2-5, C&M Scientific, Livingston,West Lothian, UK) for 5 min 
at 250x g. 
After centrifugation, pellet of cells was re-suspended in new complete RPMI media in order to 
reach a final concentration of approximately 2.5x105 cells / volume. Two hundred microliters of 
cell suspension (containing approximately 5x104 cells) in octuplicate were aliquoted into the 
wells of a 96-well dark microtiter plate and incubated for 24 h at 37 °C and 5 – 7 % CO2, in 
order to induce the cell adhesion to the surface of microtiter plate. The ACN (calculated 
considering the total ACNs concentration) and Phe fractions (calculated considering the 
chlorogenic acid concentration), as well as the single ACNs (Mv, Cy and Dp 3-glucoside) and 
their correspondent metabolites (syringic, protocatechuic and gallic acid, respectively) were 
tested. Media was removed and 200 µL of new complete RPMI media (containing 500 µM FA 
and different concentrations of bioactive compounds) was added. Concentrations of ACN and 
Phe fractions, of the single ACN and metabolite standards used were 0.05; 0.1; 0.3; 0.6; 1.25; 
2.5; 5 and 10 µg mL-1. Cells were incubated for 24 h at 37 °C and 5 – 7 % CO2. The lipid 
accumulation was measured by using the fluorescent dye Nile red. Nile red is not fluorescent in 
most polar solvents, but can be extensively fluorescent in lipid rich environments. Nile red is 
thus suitable for measuring lipid accumulation both in cells and in tissues. To measure the lipid 
accumulation in macrophages, after treatment, the cells were washed with Hanks solution and 
then stained in Hanks solution containing 0.5 µg mL-1 Nile red and 0.01% Pluronic F127 for 15 
min at 37 °C and 5 – 7 % CO2. Later, cells were washed twice with 200 µL of Hanks solution 
and then exposed to 100 µL Hanks solution. The fluorescence (excitation: 544 nm, emission: 
590 nm) was measured in a fluorescence spectrophotometer (mod. Fluoroskan Ascent FL, 
Thermo Scientific, USA) and the number of fold increase respect to the control (without FA) 
was calculated.  
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9.2.10 Study of the effect of wild blueberry fractions in the modulation of THP-1 
attachment to HUVEC cells 
 
During atherosclerotic plaque formation, endothelial cells attract and bind monocytes to the 
inflammatory area in the intima of the endothelium. The inflammatory response may be caused 
by several pro-inflammatory citokynes. Co-cultures between THP-1 and human umbilical vein 
endothelial cells (HUVECs) have been used to study this process. In a typical experiment 
designed to detect the interaction, THP-1 cells are labelled with a fluorescent dye. The binding 
ability of THP-1 is determined by the fluorescent intensity of the adhered versus total cells, 
which is measured by a fluorescence plate reader.  
In the present study, HUVECs were cultured in endothelial cell growth medium kit which 
contains 2% serum. After growth, cells were washed once with Hanks Solution to remove all 
non-adherent cells. Subsequently, 3 mL trypsin (0.05%)–EDTA (0.53mM) was added and 
incubated for 2 min at 37°C and 5 – 7 % CO2 in order to re-suspend cells adherent to the flask. 
After incubation, 2 mL of media was added to inactivate trypsin. Cells were collected in falcon 
tubes, quantified and then centrifuged for 5 min at 250 x g. The pellet of cells was re-suspended 
in new media in order to reach a final concentration of approximately 1x106 cells / volume. Two 
hundred microliters of cell suspension containing approximately 2x104 cells in quintuplicate 
were aliquoted on 0.1% gelatin pre-coated 96-well black plate and growth for 24 h at 37°C and 5 
– 7 % CO2. After 24h, media was removed and 200 µL of new media, containing different 
concentrations of ACN and Phe fractions, was added. Concentrations of ACN and Phe fraction 
used were: 0.05; 0.1; 0.3; 0.6; 1.25; 2.5; 5 and 10 µg mL-1; cells were incubated for 24 h at 37°C 
and 5 – 7 % CO2. After incubation, 2x106 THP-1 cells were spin-out, re-suspended in 1 ml 
serum free RPMI cell media (RPMI-1640 medium supplemented with 1% Hepes, 1% sodium 
pyruvate, 0.1% gentamicin) and labelled with CellTrackerTM Green CMFDA (5-
Chloromethylfluorescein Diacetate, Invitrogen, USA) for 30 min at 37°C and 5 – 7 % CO2. 
After staining, THP-1 cells were rinsed twice with complete RPMI cell media and re-suspended 
in HUVEC media at a density of 2x105 cells/ml. One hundred microliter of THP-1 cells and 100 
µl of TNF-α (1µg mL-1) were added to HUVECs and incubated for 24 h at 37° C and 5 – 7 % 
CO2. TNF-α induces a pro-inflammatory status and promote THP-1 adhesion as reported in 
several studies (Zhao et al., 2010; Sneddon et al., 2006).. After 24h cells were rinsed twice with 
Hank solution and the fluorescence (excitation: 485nm, emission: 538 nm) was measured in a 
fluorescence spectrophotometer. The increase of absorbance is dependent to the amount of 
labelled-THP-1 attached to HUVEC. So, data are presented as number of fold increase THP-1 
attachment respect to the control (without stimulation with TNF-α). 
 
9.2.11 Statistical analysis 
 
The statistical analysis was performed by means of STATISTICA software (Statsoft Inc., Tulsa, 
OK, US). Analysis of variance (ANOVA) was used to assess the effect of the different 
concentrations of ACN and phenolic compounds  on lipid accumulation in THP-1 macrophages 
following stimulation with FA. Moreover, ANOVA was used to evaluate the capacity of ACN 
and phenolic fractions to reduce THP-1 attachment to HUVEC cells. Post-hoc analysis of 
differences between treatments was assessed by the Least Significant Difference (LSD) test with 
p ≤ 0.05 as level of statistical significance. Data are presented as mean±standard deviation (SD). 
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9.3 RESULTS AND DISCUSSION 
 
9.3.1 Characterization of Wild blueberry fractions 
 
The two extracts obtained from WB powder were analyzed in order to evaluate the content of 
sugars, Phe and ACNs. The ACN fraction composition is reported in Table 9.3.1. The total ACN 
content was 29.8 ± 5.17 mg mL-1. Seventeen different ACNs were detected in the extract; the 
dominant compounds were: malvidin glycosides (about 14.4 mg mL-1; 48% of the total ACN 
amount) and cyanidin glycosides (about 4.8mg mL-1; 16%), followed by delphinidin glycosides 
(about 4.5mg mL-1; 15%), while petunidin and peonidin glycosides represented about 13% and 
7% of the total ACNs, respectively. In regard to conjugated sugars, the ranking order was 
glucoside > galactoside > arabinoside from the most to the least representative. No phenolic 
compounds, sugars were detected in the ACN fraction. 
Chlorogenic acid was the main phenolic compound (13.1 ± 2.5 mg mL-1) detected in the Phe 
fraction, while only traces of caffeic and ferulic acids were found. No sugar was detectable. 
 
Table 9.3.1: Characterization of the ACN fraction 
Compounds 
Extracted 
mg mL-1  
malvidin 3-glc 
malvidin 3-gal 
malvidin 3-ara 
delphinidin 3-glc 
delphinidin 3-gal 
delphinidin 3-ara 
7.89 ± 0.8 
4.65 ± 0.7 
  1.84 ± 0.04 
 2.18 ± 0.7 
   1.55 ± 0.15 
   0.75 ± 0.02 
 
cyanidin 3-glc 
cyanidin 3-gal 
cyanidin 3-ara 
2.19 ± 0.6 
1.31 ± 0.4 
1.26 ± 0.2 
 
petunidin 3-glc 
petunidin 3-gal  
2.49 ± 0.8 
  0.67 ± 0.01  
petunidin 3-ara 
peonidin 3-glc 
peonidin 3-gal 
peonidin 3-ara 
  0.62 ± 0.03 
1.61 ± 0.7 
  0.31 ± 0.04 
  0.11 ± 0.03 
 
Total   29.9 ± 5.17  
Data are reported as mean ± standard deviation. 
glc, glucoside; gal, galactoside; ara, arabinoside 
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9.3.2 Effect of anthocyanin fraction and single anthocyanin compounds on lipid 
accumulation in THP-1 macrophages 
 
The effect of ACN fraction on lipid accumulation in TPH-1 macrophages is reported in Figure 
9.3.1. ANOVA revealed a significant effect of the treatment (p<0.0001). In particular, the ACN 
fraction induced a reduction in the lipid accumulation at all the concentrations tested with 
respect to the control treatment with FA, but not with respect to the FA free control. The 
maximum reduction was observed for the highest concentration, i.e. 10 µg mL-1 (-27.4%; 
p≤0.0001). 
 
Fig. 9.3.1 Effect of ACNs fraction on lipid accumulation in THP-1 macrophages. Data are 
reported as fold increase in lipid accumulation with respect to the control cells without fatty 
acids. Results are expressed as mean±standard deviation. 
 
 
FA, fatty acids; ACNs, anthocyanins; NO FA, fatty acids free 
a,b,c Data with different letters are significantly different (P≤0.05) 
 
The modulation of lipid accumulation observed in our experiments seem in accordance with 
several mechanistic studies where the role of extracts of ACN-rich foods (e.g., sweet potato, 
berries, and oranges) was investigated (Chang et al., 2013; Hwang et al., 2011; Vendrame et al., 
2013; Salamone et al., 2012; Peng et al., 2011). In the present study no information is reported 
on the molecular mechanisms involved, however the reduction observed in the lipid 
accumulation following ACNs supplementation could be attributed to different factors. For 
example, ACNs could have regulated the expression of numerous genes including: fatty acid 
synthase, lipoprotein lipase. Moreover, ACNs may modulate the transcriptional activities of 
different nuclear receptors that control lipid homeostasis, including sterol regulatory elevated 
binding protein, and peroxisome proliferator-activated receptor (Guo et al., 2012; Liang et al., 
2012; Wei et al., 2011).  
 
Studies evaluating also the effect of the single ACNs have shown conflicting results, probably 
due to the specific role played by each single compound. In the present study the effect of the 
some ACNs (Mv, Dp, and Cy 3-glc) on lipid accumulation is reported in Figure 9.3.2 (A-C). 
These compounds were selected since they were the most representative compounds in the WB 
fraction. Moreover, as previously reported (see study 3), these compounds where the only ACNs 
absorbed in human plasma following blueberry intake. 
In general, ANOVA revealed a significant effect of the treatment for Mv 3-glc and Dp 3-glc 
(p<0.0001). Concerning Mv 3-glc, the reduction in the lipid accumulation was shown at each  
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concentration tested with the exception of that at 1.25 µg mL-1(Figure 9.3.2A). The reduction 
was high at the low doses (0.05-0.1 µg mL-1, -63%  and -53%, respectively) and significantly 
different compared to the control (FA). Dp 3-glc (Figure 9.3.2B) showed to reduce lipid 
accumulation at all the concentrations tested (from 0.05 till 10 µg mL-1), but it was particularly 
highat the low doses (0.05-0.1 µg mL-1, -59% and -52%, respectively; p<0.0001). On the 
contrary, no significant effect was observed for Cy 3-glc (Figure 9.3.2C)  thus this compound 
may be not involved in the regulation of lipid accumulation.  
This latter result seems in accordance with previous observation reported by Titta et al., (2010) 
in which Cy-3-glc was not able to counteract the lipid accumulation in rat adipocytes, but in 
contrast with other studies in which a role in the regulation of lipid metabolism was documented 
(Guo et al., 2012; Wei et al., 2011). Several studies have shown that cyanidin-rich diet decreased 
significantly cholesterol, triglyceride, ApoB plasma concentrations and aortic fatty streak area. 
Jia et al., (2013) documented that Cy-3-glc significantly reduced cellular lipid concentrations in 
lipid-loaded steatotic hepatocytes. 
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Figure 9.3.2 Effect of the single ACNs on lipid accumulation in THP-1 macrophages. A) 
malvidin, B) delphinidin and C) cyanidin 3-glucoside. Data are reported as fold increase in lipid 
accumulation with respect to the control cells without fatty acids. Results are expressed as 
mean±standard deviation. 
 
 
 
FA, fatty acids; Mv, malvidin; Dp, delphinidin; Cy, cyanidin FA, fatty acids; NO FA, fatty acids 
free 
a,b,c Data with different letters are significantly different (P≤0.05) 
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9.3.3 Effect of phenolic fraction and single compounds (anthocyanin metabolites) on lipid 
accumulation in THP-1 macrophages 
 
Several studies documented the ability of phenolic compounds in the modulation of lipid 
accumulation. Cho et al., (2010) reported that a supplementation with caffeic acid or chlorogenic 
acid (0.02% wt/wt) was able to inhibit lipid metabolism and obesity-related hormones levels in 
high-fat fed mice.   
The effect of Phe fraction on lipid accumulation in TPH-1 macrophages is reported in Figure 
9.3.3. ANOVA revealed a significant effect of the treatment (p<0.0001). In particular, a 
significant reduction in the lipid accumulation was observed only at the low concentrations from 
0.0125 µg mL-1 till 0.3 µg mL-1, with respect to the control with FA, but not with respect to FA 
free control. No significant effect has been observed at higher concentrations (from 0.6 till 10 µg 
mL-1).  
 
Figure 9.3.3 Effect of the phenolic fraction on lipid accumulation in THP-1 macrophages. Data 
are reported as fold increase in lipid accumulation with respect to the control cells without fatty 
acids. Results are expressed as mean±standard deviation. 
 
 
FA, fatty acids; Phe, phenolic fraction; NO FA, fatty acids free  
a,b,c Data with different letters are significantly different (P≤0.05) 
 
The effects at the low doses may be explained through the concept of hormesis. In fact, several 
plant antioxidants exhibit hormetic properties, by acting as 'low-dose stressors' that may prepare 
cells to resist more severe stress (Speciale et al., 2011; Rattan & Demirovic 2009). In fact, low 
doses of these phytochemicals activate signaling pathways that result in increased expression of 
genes encoding cytoprotective proteins, while high doses are instead cytotoxic. The most 
prominent example is the modulation of Nrf2/Keap1 pathway, the NF-κB pathway and the 
Sirtuin-FOXO pathway (Speciale et al., 2011).   
 The effects of the ACN metabolites on lipid accumulation in THP-1 macrophages are 
reported in Figure 9.3.4 (A-C). Syringic (Figure 9.3.4A) and gallic (Figure 9.3.4B) acids (the 
metabolic products of Mv and Dp 3-glc, respectively) showed to decrease lipid accumulation at 
all the concentrations. In particular, the higher effects were observed at the low concentrations as 
reported for Phe fraction. In particular, the maximum reduction in lipid accumulation was 
observed at 0.05 µg mL-1 for syringic acid (-64.8%, p˂0.0001), and at 0.3 µg mL-1 for gallic acid 
(-59.3%, p˂0.0001).  On the contrary, protocatechuic acid (metabolic product of Cy 3-glc) 
showed (Figure 9.3.4C) to reduce the lipid accumulation only for some concentrations (0.05, 0.1 
and 2.5µg mL-1), by suggesting that this compound, like Cy 3-glc, is not particularly active in  
 
9.3 Results and Discussion 
________________________________________________________________ 
 
 
156
 
the regulation of lipid metabolism but it cannot be exclude it is involved in other important 
pathways such as the inflammatory process as documented by Wei et al., (2012).  
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Figure 9.3.4 Effect of the ACN metabolites on lipid accumulation in THP-1 macrophages. A) 
syringic acid, B) gallic acid and C) protocatechuic. Data are reported as fold increase in lipid 
accumulation with respect to the control cells without fatty acids. Results are expressed as 
mean±standard deviation. 
 
 
 
FA, fatty acids; SA, syringic acid; GA, gallic acid; PA, protocatchuic acid; NO FA, fatty acids 
free 
a,b,c Data with different letters are significantly different (P≤0.05) 
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9.3.4 Effect of wild bluebrry fractions in the modulation of the THP-1 attachment to 
HUVEC cells 
 
In Figure 9.3.5 (A-B) are reported the results obtained by testing the capacity of WB fractions to 
counteract the development of atherosclerotic process. In particular, in this study it was 
investigated the ability of WB fractions to reduce THP-1 attachment to HUVEC following 
stimulation with pro-inflammatory cytokines as TNF-α.   
Polyphenol compounds in general have shown to possess anti-inflammatory properties by acting 
on NF-kB and LPS response. These effects have been already demonstrated for different 
categories of polyphenols, and isolated form origins (Denis et al., 2013; Kostyuk et al., 2011; 
Liu et al., 2004; Youdin et al., 2002). For example, a grape-powder extract used in in vitro 
experiments on U937 macrophages reduced the LPS-induced production of inflammatory 
cytokines (Overman et al., 2010). A proanthocyanidin-rich cranberry fraction showed to 
decrease the LPS-induced cytotoxicity in macrophages and oral epithelial cells (La et al., 2009).  
Wang et al., (2009) demonstrated that protocatechuic acid inhibited monocyte adhesion to TNF-
α-activated mouse aortic endothelial cells, associated with the inhibition of VCAM-1 and 
ICAM-1 expression. 
In a recent study performed in our laboratories, it has been documented that the same WB 
extract was able to reduce the inflammatory response induced by LPS on U937 by decreasing 
also the induction of TNF-α (unpublished data). 
In the present study, we further demonstrated that ACN and Phe fractions reduced THP-1 
attachment to HUVEC cells following stimulation with the pro-inflammatory cytokine. In 
particular, ACN fraction (Figure 9.3.5A) showed a positive and significant effect at the 
concentration of 10 µg mL-1 (-33%, p=0.04), while the Phe fraction (Figure 9.3.5B) was able to 
reduce significantly THP-1 attachment at the low doses (0.0125, 0.025, 0.05, 0.1 and 0.3 µg mL-
1, -52%, -49%, -45%, -49% and -51%, respectively). These results seem in accordance with the 
previous observations we obtained in the lipid accumulation study. Despite the lack of a 
mechanistic approach, the overall results suggest that WB fractions can exhibit an anti-
inflammatory effect.  
 
Figure 9.3.5 Effect of the ACN and Phe fraction on THP-1 attachment to HUVEC cells 
following stimulation with TNF-α.  A)ACN fraction, B)Phe fraction. Data are reported as fold 
increase in THP-1 attachment with respect to the control cells without TNF-α. Results are 
expressed as mean±standard error of the mean. 
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TNF-α, tumor necrosis factor alpha; ACN, anthocyanin; Phe, phenolic 
a,b,c Data with different letters are significantly different (P≤0.05) 
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9.4 CONCLUSIONS 
 
Several studies reported that ACNs display antiatherosclerosis effects; this may be attributed to 
their anti-inflammatory and/or antioxidant activity exerted through the regulation of the 
expression of genes involved in these responses.  
In the present study it has been documented that ACN and Phe fractions, isolated from WB, 
could play an important role in the modulation of lipid accumulation and in the prevention of 
atherosclerosis. These effects were also observed at very low doses of ACNs and Phe 
compounds by suggesting that a protective effect could be reached also in vivo at  physiological 
concentrations.    
The results obtained supported the potential antiatherogenic and antiatherosclerotic effect of 
blueberry bioactives. Future in vitro studies will focus on the specific mechanisms involved in 
such modulation.  
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2nd International Conference on Food-Omics, Cesena 22th-24th June, 2011.  
 
Regulation of adipose tissue gene expression in vitro and in vivo studies: review on the role 
of anthocyanins.  
 
Cristian Del Bo’1, Lucilla Titta2, Stefano Vendrame1,3, Patrizia Riso1, Dorothy Klimis-Zacas1,3 
and Marisa Porrini1 
 
1Università degli Studi di Milano, DiSTAM Sezione Nutrizione, Milano, Italy. 2 Dipartimento di 
Oncologia Sperimentale IEO, Milano, Italy. 3Department of Food Science and Human Nutrition, 
University of Maine, Orono, USA. 
   
Anthocyanins (ACNs) are a group of natural pigments found in red-blue fruits and vegetables 
with a wide range of biological activities including: antioxidant, anti-inflammatory and 
anticarcinogenic activities. In vitro and in vivo experiments suggest that ACNs can inhibit 
adipogenic development and fat accumulation1-2. Lipogenesis consists of fatty acids and 
triglycerides synthesis and occurs both in liver and fat tissue. The molecular pathways involved 
in the adipocyte differentiation it is not well known; however the adipocyte differentiation 
transcription factor PPAR could be involved in the regulation of lipogenesis1. To our 
knowledge, only few reports exist suggesting that food factors directly modulate the adipocyte 
function including adipocytokine secretion or adipocyte specific gene expression. We present a 
review on the role of ACNs in the regulation of adipose tissue, reporting also data we obtained 
through a high ACNs Moro juice supplementation in a mice model3. Further studies are 
required to clarify the effect of dietary ACNs on adipose tissue gene expression during 
differentiation (from preadipocyte into mature adipocyte) and to confirm results obtained in the 
animal model through human studies. 
1 Tsuda T. Regulation of adipocyte function by anthocyanins: possibility of preventing the 
metabolic syndrome. J Sci Food Agric. 2008; 56(3):642-46. 2 Wei X, Wang D, Yang Y, Xia M, 
Li D, Li G, et al. Cyanidin-3-O-β-glucoside improves obesity and triglyceride metabolism in 
KK-Ay mice by regulating lipoprotein lipase activity. J Sci Food Agric. 2011; 91(6):1006-13. 3 
Titta L, Trinei M, Stendardo M, Berniakovich I, Petroni K, Tonelli C, et al. Blood orange juice 
inhibits fat accumulation in mice. Int J Obes (Lond). 2010; 34(3):578-88. 
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Umana, Napoli, 12th-13th October, 2011. 
 
Effect of wild blueberries bioactive compounds on immunomodulation: preliminary in 
vitro study  
 
D. Fracassetti*1, S. Guglielmetti1, C. Del Bo’1, V. Taverniti1, P. Riso1, C. Gardana1, D. Klimis-
Zacas2 and M. Porrini1 
 
1Dipartimento di Scienze e Tecnologie Alimentari e Microbiologiche, Università di Milano 
2Department of Food Sciences and Human Nutrition, University of Maine 
 
Wild blueberries (WB) are one of the fruits having the highest antioxidant potential due to their 
polyphenol content, particularly anthocyanins. These compounds may be beneficial for human 
health because of their antioxidant, anti-inflammatory and immunomodulatory potential.   
This study aims to understand the effect of WB (Vaccinium angustifolium) components, such as 
anthocyanins and phenols on immunomodulation, in an inflammatory state model through a 
human intestinal Caco-2 cell line.  
A reporter gene system was prepared by transfecting Caco-2 cells with a vector where the 
reporter gene luciferase is under the control of an ELAM gene promoter and five NF-κB 
repeated transcription factor binding sites. Caco-2 transfected cells were stimulated with 
interleukin (IL)-1β and supplemented with different concentrations of WB extracts. The 
immunomodulatory activity of the samples under study was monitored in real time by 
quantification of bioluminescence with a luminometer. The WB fractions were separated by a 
polymeric SPE cartridge. Three different fractions were obtained: soluble fraction (eluted with 
0.1% HCl), phenolic fraction (eluted with 100% ethyl acetate) and anthocyanin fraction (eluted 
with 0.1% acidified methanol), which were further characterized.  
Results suggest that anthocyanins can attenuate Caco-2 cell inflammatory state. In fact, lower 
bioluminescence emission (i.e. inhibition of NF-κB activation) was observed as a consequence 
of anthocyanins addition to the system (5 mg/L, 25 mg/L and 50 mg/L), with a 50.2 % reduction 
at the highest concentration tested as compared to the control. On the contrary, the phenolic 
fraction did not show a dose-response effect (2.5 mg/L, 12 mg/L and 24 mg/L) and a trend 
towards increased inflammation was observed following the addition to Caco-2 cells of 
increasing amounts of the soluble fraction (organic acids: 1.1 mg/L and 2.2 mg/L; sugars: 69 
mg/L and 138 mg/L). On the whole, these data suggest a positive role of anthocyanins from WB 
on immunomodulation. 
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 “Nutrizione e Rischio Cardiovascolare” Annual Meeting Società Italiana di Nutrizione 
Umana, Napoli, 12th-13th October, 2011. 
 
Effect of wild blueberry (Vaccinium angustifolium) consumption on markers of oxidative 
stress and endothelial function in subjects with risk factors for cardiovascular disease  
 
C. Del Bo’,1 P. Riso1, D. Klimis-Zacas2, D. Martini1, J. Campolo3, S. Vendrame1,2, P. Moller4, S. 
Loft4, R. De Maria3 and M. Porrini1 
 
1Università degli Studi di Milano, Dipartimento di Scienze e Tecnologie Alimentari e 
Microbiologiche, Sezione Nutrizione, Milan, Italy. 
2Department of Food Science and Human Nutrition, University of Maine, Orono, USA. 
3Istituto di Fisiologia Clinica CNR, Dipartimento Cardiovascolare, Ospedale Niguarda Cà 
Grande, Milan, Italy. 
4Department of Public Health, Section of Environmental Health, University of Copenhagen, 
Denmark 
 
 
Background: Wild blueberries (WB) (Vaccinium angustifolium) are rich sources of polyphenols 
such as anthocyanins (ACNs) capable of counteracting oxidative stress,  influencing vasomotor 
tone and modulating gene expression associated with disease processes such as cardiovascular 
disease (CVD).   
Objective: The objective of the study was to investigate the effect of consumption of a WB 
product on lipid profiles, markers of oxidative stress (endogenous and oxidatively-induced DNA 
damage in mononuclear cells), soluble vascular adhesion molecule 1 (s-VCAM-1) and nitric 
oxide concentration and endothelium mediated changes in peripheral arterial tone in subjects 
with at least one risk factor for CVD.  
Methods: Twenty male volunteers were recruited and randomized in a cross-over design. 
Subjects received a WB drink (25 g of lyophilised WB powder corresponding to 148 g of raw 
fruits) providing 375 mg of ACNs or a placebo drink (without ACNs) for 6 weeks each. A six 
week wash-out period was scheduled. At the beginning and at the end of each treatment, blood 
samples were collected. Serum lipid and cholesterol profiles were measured by validated 
laboratory methods. The resistance to H2O2-induced DNA damage and endogenously oxidized 
DNA bases (formamidopyrimidine DNA glycosilase (FPG) sensitive sites) were evaluated in 
blood mononuclear cells by the comet assay. Peripheral arterial function was assessed by using 
finger plethysmography (Endo-PAT2000) while plasma nitric oxide and s-VCAM-1 analysis 
was performed by commercial kits. All variables were examined by a two way ANOVA for 
repeated measures.     
Results and Conclusion: Six weeks of WB drink significantly reduced the levels of H2O2-
induced DNA damage (from 45.8  7.9% to 37.2  9.1%, p0.01) and the levels of 
endogenously oxidized DNA bases (from 12.5  5.6% vs 9.6  3.5%, p0.01), while no effect 
was found after PL drink. No significant difference was observed in the total group for the 
peripheral arterial tone even though more than half of the subjects had an improvement, 
following the intervention with the WB drink. No statistically significant difference was also 
observed for lipid profile, nitric oxide and s-VCAM-1 concentrations. Considering the high 
inter-individual variation observed in endothelial function response, further studies may be 
necessary to demonstrate an effect. 
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11th European Nutrition Conference, Madrid, 26th- 29th October, 2011. 
 
Effect of a single blueberry portion on oxidative oxidative stress and endothelial function: 
a pilot study 
 
Cristian Del Bo’1, Patrizia Riso1, Jonica Campolo2, Renata De Maria2, Dorothy Klimis-Zacas3 
and Marisa Porrini1 
 
1Università degli Studi di Milano, Dipartimento di Scienze e Tecnologie Alimentari e 
Microbiologiche, Sezione Nutrizione, Milan, Italy. 2CNR Clinical Physiology Institute, 
Ospedale Niguarda Ca' Granda, Milan, Italy. 3Department of Food Science and Human 
Nutrition, University of Maine, Orono, USA. 
 
INTRODUCTION: Blueberries (Vaccinium corymbosum) are important sources of dietary 
bioactive compounds such as anthocyanins (ACNs) that could protect the integrity of DNA from 
reactive species, reduce the inflammatory state and improve endothelial function.  
OBJECTIVE: The objective of the study was to investigate the effect of one portion (300g) of 
blueberry (providing about 300mg ACNs) on markers of oxidative stress (endogenous and 
oxidatively induced lymphocyte DNA damage) and endothelial function/action (nitric oxide and 
endothelium-mediated changes in peripheral arterial tone).  
METHOD/DESIGN: Ten healthy male subjects were randomized in a cross-over design and 
received one portion of fresh blueberries ground by blender or placebo (purple jelly). The 
products were consumed early in the morning and blood was collected before consumption and 
at different times (1h, 2h and 24h). The resistance to H2O2-induced oxidative damage and 
endogenous DNA damage (formamidopyrimidine DNA glycosilase (FPG) sensitive sites) were 
evaluated in peripheral blood mononuclear cells by means of the comet assay. Peripheral arterial 
function was assessed using a new non-invasive plethysmographic method (Endo-PAT 2000), 
while plasma nitric oxide analysis was performed by commercial kits. All variables were 
examined by a two-way ANOVA for repeated measures design. 
RESULTS: The consumption of one portion of blueberry significantly reduced (p<0.01) the 
levels of H2O2-induced DNA damage (-18%) after 1h of intake with respect to that obtained 
following the placebo. No significant differences were observed for endogenous DNA damage, 
nitric oxide and peripheral arterial function following blueberry intake.  
CONCLUSIONS: This pilot study showed that one portion of blueberry may improve the 
resistance against H2O2-induced DNA damage. Further analysis, on a larger group of subjects, 
could be useful to clarify the effect of blueberry consumption on the modulation of endothelial 
function/action.      
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Effect of acute cigarette smoking on blood pressure and peripheral endothelial function in 
young healthy male smokers: preliminary data.  
 
Cristian Del Bo’1, Daniela Fracassetti1, Jonica Campolo2, Patrizia Riso1, Dorothy Klimis-Zacas3 
and Marisa Porrini1 
 
1Università degli Studi di Milano, Dipartimento di Scienze e Tecnologie Alimentari e 
Microbiologiche, Sezione Nutrizione, Milano, Italy; 2Istituto di Fisiologia Clinica CNR, 
Dipartimento Cardiovascolare, Ospedale Niguarda Cà Grande, Milan, Italy; 3Department of 
Food Science and Human Nutrition, University of Maine, Orono, Maine, USA.  
 
Aim: Smoking is one of the major risk factors for atherosclerosis associated with premature 
coronary and artery diseases. Endothelial dysfunction is an early event in atherosclerosis, and 
seems mainly related to the decreased production or availability of nitric oxide in smokers. The 
objective of the study is to investigate the effect of a single cigarette on blood pressure and 
peripheral arterial function in young moderate smokers (approximately 15 cigarettes/day).   
Methods: The study includes young, male, healthy volunteers recruited from the student 
population of the University of Milan. Sixty subjects were screened to check their eligibility 
taking into account smoking, physical activity, alcohol consumption, dietary habits, and 
endothelial function (PAT score  1.67). Blood pressure, heart rate and peripheral arterial 
function (determined through finger plethysmography; Endo-PAT2000), were assessed before 
and after smoking or non-smoking a single cigarette.  
Results: Preliminary results on 12 subjects showed that smoking increased systolic (from 
111.3±7.20 mmHg to 128.6±6.53 mmHg, p0.001) and diastolic pressure (from 71.4±7.9 mmHg 
to 82.0±6.5 mmHg p0.001), heart rate (from 56.9±10.0 beats/min to 71.8±16.5 beats/min; 
p=0.001) and reduced peripheral arterial function (from 2.16±0.30 PAT score to 1.87±0.30 PAT 
score; p=0.039). No significant difference was observed without smoking.   
Conclusions: From these preliminary data, smoking a single cigarette seems to increase blood 
pressure and heart rate, and reduce peripheral arterial function in young healthy male smokers. 
Since anthocyanin-rich foods have been suggested to modulate endothelial function, their role in 
counteracting smoke related effects is under evaluation. 
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Vaccinium 2012 – 10th International Symposium on Vaccinium and other superfruits - 
Maastricht, 17th-22th June, 2012. 
 
Minimally-processed frozen purées from Vaccinium corymbosum L.: Influence of berry 
blanching on the phenolic profile 
 
Brambilla A;1 Del Bo', C;2 Rizzolo, A.1 
 
1CRA-IAA, Agricultural Research Council, Food Technology Research Unit, Milan, Italy. 
2Università degli Studi di Milano, DeFENS - Department of Food, Environmental and 
Nutritional Sciences, Division of Human Nutrition, Milan, Italy. 
 
Pigmented fruit, especially blueberries, are a natural source of phenolic phytochemicals which 
could be exploited through proper technologies, limiting by -product loss and detrimental impact 
of processing on fruit bioactive compounds. Frozen blueberry purée could be a versatile product, 
processed without pomace loss and potentially rich in all the bioactive compounds which are 
characteristic of the whole berry. The aim of this research was to study the influence of the mild 
thermal pretreatment of steam blanching on the phenolic profile of blueberry fruits and frozen 
purée after thawing (24 h at 4°C). Purées were prepared by processing IQF blueberries cv 
Brigitta either after thawing at 20°C for 3h (NB), or after steam-blanching for 3min and tap 
water -cooling in a pilot steam blanching tunnel (BL). Then 300g aliquots of purées were packed 
in 400mL plastic vessels, sealed under partial vacuum using a 25 μm thick polypropylene film 
and frozen and stored at −20°C. Chlorogenic acid and anthocyanins were quantified in berries 
and purées samples after extraction in formic acid-water (5:95 v/v) and in formic acid -water-
acetone (5:35:60 v/v/v) and gradient -RP-HPLC and diode array detection. Fourteen anthocyanin 
compounds were identified; in NB berries delphinidin and malvidin glycosides made up more 
than 70% of total anthocyanins. Steam blanching did not affect chlorogenic acid berry 
concentration, as well as delphinidin-3-galactoside and delphinidin-3-arabinoside contents, 
whereas did it decrease the berry contents of malvidin-3-galactoside, malvidin-3-glucoside and 
malvidin-3-arabinoside. The NB purées were characterized by lower amounts of chlorogenic 
acid and delphinidin-3-galactoside and higher amounts of malvidin glycosides, compared to BL 
ones. However, in BL berries there were no quantitative changes for chlorogenic acid and all the 
fourteen anthocyanin compounds at the end of processing (puréeing, freezing and thawing). In 
contrast, processing NB berries resulted in lower amounts of chlorogenic acid and anthocyanin 
compounds, except for malvidin-3-galactoside and malvidin-3-arabinoside, which did not 
change. Our results indicated that berry blanching acts on anthocyanins pattern in two ways: 
firstly by glucosides and malvidine glycosides thermal degradation in berries and, secondly, 
protecting delphinidin and petunidin from oxidative degradation during processing. 
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Oxidants and Antioxidants in Biology. Cell Signaling and Nutrient – Gene Interactions – 
Oxygen Club of California, Alba, 20th-23th June, 2012. 
 
Immunomodulatory potential of wild blueberries (Vaccinium angustifolium) in human 
intestinal epithelial Caco-2 cells: preliminary data 
 
Daniela Fracassetti1, Cristian Del Bo’1, Simone Guglielmetti1, Patrizia Riso1, Valentina 
Taverniti1, Dorothy Klimis-Zacas2 and Marisa Porrini1 
 
1Università degli Studi di Milano, Department of Food, Environmental and Nutritional Sciences, 
Milan, Italy; 2Department of Food Science and Human Nutrition, University of Maine, Orono, 
Maine, USA. 
 
Wild blueberries (WB) are a rich source of polyphenols, particularly anthocyanins, which may 
be beneficial for human health because of their antioxidant, antiinflammatory and 
immunomodulatory potential. This study aims to investigate the immunomodulatory potential of 
three WB fractions (anthocyanin, phenolic and soluble fraction) in an inflammatory state model, 
based on human intestinal Caco-2 cells. A reporter gene system was prepared by transfecting 
Caco-2 cells with the pNiFty-SEAP reporter- construct containing an engineered ELAM 
promoter with 5 NF-kB binding sites and an insect luciferase reporter gene. The transfected 
Caco-2 cells were stimulated with interleukin (IL)-1β to mimic an inflammatory state and then 
supplemented with 5 mg/L, 25 mg/L, 50 mg/L and 100 mg/L of the anthocyanin, phenolic and 
soluble fractions. Immunomodulatory activity for each fraction was monitored in real time by 
quantification of bioluminescence with a luminometer. The addition of anthocyanins at the 
concentration of 50 and 100 mg/L reduced the bioluminescence, and therefore NF-κB activation, 
up to 70% and 85% (p≤0.05), respectively. No dose-response was observed after supplementing 
Caco-2 cells with both phenolic and soluble fractions. These data suggest that only the 
anthocyanin fraction can modulate Caco-2 cells inflammatory state in the experimental 
conditions adopted. Future experiments will address supplementation of Caco-2 cells with 
anthocyanin standards to elucidate the compound(s) responsible for the observed 
immunomodulatory effect.  
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Oxidants and Antioxidants in Biology. Cell Signaling and Nutrient – Gene Interactions – 
Oxygen Club of California, Alba, 20th-23th June, 2012. 
 
The intake of a single blueberry (Vaccinium corymbosum L.) portion affects blood pressure 
and peripheral arterial function in smokers: preliminary data. 
 
Cristian Del Bo’1, Daniela Fracassetti1, Patrizia Riso1, Jonica Campolo2, Dorothy Klimis-Zacas3 
and Marisa Porrini1 
 
1Università degli Studi di Milano, Department of Food, Environmental and Nutritional Sciences, 
Milan, Italy, 2Istituto di Fisiologia Clinica CNR, Dipartimento Cardiovascolare, Ospedale 
Niguarda Cà Grande, Milan, Italy, 3Department of Food Science and Human Nutrition, 
University of Maine, Orono, Maine, USA. 
 
Cigarette smoking is one of the primary risk factors for the development of endothelial 
dysfunction, an early event in atherosclerosis, due to an increase of oxidative stress and the 
impairment of nitric oxide production. Anthocyanin-rich foods, have been suggested to offer 
protection against oxidative stress and modulate endothelial function. This study aims to 
investigate whether a single portion of blueberry improves endothelial dysfunction induced by 
acute cigarette smoking. Fifteen healthy smokers were recruited for a crossover study. Three 
types of conditions were assessed: 1-blueberry treatment (300g of blueberry) + smoking (1 
cigarette); 2-control treatment (300mL of water with 27g of sugars; the same amount present in 
blueberry) + smoking (1 cigarette); 3- smoking only (1 cigarette). Peripheral arterial function 
(determined through Endo-PAT2000) and blood pressure were evaluated. Preliminary results on 
8 subjects showed that acute smoking caused a reduction in peripheral arterial function (from 
2.22 ± 0.3 to 1.62 ± 0.4 RHI, p<0.01) and an increase in systolic blood pressure (from 112.3 ± 
7.9 to 129.7 ± 6.7 mmHg, p0.001) and diastolic blood pressure (from 71.2 ± 7.8 mmHg to 81.3 
± 6.0 mmHg, p≤0.01) with respect to baseline. The consumption of blueberry, but not of the 
control drink, seems to counteract the observed effects of smoking by reducing the impairment 
of peripheral arterial function (-4.0±10.3% vs -26.2±17.1% RHI, p<0.01) and the increase of 
systolic blood pressure (+9.1±7.1% vs +16.6±4.9% mmHg, p<0.05).  
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5th International Symposium on Nutrition, Oxygen Biology and Medicine, Paris, 5th-7th June, 
2013. 
A single blueberry (Vaccinium corymbosum L.) portion counteracts peripheral arterial 
dysfunction, induced by acute cigarette smoking, in healthy volunteers 
 
Del Bo' Cristian1, Riso Patrizia1, Campolo Jonica2, Fracassetti Daniela1, Klimis-Zacas Dorothy3 
and Porrini Marisa1 
 
1Università degli Studi di Milano, Department of Food, Environmental and Nutritional Sciences, 
Milan, Italy, 2Istituto di Fisiologia Clinica CNR, Dipartimento Cardiovascolare, Ospedale 
Niguarda Cà Grande, Milan, Italy, 3Department of Food Science and Human Nutrition, 
University of Maine, Orono, Maine, USA. 
 
Cigarette smoking is one of the primary risk factors for the development of endothelial 
dysfunction, an early event in atherosclerosis, due to an increase of oxidative stress and the 
impairment of nitric oxide production. Anthocyanin-rich foods, have been suggested to offer 
protection against oxidative stress and modulate endothelial function. This study aims to 
investigate whether a single portion of blueberries counteracts endothelial dysfunction induced 
by acute cigarette smoking. Sixteen healthy smokers were recruited for a crossover study. Three 
types of conditions were assessed: 1- S: smoking only (1 cigarette); 2- BS: blueberry treatment 
(300g of whole blueberries) + smoking (1 cigarette); 3- CS: control treatment (300mL of a sugar 
drink; the same amount present in blueberry) + smoking (1 cigarette). Each condition was 
separated by one week of wash-out period. Blood pressure, heart rate and peripheral arterial 
function (reactive hyperemia index, RHI) was measured 20 min after smoking by a finger 
plethysmography named Endo-PAT2000.  
Data were analyzed by one way ANOVA with time (before and after smoking) or treatment (S 
vs BS vs CS) as dependent factors. Post-hoc analysis of differences between treatments was 
assessed by the Least Significant Difference (LSD) test. A p-value ≤ 0.05 was considered 
significant. Data are expressed as mean values and standard deviation (SD) or standard error of 
the mean (SEM). 
Acute smoking impaired peripheral arterial function (from 2.23 ± 0.28 to 1.59 ± 0.27 RHI, 
p=0.0001) and, increased systolic blood pressure (from 116.0 ± 6.9 to 131.7 ± 6.2 mmHg, 
p=0.0001), diastolic blood pressure (from 76.1 ± 8.2 to 83.5 ± 7.7 mmHg, p=0.005) and heart 
rate (from 63.3 ± 11.4 to 70.7 ± 11.8 beat/min, p=0.047) at 5 min from smoking. This effect was 
transitional and no effect was observed after 30 min.  
The consumption of blueberry, but not of the sugar drink, reduced the impairment of RHI (-
4.4±0.8% BS vs -22.0±1.1% S, p<0.01) and the increase of systolic blood pressure (+8.4±0.02% 
BS vs +13.1±0.02% S mmHg, p<0.05). The effect on RHI and systolic blood pressure was 
significantly different with respect to CS treatment (BS vs CS, p= 0.01), while no effect was 
observed between S vs CS treatment for both the variables. Diastolic blood pressure and heart 
rate were unaffected following BS and CS treatments. 
In conclusion, the consumption of a portion of whole blueberries counteracted peripheral arterial 
dysfunction induced by acute cigarette smoking. These results support the role of ACN-rich food 
in the modulation of endothelial function, suggesting the importance to consume fruit regularly.  
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10th International Comet Assay Workshop, Porto, Portugal, 18th – 20th September, 2013. 
DNA damage evaluated through comet assay in fresh versus cryopreserved peripheral 
blood mononuclear cell samples from a dietary intervention study.   
Cristian Del Bo', Marisa Porrini and Patrizia Riso 
Department of Food, Environmental and Nutritional Sciences (DeFENS), Università degli Studi 
di Milano, via Celoria 2, 20133 Milan, Italy. 
Endogenous and oxidatively induced DNA damage evaluated through the comet assay in 
peripheral blood mononuclear cells (PBMCs) is widely utilized as biomarker of oxidative stress 
in numerous dietary intervention studies.1-2 The analysis can be performed on fresh PBMCs or 
for logistic reasons on cells adequately cryopreserved until analysis. In this regard, information 
on how cryopreservation can affect results on DNA damage is often not considered. This is 
particularly important in studies where samples are analyzed before and after different 
treatments as in dietary intervention studies with repeated measures design.  
To this aim we planned to compare results obtained on formamidopyrimidine DNA glycosylase 
(FPG)-sensitive sites and hydrogen peroxide-induced DNA strand breaks in cryopreserved 
human PBMCs with respect to results obtained in fresh samples. For the comparison, we used 
the samples obtained from a dietary intervention study in which 20 male volunteers received, for 
a period of 6 weeks, a wild blueberry or a placebo drink.3 In particular fresh PBMCs were used 
to analyze FPG-sensitive sites and H2O2-induced strand breaks; contemporary aliquots of cells 
were stored for 12 months at -80°C in an appropriate medium. Results presented are relative to a 
subgroup of 9 subjects. The intake of the wild blueberry drink, but not placebo drink, 
significantly reduced FPG-sensitive sites (from 16.4  5.3% to 11.0  2.8%, p=0.02) and H2O2-
induced strand breaks (from 48.8  11.8% to 40.0  10.1%, p=0.03) as evaluated in fresh 
PBMCs. Cryopreservation maintained the trend in the reduction of FPG-sensitive site levels 
following wild blueberry treatment (from 18.8  2.9% to 15.9  4.0%, p=0.04). On the contrary, 
a greater resistance against H2O2-induced DNA damage have been observed in cryopreserved 
samples, thus the protective effect of wild blueberry treatment demonstrated in the fresh samples 
was not evidenced in stored samples (from 27.1  3.1% to 26.1  2.5%, p=0.48).  
In conclusion, the levels of oxidized bases, measured as FPG-sensitive sites, seem comparable in 
fresh and frozen PBMCs even after 1 year storage. On the contrary, cell protection against 
oxidative insult seems consistently different between fresh and frozen cells. The analysis of 
samples from the whole group of subjects will enable to demonstrate the effect of storage on 
both endpoints of DNA damage. 
 
References 
1Hoelzl C, et al. Mutat Res. 2009;681:68-79. 2Freese R. Nutr Cancer. 2006;54:143-7. 3Riso P, et 
al. Eur J Nutr. 2013;52:949-61.  
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“Comprendere e Applicare i LARN” Annual Meeting Società Italiana di Nutrizione Umana, 
Firenze, 21th-22th October, 2013. 
 
Anthocyanins from Wild Blueberry (Vaccinium aungustifolium) exert in vitro 
immunomodulatory effect 
 
C. Lanti1, V. Taverniti2, D. Fracassetti1, C. Del Bo’ 1, P. Riso1, M. Porrini1, D. Klimis-Zacas3 
and S. Guglielmetti2 
 
Department of Food, Environmental and Nutritional Sciences (DeFENS), 1Division of Human 
Nutrition, 2Division of Food Microbiology and Bioprocessing, Università degli Studi di Milano, 
20133 Milano, Italy. 3Department of Food Science and Human Nutrition, University of Maine, 
Orono, ME 04469, USA 
 
Background: Research on berries is increasing considering their significant content in bioactive 
compounds such as polyphenols, especially anthocyanins (ACNs). These compounds have been 
demonstrated to possess antioxidant, anti-inflammatory and immunomodulatory effects.  
Aim: The present study aimed to investigate the effect of three different fractions (ACN, 
phenolic and water soluble fractions) obtained from a wild blueberry (WB) powder on immune 
responses in intestinal epithelial Caco-2 cells and U937 human  macrophages, in presence of  
pro-inflammatory molecules. 
Methods: Caco-2 cells were transfected with the plasmid pNiFty2-Luc containing a promoter 
with five NF-B-binding sites followed by the firefly luciferase reporter gene luc. The effect of 
WB fractions was evaluated in the presence of IL-1, a pro-inflammatory cytokine. Caco-2 cells 
were supplemented with 25, 50 and 100g/mL of the water soluble fraction and 5, 25, 50 and 
100g/mL of ACN and of the phenolic fractions. Immunomodulatory activity for each fraction 
was monitored in real time by quantification of bioluminescence with a luminometer. Human 
U937 macrophages were supplemented with three different concentration of the ACN fraction 
(1, 10 and 25 g/mL) in presence of LPS to evaluate the modulation of the pro-inflammatory 
cytokine TNF- expression by means of q-PCR. 
Results: The ACN fraction reduced the activation of NF-κB induced by IL-1 in Caco-2 cells in 
a dose-dependent manner. Specifically, the concentration of 50 and 100g/mL decreased the 
bioluminescence by 68.9% and 85.2% respectively (p≤0.05). Neither the phenolic nor the water 
soluble fractions showed a modulation in the activation of NF-κB. In U937 macrophages only 
the highest concentration of ACN fraction had a significant effect in reducing the LPS-
dependent induction of TNF-. 
Conclusion: Only the ACN fraction displayed anti-inflammatory properties by decreasing the 
activation of NF-κB in presence of IL-1 in Caco-2 cells and exerting a dampening effect 
towards LPS-induced TNF-α production in immune cells. Further experiments will be focused 
on the identification of single compounds and metabolites possibly involved in the anti-
inflammatory effect (s) of WB. 
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“Comprendere e Applicare i LARN” Annual Meeting Società Italiana di Nutrizione Umana, 
Firenze, 21th-22th October, 2013. 
 
The acute effect of cigarette smoking on inflammatory markers in young moderate 
smokers: a potential model for studying the protective properties of food bioactives. 
 
C. Del Bo’1, M. Porrini1, J. Campolo2, D. Klimis-Zacas3 and P. Riso1 
 
1Department of Food, Environmental and Nutritional Sciences (DeFENS), Division of Human 
Nutrition, Università degli Studi di Milano, Milano, Italy.  
2CNR Institute of Clinical Physiology, CardioThoracic and Vascular Department, Niguarda Ca' 
Granda Hospital, Milan, Italy.  
3Department of Food Science and Human Nutrition, University of Maine, Orono, ME, USA. 
 
Background: We recently documented that acute cigarette smoking is able to impair peripheral 
arterial function (reactive hyperemia index, RHI) in young healthy smokers. The intake of a 
single portion of blueberry counteracts this deleterious effect. The causes of this transient 
endothelial dysfunction may be related to an increase of oxidative stress and inflammation.      
Aim: This study aims to investigate whether the temporary impairment of vascular function 
evaluated through the acute experimental design may be correlated with the modulation of some 
markers of endothelial function and inflammation such as intercellular adhesion molecule-1 
(ICAM-1), vascular cell adhesion molecule-1 (VCAM-1), vascular endothelial growth factor 
(VEGF) and interleukin-8 (IL-8).  
Methods: Sixteen young healthy volunteers participated in a crossover study. Three types of 
treatments were studied; 1) smoking (1 cigarette); 2) blueberry treatment (300 g of whole 
blueberries + smoking; 3) control treatment (300 mL of water and 27g of sugars; the same 
amount present in blueberry + smoking). Each condition was separated by a one week of wash-
out period. Cigarette was smoked 1 h 45 min after blueberry or control drink consumption. RHI 
was measured by Endo-PAT2000 at the baseline and 20 min after. Blood samples were collected 
at baseline and after 20 min, 1 h, 1.30 h, 2 h and 24 h from smoking. Markers of inflammation 
and endothelial function were measured in serum by Bio-plex Pro TM Array. 
Results: Blueberry consumption, but not the control drink, counteracted the impairment of RHI 
(-4.4±0.8% blueberry treatment vs -22.0±1.1% smoking treatment, p<0.01). Preliminary results 
on a subgroup of 6 subjects showed an apparent increase in serum circulating levels of VEGF, 
ICAM-1, VCAM-1, 20 min from cigarette smoking, while a decrease occurred for IL-8 levels.  
Conclusions: In conclusion, blueberry consumption reverses the peripheral arterial dysfunction 
following acute cigarette smoking. The selected biomarkers modulated after smoking suggest 
their direct or indirect involvement in the transient process of endothelial dysfunction. The 
feasibility of the repeated measurements of such markers in the short term and the role of 
blueberry in their modulation will be discussed.   
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